Idx,Case_id,Case_excluded,Batch,Plex,ReporterName,Aliquot_ID,Group,Discovery_study,Age,Sex,Histologic_Type,Histologic_grade,Tumor_size_cm,Height_at_time_of_surgery_cm,Weight_at_time_of_surgery_kg,BMI,Myometrial_invasion,Myometrial_invasion_present_specify,AJCC_tnm_cancer_staging_edition_used,Pathologic_staging_primary_tumor_pt,Pathologic_staging_regional_lymph_nodes_pn,Number_of_pelvic_lymph_nodes_examined,Tumor_stage_pathological,Race,CNV_ratio,CNV_status,POLE,MSIsensor_ratio,MSI_status,Genomic_subtype,Mutation_load,TP53,PTEN,CTNNB1,ARID1A,PIK3CA,xCell_Myeloid_dendritic_cell_activated,xCell_B_cell,xCell_T_cell_CD4+_memory,xCell_T_cell_CD4+_naive,xCell_T_cell_CD4+_(non-regulatory),xCell_T_cell_CD4+_central_memory,xCell_T_cell_CD4+_effector_memory,xCell_T_cell_CD8+_naive,xCell_T_cell_CD8+,xCell_T_cell_CD8+_central_memory,xCell_T_cell_CD8+_effector_memory,xCell_Class-switched_memory_B_cell,xCell_Common_lymphoid_progenitor,xCell_Common_myeloid_progenitor,xCell_Myeloid_dendritic_cell,xCell_Endothelial_cell,xCell_Eosinophil,xCell_Cancer_associated_fibroblast,xCell_Granulocyte-monocyte_progenitor,xCell_Hematopoietic_stem_cell,xCell_Macrophage,xCell_Macrophage_M1,xCell_Macrophage_M2,xCell_Mast_cell,xCell_B_cell_memory,xCell_Monocyte,xCell_B_cell_naive,xCell_Neutrophil,xCell_NK_cell,xCell_T_cell_NK,xCell_Plasmacytoid_dendritic_cell,xCell_B_cell_plasma,xCell_T_cell_gamma_delta,xCell_T_cell_CD4+_Th1,xCell_T_cell_CD4+_Th2,xCell_T_cell_regulatory_(Tregs),xCell_immune_score,xCell_stroma_score,xCell_microenvironment_score,Cibersort_B_cell_naive,Cibersort_B_cell_memory,Cibersort_B_cell_plasma,Cibersort_T_cell_CD8+,Cibersort_T_cell_CD4+_naive,Cibersort_T_cell_CD4+_memory_resting,Cibersort_T_cell_CD4+_memory_activated,Cibersort_T_cell_follicular_helper,Cibersort_T_cell_regulatory_(Tregs),Cibersort_T_cell_gamma_delta,Cibersort_NK_cell_resting,Cibersort_NK_cell_activated,Cibersort_Monocyte,Cibersort_Macrophage_M0,Cibersort_Macrophage_M1,Cibersort_Macrophage_M2,Cibersort_Myeloid_dendritic_cell_resting,Cibersort_Myeloid_dendritic_cell_activated,Cibersort_Mast_cell_activated,Cibersort_Mast_cell_resting,Cibersort_Eosinophil,Cibersort_Neutrophil,Mutation_signature_SBS1,Mutation_signature_SBS5,Mutation_signature_SBS6,Mutation_signature_SBS7a,Mutation_signature_SBS10a,Mutation_signature_SBS10b,Mutation_signature_SBS15,Mutation_signature_SBS20,Mutation_signature_SBS21,Mutation_signature_SBS42,Mutation_signature_SBS54,ABSOLUTE_tumor_purity,Diabetes,Metformin_treatment,Progeny_Androgen,Progeny_EGFR,Progeny_Estrogen,Progeny_Hypoxia,Progeny_JAK.STAT,Progeny_MAPK,Progeny_NFkB,Progeny_p53,Progeny_PI3K,Progeny_TGFb,Progeny_TNFa,Progeny_Trail,Progeny_VEGF,Progeny_WNT,Estimate_StromalScore,Estimate_ImmuneScore,Estimate_ESTIMATEScore,Peritoneal_ascitic_fluid,Tumor_necrosis,Margin_status,Ethnicity,Ethnicity_race_ancestry_identified,Participant_country,Tumor_site,Tumor_site_other,Tumor_focality,Number_of_pelvic_lymph_nodes_positive_for_tumor_by_ihc_staining_only,Number_of_pelvic_lymph_nodes_positive_for_tumor_by_he,Number_of_para-aortic_lymph_nodes_examined,Number_of_para-aortic_lymph_nodes_positive_for_tumor_by_ihc_staining_only,Number_of_para-aortic_lymph_nodes_positive_for_tumor_by_he,Number_of_other_lymph_nodes_examined,Number_of_other_lymph_nodes_positive_for_tumor_by_ihc_staining_only,Number_of_other_lymph_nodes_positive_for_tumor_by_he,Clinical_staging_distant_metastasis_cm,Residual_tumor,Ancillary_studies_estrogen_receptor,Ancillary_studies_progesterone_receptor,Ancillary_studies_mlh1,Ancillary_studies_msh2,Ancillary_studies_msh6,Ancillary_studies_pms2,Ancillary_studies_p53,Ancillary_studies_other_immunohistochemistry_performed,Ancillary_studies_mlh1_promoter_hypermethylation,Ancillary_studies_other_testing_performed,Donor_information_menopause_status,Donor_information_has_the_patient_ever_taken_menopausal_hormone_therapy,Donor_information_number_of_full_term_pregnancies,Ancillary_studies_other_immunohistochemistry_type_and_result,baseline_ancillary_studies_other_testing_type_and_result,History_of_cancer,Alcohol_consumption,Tobacco_smoking_history,Age_at_which_the_participant_started_smoking,Age_at_which_the_participant_stopped_smoking,On_the_days_participant_smoked_how_many_cigarettes_did_he_she_usually_smoke,Number_of_pack_years_smoked,Was_the_participant_exposed_to_secondhand_smoke,Personal_medical_history_history_source,medical_history_current_medications,Current_medications_history_source,Current_medications_medication_name_vitamins_supplements,Cancer_history_cancer_type,Cancer_history_history_source,Cancer_history_history_of_any_treatment,Cancer_history_medical_record_documentation_of_this_history_of_cancer_and_treatment,Procurement_blood_collection_minimum_required_blood_collected,Procurement_blood_collection_number_of_blood_tubes_collected,Follow-up_follow_up_period,Follow-up_is_this_patient_lost_to_follow-up,Follow-up_vital_status_at_date_of_last_contact,Follow-up_days_from_date_of_initial_pathologic_diagnosis_to_date_of_last_contact,Follow-up_adjuvant_post-operative_radiation_therapy,Follow-up_adjuvant_post-operative_pharmaceutical_therapy,Follow-up_adjuvant_post-operative_immunological_therapy,Follow-up_tumor_status_at_date_of_last_contact_or_death,Follow-up_has_the_patient_ever_taken_menopausal_hormone_therapy,Follow-up_has_the_patient_ever_taken_oral_contraceptives,Follow-up_has_the_patient_ever_taken_tamoxifen,Follow-up_hypertension,Follow-up_has_the_patient_ever_been_diagnosed_with_diabetes_by_a_physician,Follow-up_number_of_full_term_pregnancies,Follow-up_has_the_patient_had_colorectal_cancer,Follow-up_measure_of_success_of_outcome_at_the_completion_of_initial_first_course_treatment,Follow-up_measure_of_success_of_outcome_at_completion_of_this_follow-up_form,Follow-up_measure_of_success_of_outcome_at_date_of_last_contact_or_death,follow-up_new_tumor_after_initial_treatment,Follow-up_type_of_new_tumor,Follow-up_site_of_new_tumor,Follow-up_days_from_date_of_initial_pathologic_diagnosis_to_date_of_new_tumor_after_initial_treatment,Follow-up_additional_surgery_for_new_tumor,Follow-up_additional_treatment_radiation_therapy_for_new_tumor,Follow-up_additional_treatment_pharmaceutical_therapy_for_new_tumor,Follow-up_additional_treatment_immuno_for_new_tumor,Follow-up_days_from_date_of_collection_to_date_of_last_contact,Follow-up_cause_of_death,Follow-up_days_from_date_of_initial_pathologic_diagnosis_to_date_of_death,Follow-up_days_from_date_of_initial_pathologic_diagnosis_to_date_of_additional_surgery_for_new_tumor,Follow-up_procedure_type_of_new_tumor,Follow-up_residual_tumor_after_surgery_for_new_tumor
C3L-00086,C3L-00086,No,b4,16,128N,CPT0092460003,Tumor,No,56,Female,Endometrioid carcinoma,G1 Well differentiated,4,165,80,29.38,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,0,CNV_L,No,10.06,MSI-H,MSI-H,415,WT,Mutated,WT,Mutated,WT,0.164143479,1.70E-02,1.22E-02,0,2.45E-19,2.16E-18,5.14E-02,9.90E-03,2.97E-02,7.16E-02,1.61E-18,1.41E-02,1.55E-02,0,1.87E-02,0,1.91E-03,0,3.60E-19,1.40E-02,1.69E-02,1.59E-02,9.57E-03,1.20E-03,1.00E-19,0,6.63E-03,0,0,5.20E-03,6.04E-02,7.04E-03,0,5.56E-02,0.17289414,0,5.69E-02,0,5.69E-02,7.44E-03,0,6.32E-02,0.201396514,0,6.89E-02,6.41E-02,0.141278353,0,0,0,3.86E-02,0,3.80E-02,7.33E-02,0.218959886,4.88E-02,0,0,3.52E-02,8.61E-04,0,18,64,151,0,0,0,0,53,0,0,0,0.44,Yes,Yes,0.210514771,0.845332306,-7.00E-02,0.631011539,-0.659031004,1.210711348,-0.330955873,8.12E-02,-0.492262958,-0.145793715,-0.40528041,0.806494585,9.75E-02,0.428632856,4018.51975,4826.094192,8844.613942,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,1,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,Unknown,NA,4,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Metformin|Lisinopril|Amlodipine|Ibuprofen|Omeprazole,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months|60 Months,No|No|No|No|No,Living|Living|Living|Living|Deceased,330|701|1046|1436|1578,No|No|No|No|Yes,No|No|No|No|Yes,No|No|No|No|No,Tumor Free|With Tumor|With Tumor|With Tumor|With Tumor,Unknown|Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes|Yes,1|1|1|1|1,No|No|No|No|No,Not Applicable|Not Applicable|Not Applicable|Not Applicable|Not Applicable,Complete Remission|Unknown|Unknown|Persistent Disease|n/a,n/a|n/a|n/a|n/a|Persistent Disease,No|Yes|Yes|Yes|Yes,n/a|New Primary Tumor|New Primary Tumor|New Primary Tumor|New Primary Tumor,n/a|Other: Breast mets to liver and bone|Other: Breast mets to liver and bone|Other: Breast with mets to bone|Other: Breast with metastatic disease to bone,n/a|580.0|580.0|580.0|580.0,n/a|No|No|No|No,n/a|Yes|Yes|Yes|Yes,n/a|Yes|Yes|Yes|Yes,n/a|No|No|No|No,330.0|701.0|1046.0|1436.0|n/a,n/a|n/a|n/a|n/a|Breast Carcinoma,n/a|n/a|n/a|n/a|1578.0,n/a|n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a|n/a
C3L-00898,C3L-00898,No,b4,14,128C,CPT0172200008,Tumor,No,54,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.6,152,88,37.88,Present,=50% myometrial invasion,Eighth Edition (2017),3b,0,5,IIIB,White,NA,NA,No,0,MSS,NA,42,WT,Mutated,Mutated,Mutated,Mutated,9.09E-02,0,4.85E-19,1.17E-17,0,7.74E-19,0,0,3.59E-03,1.15E-02,1.38E-18,0,0,0,2.04E-03,1.20E-02,0,0,0,4.06E-02,0,5.94E-03,5.27E-03,0,0,5.55E-18,2.08E-03,0,0,1.10E-17,3.96E-02,7.35E-03,0,0,3.68E-03,2.89E-02,3.75E-03,6.01E-03,9.76E-03,4.35E-02,0,4.62E-02,5.96E-02,0,0.276882335,0,0.143517668,0,0,0,7.72E-03,0.115580977,5.65E-02,8.74E-03,9.06E-02,0,4.94E-02,0,4.81E-02,4.21E-02,1.15E-02,19,21,0,0,0,0,0,0,0,0,0,NA,Yes,Yes,2.697956942,0.786356057,1.40E-02,-0.379503483,0.473007978,1.073747775,0.829383089,1.962050762,1.278534955,0.68325692,0.996951118,0.422786724,-0.45798663,1.994994225,4477.315071,5016.932324,9494.247395,Not Examined,Not identified,Margin(s) involved by invasive carcinoma,Hispanic or Latino,Mexican,Other: Mexico,Other,Endometrium,Multifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Metformin|Ferrous Sulfate|Flexeril|Provera,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,396|746|982|1600,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,No|No|No|No,Yes|Yes|Yes|Yes,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,396.0|746.0|982.0|1600.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-00943,C3L-00943,No,b4,15,130C,CPT0086090003,Tumor,No,63,Female,Endometrioid carcinoma,G1 Well differentiated,3,163,91,34.33,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,White,0,CNV_L,No,0.02,MSS,CNV_L,36,WT,Mutated,Mutated,WT,WT,4.55E-02,3.88E-19,6.28E-04,1.01E-19,0,0,2.97E-04,3.35E-03,1.22E-02,2.05E-02,0,3.06E-18,2.74E-03,1.26E-03,4.46E-03,5.46E-02,5.71E-06,0.130546505,0,7.51E-02,4.50E-03,7.24E-03,2.55E-03,3.30E-03,0,2.52E-19,0,6.14E-05,0,0,3.53E-02,4.31E-03,0,1.51E-02,6.47E-02,1.28E-02,1.63E-02,9.26E-02,0.108946436,3.55E-03,0,0.109157157,3.24E-02,0,0.281253761,2.94E-02,6.24E-03,0,0,0,3.24E-02,6.70E-03,6.83E-02,2.94E-02,0.182317284,2.54E-02,2.34E-02,0.119092507,1.68E-02,0,3.41E-02,8,25,0,0,0,0,0,0,0,0,0,0.28,NA,NA,0.551969114,0.585823101,0.996080842,-0.406584048,9.15E-03,0.721380215,0.380035549,0.410550463,0.177851742,1.717087546,0.586458653,0.121059206,-1.662404381,1.319793474,5918.231281,4417.462317,10335.6936,Negative for malignancy/normal/benign,Not identified,Cannot be assessed,Not reported,Medical record does not state.,Other: Medical record does not state.,Other,Lesion occupies both anterior and posterior aspects,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,1,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Levothyroxine (TIROSINT|cloNIDine HCl (CATAPRES|hydrALAZINE (APRESOLINE,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,291|747|1093,No|No|No,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Never|Never|Never,Yes|Yes|Yes,No|No|No,1|1|1,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,237.0|693.0|1039.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01064,C3L-01064,No,b3,9,129N,CPT0113430004,Tumor,No,54,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.3,160,92,35.74,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,0,Stage I,White,0,CNV_L,No,0,MSS,CNV_L,71,WT,Mutated,Mutated,Mutated,Mutated,8.01E-02,1.50E-03,1.81E-20,0,9.80E-19,0,2.63E-02,2.27E-19,0,4.92E-03,1.19E-19,0,5.51E-03,0,3.91E-03,7.34E-03,0,3.56E-02,6.98E-19,2.07E-02,0,1.94E-03,0,1.19E-03,1.17E-18,0,1.17E-03,0,3.79E-18,2.40E-02,1.86E-02,3.53E-03,0,8.26E-02,2.97E-02,2.34E-03,4.40E-03,2.23E-02,2.67E-02,1.79E-02,0,0.101475896,5.55E-02,0,0.154581642,0,6.93E-02,4.11E-02,0,0,8.48E-02,4.02E-03,0.167085811,1.93E-02,0.144941088,1.04E-03,1.05E-02,0,6.01E-02,2.74E-02,4.09E-02,25,37,0,0,0,0,0,0,0,0,0,0.56,NA,NA,0.422129433,1.432963934,1.287031128,-0.148923826,-7.13E-02,0.298775896,1.103549818,0.560907512,-0.418490806,0.12103621,1.091016887,-0.18203253,-0.326817001,0.685441273,3950.256141,4090.849852,8041.105993,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and posterior endometrium,Unifocal,0,0,0,0,0,1,0,0,Staging Incomplete,R0:  No residual tumor,Positive : 90 %,Positive : 65 %,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Normal,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Current Therapy,2,NA,NA,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,24,NA,20,30,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Benadryl|Estroven|Melatonin,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,524|797|1133|1518,Yes|Yes|Yes|No,Yes|Yes|Yes|Yes,No|No|No|No,With Tumor|Tumor Free|With Tumor|With Tumor,Former Therapy|Former Therapy|Current Therapy|Former Therapy,Former Therapy|Former Therapy|Former Therapy|Former Therapy,Never|Never|Never|Never,No|No|No|No,No|No|No|No,2|2|2|3,No|No|No|No,Persistent Disease|Persistent Disease|Persistent Disease|Persistent Disease,Persistent Disease|Persistent Disease|Persistent Disease|Persistent Disease,n/a|n/a|n/a|n/a,Yes|Yes|Yes|Yes,Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence,Other: omentum and vaginal cuff|Other: Omentum|Lung|Other: Recurrent to endometrium,341.0|345.0|833.0|871.0,No|No|No|No,No|Yes|No|No,Yes|Yes|Yes|Yes,No|No|No|No,453.0|726.0|1062.0|1447.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-01277,C3L-01277,No,b4,13,130N,CPT0093170003,Tumor,No,61,Female,Clear cell carcinoma,G3 Poorly differentiated,3.1,152,90,38.66,Present,<50% myometrial invasion,Seventh Edition (2010),pT4 ((FIGO IVA),pN1 (FIGO IIIC1),20,Stage IV,White,27.0318891,CNV_H,No,0.63,MSS,CNV_H,79,Mutated,WT,WT,WT,WT,6.70E-02,3.20E-02,0,7.19E-20,3.43E-18,0,1.71E-19,1.37E-03,0,0,1.85E-18,4.00E-18,3.86E-03,9.83E-20,0,1.04E-02,1.89E-18,6.68E-02,8.84E-18,0.227418213,1.63E-02,1.66E-02,7.02E-03,6.29E-03,0,0,1.94E-03,0,0,2.39E-03,0,2.56E-02,0,4.36E-02,0.169763751,0,3.64E-02,4.21E-02,7.84E-02,9.01E-02,0,9.87E-03,0.107773885,0,0.102388176,0,5.12E-02,0,0,0,7.22E-02,5.25E-02,0,3.77E-02,0.335894941,0,0,0,0.108333594,3.20E-02,0,10,45,0,18,0,0,0,0,0,0,0,0.55,NA,NA,-1.058231531,-0.210626637,6.22E-02,-0.477398904,-1.192535284,0.542375786,-0.383990391,-1.006978064,0.952184605,0.798950576,-0.432900851,-0.127951891,-1.408838516,0.58655408,5240.776464,3292.003806,8532.78027,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not reported,Medical Record Does Not State,Other: Medical Record Does Not State,Other,he mass occupies the anterior and posterior aspects of the endometrial cavity,Unifocal,IHC staining not done,3,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record,Lisinopril|levothyroxine,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,380|742|996,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|With Tumor,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,No|No|No,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Persistent Disease|Persistent Disease,n/a|n/a|n/a,No|Yes|Yes,n/a|Distant Metastasis|Distant Metastasis,n/a|Other: Omental lymphadenopathy|Lung,n/a|482.0|986.0,n/a|No|No,n/a|No|Yes,n/a|Yes|No,n/a|No|No,351.0|713.0|967.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01355,C3L-01355,No,b4,16,129N,CPT0083580003,Tumor,No,55,Female,Endometrioid carcinoma,G1 Well differentiated,5,163,123,46.44,Not identified,NA,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,0.942652274,CNV_L,No,0.08,MSS,CNV_L,50,WT,Mutated,WT,Mutated,Mutated,8.62E-02,1.98E-02,1.96E-19,5.88E-19,0,0,1.91E-02,4.26E-19,0,5.35E-03,0,3.49E-03,0,1.58E-19,8.12E-03,0,3.91E-20,0,1.41E-18,5.17E-02,4.64E-02,3.94E-02,1.94E-02,4.00E-03,6.45E-19,3.77E-18,5.70E-03,6.47E-19,0,1.82E-02,1.53E-02,9.70E-03,6.38E-18,5.71E-02,4.11E-02,0,5.22E-02,0,5.22E-02,0,2.25E-02,2.93E-03,0.100605,0,0.197192035,0,0,1.23E-02,0,2.49E-02,0,1.73E-02,8.96E-02,1.77E-02,0.328690503,2.15E-02,4.21E-02,0.114054101,0,8.70E-03,0,14,32,0,0,0,0,0,0,0,0,0,0.22,NA,NA,-0.126893861,-0.984616904,0.801397286,-0.637450073,1.700052511,-1.329351105,-1.46E-02,0.472783019,0.166217987,-0.691435261,0.114622588,-0.111552549,-0.591740795,-0.469145403,3587.024284,4501.375963,8088.400247,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,United States,Other,Anterior and Posterior Endometrium,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Self-reported and Medical Record|Medical Record|Medical Record,Yes,Self Report|Self Report|Self Report|Self Report|Self Report,Calcium - Vitamin D|Levothyroxine|Aspirin|Prednazole|Erythromycin,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,75|75,Unknown|Unknown,Unknown|Unknown,Unknown|Unknown,Tumor Free|Tumor Free,Never|Never,Former Therapy|Former Therapy,Unknown|Unknown,No|No,No|No,2|2,No|No,Unknown|Unknown,Unknown|Unknown,n/a|n/a,Unknown|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,75.0|75.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-01599,C3L-01599,No,b3,12,129N,CPT0087260003,Tumor,No,65,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.7,147,97,44.89,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,0.156405766,CNV_L,No,0,MSS,CNV_L,112,WT,Mutated,WT,Mutated,Mutated,8.49E-02,6.91E-03,0,8.61E-20,1.59E-18,0,1.85E-02,3.54E-04,0,7.28E-03,0,1.77E-02,1.30E-02,0,4.77E-03,8.40E-03,2.16E-03,3.22E-02,0,3.16E-02,5.58E-03,5.63E-03,3.95E-03,2.83E-03,4.99E-18,3.75E-03,0,9.21E-04,1.73E-18,8.33E-03,2.50E-02,4.89E-03,6.33E-18,6.74E-02,5.44E-02,1.40E-19,1.79E-02,2.13E-02,3.92E-02,1.55E-02,0,0.114405509,0,0,0.198053445,0,5.11E-02,0,0,0,6.73E-02,1.84E-02,0,1.66E-02,0.272709018,7.14E-02,3.20E-02,0,3.93E-02,3.26E-03,9.99E-02,22,56,0,0,0,0,24,0,0,0,0,0.18,Yes,No,-2.15E-02,0.426131535,0.131651293,0.394229669,0.176353543,0.315489148,0.196728148,1.291477847,0.223097873,0.276834236,0.324712921,0.870133132,-1.74E-02,0.794763495,4440.305867,4308.379012,8748.684879,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior Endometrium,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,cytotec|lipitor|lisinopril|norvasc|glucophage|alphagan|timoptic,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,343|683|1063|1434,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,343.0|683.0|1063.0|1434.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-01631,C3L-01631,No,b3,11,128C,CPT0091720003,Tumor,No,56,Female,Endometrioid carcinoma,G1 Well differentiated,6,160,99,38.67,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,6.78E-02,CNV_L,No,11.17,MSI-H,MSI-H,682,WT,Mutated,WT,Mutated,Mutated,0,3.09E-03,0,0,6.80E-20,8.66E-19,0,1.15E-20,5.91E-18,0,0,3.12E-03,1.13E-02,2.35E-18,0,1.01E-02,0,7.74E-03,0,4.83E-03,5.81E-04,3.74E-04,0,1.71E-04,0,9.46E-19,3.68E-03,1.87E-03,1.15E-17,1.07E-02,3.27E-02,0,0,0.119919416,0.102864575,0,3.81E-03,9.38E-03,1.32E-02,0,9.36E-03,0,0,0,0.223499106,0,1.32E-02,0,0,0,6.19E-02,0,0.33586025,0,7.82E-02,0,8.82E-02,0,0.133073003,0,5.67E-02,0,139,207,0,0,0,0,174,0,0,0,0.47,NA,NA,-0.341020298,1.20761473,-0.989413729,0.489077105,0.320796914,0.542830899,1.645872576,0.285063461,0.789691314,6.23E-02,1.703117126,-0.416434551,1.237731988,0.871017415,4219.507861,3832.887634,8052.395495,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both Anterior and Posterior Endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,NA,NA,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,11,NA,30,67.5,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record,Aspirin,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,414|610|798,No|No|No,No|No|No,No|No|No,Tumor Free|Tumor Free|With Tumor,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,No|No|No,No|No|No,3|3|3,No|No|No,Not Applicable|Not Applicable|Not Applicable,Unknown|Unknown|Patient Deceased,n/a|n/a|n/a,No|No|Yes,n/a|n/a|Locoregional Recurrence,"n/a|n/a|Other: Left iliac fossa, Left sacrum, peritoneum",n/a|n/a|762.0,n/a|n/a|No,n/a|n/a|No,n/a|n/a|No,n/a|n/a|No,414.0|610.0|n/a,n/a|n/a|Other : Endometrial adenocarcinoma,n/a|n/a|798.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01633,C3L-01633,No,b1,4,127N,CPT0091910003,Tumor,No,60,Female,Endometrioid carcinoma,G1 Well differentiated,4.5,160,143,55.86,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,0.178322095,CNV_L,No,0,MSS,CNV_L,73,WT,Mutated,WT,Mutated,WT,3.45E-02,0,0,3.39E-18,7.93E-19,1.02E-02,4.03E-02,0,3.07E-20,2.04E-02,0,7.70E-03,6.87E-03,1.99E-03,7.99E-03,3.77E-03,1.71E-02,8.06E-02,4.53E-03,4.86E-02,1.24E-03,2.28E-03,2.21E-03,5.06E-03,9.19E-20,0,9.44E-05,2.03E-19,2.26E-18,0,2.23E-02,7.18E-03,0,1.86E-02,1.47E-02,6.36E-23,2.09E-02,4.39E-02,6.48E-02,0,2.04E-02,4.91E-02,2.84E-02,0,0.352906161,0,2.18E-02,0,0,0,7.23E-02,1.62E-02,0,1.29E-02,0.240613914,4.36E-02,0,5.24E-02,0,8.46E-02,4.71E-03,25,18,22,0,0,0,0,0,0,0,0,0.21,Yes,No,0.781632785,-0.566092091,1.704101023,-0.147346941,8.50E-02,-1.034017547,-9.00E-02,0.39991664,-0.885729034,-0.166252468,8.15E-02,0.462751848,-0.929132935,4.41E-02,4592.763231,4055.100729,8647.86396,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,1,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Actos|Amitiza|Celexa|Flexeril|KlonoPIN|Lipitor|Mobic|Norco|sinemet|Tekturna HCT|Allopurionol|AsA 81mg,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,327|664,No|No,No|No,No|No,Tumor Free|Tumor Free,Unknown|Unknown,Unknown|Unknown,Never|Never,Yes|Yes,Yes|Yes,1|1,No|No,Not Applicable|Not Applicable,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,327.0|664.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-01639,C3L-01639,No,b4,13,127C,CPT0091780003,Tumor,No,71,Female,Endometrioid carcinoma,G1 Well differentiated,5,160,89,34.77,Present,<50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pNX,0,Stage III,White,1.011907283,CNV_L,No,1.13,MSS,CNV_L,456,Mutated,Mutated,WT,Mutated,Mutated,8.90E-02,3.19E-19,2.19E-19,3.06E-19,5.73E-19,2.49E-18,4.63E-18,1.15E-18,5.82E-18,6.66E-19,0,2.94E-21,1.19E-02,6.96E-19,8.84E-04,5.88E-03,0,0,0,4.97E-02,1.70E-02,1.68E-02,2.82E-03,4.89E-20,1.61E-18,1.21E-03,1.24E-03,3.09E-03,4.75E-19,1.04E-02,2.21E-02,0,0,5.86E-02,7.04E-02,9.62E-20,1.48E-02,1.01E-02,2.49E-02,0,0,6.43E-02,1.93E-02,0,0.11618684,0,8.71E-02,5.89E-03,0,0,0.104893787,0,9.17E-02,0,0.174455326,5.31E-02,6.78E-02,0,8.66E-02,3.37E-02,9.49E-02,0,27,192,0,0,0,0,85,0,0,43,0.26,NA,NA,-0.255091243,1.579198302,0.576991577,-0.190444625,0.71782467,1.115454172,1.679047346,1.269904533,-0.498095798,9.04E-02,1.954341006,-0.554553453,0.18035603,1.015914016,4196.777011,4648.744533,8845.521543,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Anterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,Yes,Lifelong non-drinker,"Current reformed smoker, more than 15 years",18,21,20,3,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,sinemet|Metoprolol tartrate|Prilosec|Requip|Zoloft|Zocor|ibuprofen,Breast Cancer|Skin Cancer,Medical Record|Medical Record,Surgery|Surgery,Yes|Yes,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,342|670|1060|1427,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,No|No|No|No,4 or more|4 or more|4 or more|4 or more,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,342.0|670.0|1060.0|1427.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-01664,C3L-01664,No,b2,5,127N,CPT0086490003,Tumor,No,75,Female,Endometrioid carcinoma,G2 Moderately differentiated,5.2,155,83,34.55,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,5.051972445,CNV_L,No,3.14,MSS,CNV_L,183,WT,Mutated,WT,WT,WT,7.35E-02,2.07E-02,0,0,0,7.11E-03,5.06E-02,2.54E-20,0,0,1.90E-20,2.10E-02,3.07E-02,2.76E-18,1.54E-03,3.33E-18,6.97E-03,0,3.25E-18,1.84E-03,1.42E-02,1.53E-02,4.99E-03,2.88E-03,7.48E-19,7.04E-04,0,3.61E-03,1.32E-17,2.84E-02,3.17E-02,1.88E-02,4.85E-18,5.60E-02,2.00E-02,0,3.37E-02,1.67E-18,3.37E-02,0,0,8.81E-02,9.91E-02,0,0.114647906,0,1.64E-03,2.05E-02,7.98E-02,0,0,0,0.266968512,2.71E-02,0.189947201,2.03E-02,0,0,3.27E-02,0,5.92E-02,17,50,0,0,0,0,52,26,0,0,0,0.52,NA,NA,-8.13E-02,-0.464820621,7.18E-02,1.29461329,-0.672822458,-1.092269129,0.353726316,0.281782086,-0.758120995,-1.219757543,0.613020629,0.780610055,0.434320852,-0.497425494,2086.954404,4254.848677,6341.80308,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Anterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,"Ascorbic Acid|Aspirin 81 mg|Calcium |acetaminophen |warfarin |propafenone|polyethyl glycol-prop glycol |Hydrochlorothiazide|multiple vitamin |Folic acid-Vit -B 12|Dorzolamide |Vitamin D 1,000",NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,345|655|1071|1373,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,No|No|No|No,3|3|3|3,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,345.0|655.0|1071.0|1373.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-01668,C3L-01668,No,b2,5,131C,CPT0186560008,Tumor,No,37,Female,Endometrioid carcinoma,G2 Moderately differentiated,5,163,117,44.11,Not identified,NA,Eighth Edition (2017),pT1a,pN0,4,Stage IA,White,0,CNV_L,No,0.02,MSS,CNV_L,46,WT,Mutated,WT,Mutated,WT,7.12E-02,1.62E-02,4.69E-03,0,9.23E-18,2.16E-02,2.99E-02,1.30E-19,0,0,0,2.99E-02,5.24E-04,2.83E-18,9.36E-03,3.83E-03,1.93E-02,8.43E-18,0,2.74E-02,7.21E-20,0,1.96E-03,1.57E-02,2.28E-18,0,5.28E-03,7.87E-19,1.29E-17,2.05E-02,7.75E-02,7.18E-03,5.56E-18,0.115500556,2.24E-02,0,4.03E-02,1.92E-03,4.22E-02,1.21E-02,0,2.89E-02,0,0,0.297161092,0,1.12E-02,0,0,0,0.172118374,0,0.120838091,9.32E-03,0.186732225,3.75E-02,1.46E-02,7.29E-02,0,0,3.65E-02,2,24,0,0,0,0,13,0,0,0,0,0.47,Yes,Yes,-0.341556581,-0.957719768,0.284534034,-1.008999551,-0.137769316,-1.307441357,0.201843564,0.450185646,0.435963206,-0.825829562,0.210414014,1.549853643,-0.736410631,0.153118849,3716.933961,4389.747735,8106.681696,Not Examined,Not identified,Cannot be assessed,Not-Hispanic or Latino,American,United States,Other,Anterior and Posterior Endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Not applicable,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Former Therapy,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Lisinopril-HCTZ|Simvastatin|Metformin,NA,NA,NA,NA,Yes,1,12 Months,No,Living,377,No,Yes,No,Tumor Free,Never,Unknown,Never,Yes,Yes,None,No,Unknown,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,377,n/a,n/a,n/a,n/a,n/a
C3L-01672,C3L-01672,No,b2,8,130C,CPT0172460008,Tumor,No,53,Female,Endometrioid carcinoma,G2 Moderately differentiated,3,163,118,44.67,Present,=50% myometrial invasion,Eighth Edition (2017),pT3a,pNX,0,IIIA,White,0.672473285,CNV_L,No,7.92,MSI-H,MSI-H,208,WT,Mutated,WT,WT,WT,1.36E-02,1.06E-02,7.97E-20,8.62E-19,1.07E-18,0,0,3.69E-19,1.60E-19,1.13E-18,3.54E-18,5.33E-19,1.43E-02,7.24E-19,1.30E-21,2.32E-03,3.52E-04,4.33E-18,0,8.50E-02,3.22E-03,1.26E-03,8.67E-03,1.17E-02,3.23E-18,5.36E-19,3.17E-03,6.05E-20,5.98E-18,2.38E-02,2.41E-02,2.09E-02,8.14E-18,3.32E-02,9.69E-02,7.38E-20,1.72E-02,1.16E-03,1.84E-02,4.84E-03,0,3.77E-02,1.03E-02,0,0.198499667,0,0,2.63E-02,0,2.11E-03,1.92E-02,2.48E-02,3.29E-03,6.71E-03,0.476896526,1.76E-02,4.10E-02,0.128732063,0,0,2.20E-03,29,32,0,0,0,19,47,23,0,0,0,0.85,Yes,Yes,-0.594531395,-0.864923509,1.451895509,0.799795961,-3.88E-02,-1.971425109,-1.824433787,-1.053802318,-0.191403293,-1.391352346,-1.807848599,-0.457897228,2.065854687,-1.625929264,1758.206873,2505.853245,4264.060118,Not Examined,Not identified,Cannot be assessed,Hispanic or Latino,Hispanic,Other: Mexico,Other,"Anterior Endomyometrium, Posterior Endomyometrium, Right and left fallopian tubes",Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Lisinopril|Hydrochlorothiazide|Metformin|amlodipine,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,353|683|1001,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Never|Never|Never,Yes|Yes|Yes,Yes|Yes|Yes,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,353.0|683.0|1001.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01729,C3L-01729,No,b4,16,128C,CPT0127610003,Tumor,No,60,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.8,157,63,25.24,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,1,Stage II,White,0.229568734,CNV_L,No,0.04,MSS,CNV_L,97,WT,Mutated,WT,Mutated,WT,0.103004948,1.01E-02,3.94E-19,0,3.84E-18,0,4.89E-02,0,3.44E-03,3.13E-02,0,8.39E-03,1.46E-02,0,1.94E-02,7.76E-03,4.85E-03,0.103948125,0,5.77E-02,1.38E-02,1.81E-02,4.05E-03,1.22E-04,3.70E-20,1.18E-03,1.58E-04,0,1.66E-17,2.09E-02,1.19E-02,6.00E-03,0,3.77E-02,2.94E-02,0,3.52E-02,6.43E-02,9.96E-02,9.32E-03,6.12E-04,6.06E-02,5.08E-02,0,0.209417137,0,6.88E-02,7.21E-03,0,0,5.88E-02,0,6.47E-02,4.66E-02,0.263941742,9.01E-02,1.63E-02,5.27E-02,0,0,0,35,28,0,0,0,0,16,0,0,0,0,0.2,NA,NA,0.797454727,-0.307133033,0.906066408,-0.687164104,1.341315968,-0.734403795,0.446060979,0.280807853,-1.876080099,6.14E-02,0.513159045,0.838131779,-0.338470453,-0.174036446,4539.089442,4978.0769,9517.166342,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not reported,Medical record does not state.,Other: Medical record does not state.,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,4 or more,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,NA,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,400|755,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,No|No,No|No,4 or more|4 or more,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,371.0|726.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-01732,C3L-01732,No,b4,13,129C,CPT0099910003,Tumor,No,84,Female,Endometrioid carcinoma,G2 Moderately differentiated,8,160,59,23.2,Present,=50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN0,9,Stage II,White,2.14E-03,CNV_L,No,19.82,MSI-H,MSI-H,676,WT,Mutated,WT,Mutated,Mutated,7.66E-02,9.83E-03,0,0,0,3.96E-18,1.01E-03,0,0,5.23E-18,0,2.29E-04,2.34E-02,8.58E-18,3.84E-03,0,1.73E-18,5.42E-18,0,8.43E-03,8.65E-03,7.39E-03,3.59E-03,6.28E-03,1.76E-19,8.33E-19,4.83E-03,3.09E-19,0,1.26E-02,2.18E-02,1.56E-02,0,6.80E-02,0.125623648,0,1.91E-02,3.10E-18,1.91E-02,0,0,3.56E-03,7.59E-02,0,0.254059786,0,8.67E-02,2.00E-02,0,2.31E-03,4.13E-02,2.90E-02,6.36E-02,6.75E-02,0.221364378,6.64E-02,0,0,6.85E-02,0,0,18,98,250,0,0,0,0,0,0,0,105,0.74,NA,NA,-0.630840503,-0.159475609,0.817061802,0.940755102,-1.499832442,0.288530733,-0.698237665,-0.239938406,0.581073052,-0.971161928,-0.77449737,-1.402800452,0.459329031,-0.423072369,2658.088029,3300.90167,5958.9897,Positive for malignancy,Present,Margins uninvolved by invasive carcinoma,Not reported,Medical Record Does Not State,Other: Medical Record Does Not State,Other,umor invades 100% of endomtrial cavity,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,Cytokeratin AE1/3,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record,Simvastatin|Atenolol,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,387|743|1085,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,No|No|No,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,366.0|722.0|1064.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01739,C3L-01739,No,b2,5,131N,CPT0100100003,Tumor,No,71,Female,Other,G3 Poorly differentiated,3.5,165,89,32.78,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,17,Stage I,White,1.07E-02,CNV_L,No,18.91,MSI-H,MSI-H,1308,WT,Mutated,Mutated,Mutated,Mutated,0.29888615,8.24E-02,7.48E-02,0,0,9.31E-18,3.74E-02,1.00E-02,0.128787619,0.205004105,4.01E-02,2.96E-03,7.04E-03,1.10E-18,2.07E-02,2.76E-03,8.96E-18,0,6.56E-18,0,7.04E-02,5.81E-02,1.68E-02,3.07E-03,4.54E-04,0,1.70E-02,0,5.62E-18,4.75E-19,0.161381983,1.79E-02,9.09E-03,4.77E-02,0.358099116,7.87E-02,0.203546477,1.38E-03,0.20492677,1.36E-02,0,1.57E-02,0.272960521,0,2.39E-02,0.186977988,9.58E-02,0,1.03E-02,0,7.00E-02,1.25E-03,9.02E-03,0.125837008,0.13564878,6.90E-03,1.46E-04,0,3.19E-02,0,0,9,191,513,0,0,0,0,257,0,0,0,0.41,NA,NA,-0.712886693,0.99171413,-0.908704148,0.446270786,2.199885639,0.626313982,0.899018117,8.08E-02,1.798070804,-1.357002691,0.563161503,0.162628927,0.208403811,1.06936262,4058.723808,7279.442683,11338.16649,Negative for malignancy/normal/benign,Present,Margins uninvolved by invasive carcinoma,Not reported,Medical record does not state.,Other: Medical record does not state.,Other,Tumor occupies 80% of endometrial cavity,Unifocal,IHC staining not done,0,6,IHC staining not done,0,5,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,"PAX8, HNF-1 beta component, ER, PR, P53, P16, VIMENTIN, AE1/AE3; ALL POSITIVE, IHC done on endometrial biopsy",NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record,levothyroxine|Pantoprazole (Protonix),NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,412|783|1147,No|No|No,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,No|No|No,No|No|No,2|2|2,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,385.0|756.0|1120.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01749,C3L-01749,No,b2,6,127C,CPT0127700003,Tumor,No,54,Female,Endometrioid carcinoma,G1 Well differentiated,3.5,157,76,30.54,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,2,Stage I,White,1.79E-03,CNV_L,No,0.02,MSS,CNV_L,35,WT,WT,Mutated,WT,WT,3.17E-02,0,0,3.90E-18,3.60E-19,1.11E-02,1.73E-02,5.99E-04,3.29E-03,1.59E-02,0,3.62E-18,0,0,2.85E-03,3.58E-02,0,0.212412943,1.95E-19,0.136231588,7.30E-22,8.23E-03,2.98E-05,1.31E-03,0,1.08E-19,0,1.68E-19,2.42E-18,2.61E-02,7.69E-03,0,8.64E-18,2.69E-02,1.60E-18,1.47E-02,4.97E-03,0.125751944,0.130726411,0,4.46E-03,0,5.76E-02,0,0.308827648,0,2.51E-02,5.47E-02,0,0.116206629,0,3.56E-02,4.81E-02,3.04E-02,0.160675162,3.37E-02,5.28E-03,0.119449447,0,0,0,10,22,0,0,0,0,0,0,0,0,0,0.32,NA,NA,0.648690675,0.154573407,0.594658313,-0.907043997,-0.458487295,0.280402936,-1.096688548,0.112645172,-0.720385383,1.486700506,-0.787026631,-0.436772776,-0.800584734,1.288778283,5296.512074,3618.354054,8914.866128,Negative for malignancy/normal/benign,Not identified,Cannot be assessed,Not reported,Medical Record Does Not State,Other: Medical Record Does Not State,Other,Tumor involves 50% of the anterior endometrium and 50% of the posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,NA,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,384|727|1177,No|No|No,No|No|No,No|No|No,Tumor Free|Tumor Free|With Tumor,Never|Never|Never,Former Therapy|Former Therapy|Former Therapy,Never|Never|Never,No|No|No,No|No|No,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Persistent Disease,n/a|n/a|n/a,No|No|Yes,n/a|n/a|Locoregional Recurrence,n/a|n/a|Other: retroperitoneal mass,n/a|n/a|987.0,n/a|n/a|No,n/a|n/a|No,n/a|n/a|Yes,n/a|n/a|No,361.0|704.0|1154.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01833,C3L-01833,No,b3,11,127N,CPT0100010003,Tumor,No,62,Female,Endometrioid carcinoma,G1 Well differentiated,3.1,157,101,40.78,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,1.65E-03,CNV_L,No,0.03,MSS,CNV_L,82,WT,Mutated,Mutated,Mutated,WT,1.83E-02,0,3.12E-19,0,0,1.20E-18,5.45E-18,0,0,4.52E-03,4.44E-18,8.17E-04,1.12E-02,2.42E-03,2.89E-03,1.18E-18,1.14E-19,7.51E-18,3.07E-18,5.84E-02,0,0,1.55E-03,1.29E-02,0,0,3.07E-03,5.86E-20,0,1.67E-02,2.55E-02,1.45E-02,0,3.80E-02,9.66E-02,9.04E-03,1.05E-02,4.43E-18,1.05E-02,1.69E-02,0,0.113675626,3.73E-02,0,0.271246307,0,0,6.00E-02,0,0,2.66E-02,0,0.213022797,1.03E-02,0.219341384,2.60E-02,0,0,0,0,5.63E-03,22,38,0,17,0,0,0,0,0,0,0,0.76,Yes,No,0.454187204,-1.476122622,0.729312363,0.169100336,-0.702773155,-1.282925204,-0.471961987,-0.995322422,0.722557203,-0.623596032,-0.427346219,-2.14E-03,-0.477063936,-0.692027789,2871.523465,2857.000839,5728.524304,Negative for malignancy/normal/benign,Present,Cannot be assessed,Not reported,Medical record does not state.,Other: Medical record does not state.,Other,anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Insulin (Novolog) |Metoprolol|Pravastatin,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,421|694|1030,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,Yes|Yes|Yes,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,376.0|649.0|985.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-01840,C3L-01840,No,b1,1,127N,CPT0091990003,Tumor,No,56,Female,Endometrioid carcinoma,G1 Well differentiated,5.5,165,103,37.83,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,7.07E-03,CNV_L,No,0.05,MSS,CNV_L,49,WT,Mutated,Mutated,Mutated,Mutated,4.54E-02,4.55E-03,2.49E-04,8.10E-19,1.53E-18,0,0,0,9.80E-21,4.24E-03,0,6.80E-19,2.54E-03,4.55E-19,0,1.25E-18,0,0,0,3.45E-03,8.19E-04,2.16E-03,2.18E-03,2.39E-03,0,1.60E-18,4.93E-03,0,9.77E-18,2.72E-02,3.71E-02,8.43E-03,0,4.31E-02,4.19E-02,3.05E-02,5.17E-03,8.18E-19,5.17E-03,6.59E-02,0,4.78E-03,0.113581244,0,6.92E-02,6.42E-03,0.180356946,0,0,0,0.139898222,1.03E-02,0.172936562,5.23E-02,9.57E-02,7.39E-02,0,0,1.25E-02,2.33E-03,0,20,25,0,0,0,0,0,0,0,0,0,0.83,Yes,No,0.118408763,3.62E-02,0.305884605,-0.45405098,-0.603255283,0.566964808,-0.127254893,0.328834416,0.374257131,-0.55463518,5.97E-02,-0.891766804,0.629323542,0.991155523,2433.141807,3410.548022,5843.689829,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,1,NA,NA,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record,Lansoprazole|Losartan,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,348|686|1048|1442,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|With Tumor,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,No|No|No|No,1|1|1|1,No|No|No|No,Not Applicable|Not Applicable|Not Applicable|Not Applicable,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Persistent Disease,No|No|No|Yes,n/a|n/a|n/a|Locoregional Recurrence,n/a|n/a|n/a|Other: Vaginal and pelvic nodes,n/a|n/a|n/a|1243.0,n/a|n/a|n/a|No,n/a|n/a|n/a|Yes,n/a|n/a|n/a|Yes,n/a|n/a|n/a|No,348.0|686.0|1048.0|1442.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-01864,C3L-01864,No,b4,13,129N,CPT0092860003,Tumor,No,80,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.5,160,73,28.51,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,4.49E-03,CNV_L,No,18.93,MSI-H,MSI-H,787,WT,Mutated,WT,Mutated,Mutated,5.84E-02,1.15E-02,1.93E-03,0,2.79E-20,0,3.67E-18,0,2.42E-03,9.39E-03,1.60E-19,1.96E-04,3.45E-02,0,4.88E-20,0,0,1.47E-17,0,1.60E-20,2.25E-02,1.45E-02,8.85E-03,4.62E-03,1.07E-19,1.85E-19,1.11E-03,0,2.81E-18,1.88E-02,3.59E-02,1.52E-02,0,4.25E-02,0.256989657,0,2.74E-02,7.53E-18,2.74E-02,0,0,0.103691799,0.112177383,0,7.57E-02,0,5.04E-02,0,0,0,7.12E-02,0,3.93E-02,0.109020366,0.297022682,5.96E-03,1.20E-02,0,0.104741705,0,1.89E-02,14,99,244,0,0,0,0,135,0,0,59,0.86,NA,NA,-0.66907287,0.743923923,1.031585214,0.176813757,1.285171964,0.703753678,0.371534146,-0.605994245,0.492592676,-0.881873324,0.428918864,-0.86456841,1.141146436,-1.205182171,2613.250206,3552.002805,6165.253011,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record,Cholecalciferol|Hydrochlorothiazide,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,390|392,No|No,No|No,No|No,Tumor Free|Unknown Tumor Status,Unknown|Unknown,Unknown|Unknown,Unknown|Unknown,Yes|Yes,No|No,4 or more|4 or more,No|No,Not Applicable|Not Applicable,Complete Remission|Unknown,n/a|n/a,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,390.0|392.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-01913,C3L-01913,No,b2,6,128C,CPT0092690003,Tumor,No,55,Female,Endometrioid carcinoma,Other: High grade,4,160,67,26.17,Present,=50% myometrial invasion,Eighth Edition (2017),pT1b,pN1,23,Stage IIIC1,White,2.70724875,CNV_L,Yes,0.17,MSS,POLE,18840,Mutated,Mutated,Mutated,Mutated,Mutated,0.117666086,1.28E-02,1.29E-02,0,3.80E-19,0,1.04E-02,1.14E-02,7.41E-03,2.46E-02,1.06E-18,2.82E-03,3.55E-02,3.07E-18,2.01E-03,2.97E-19,0,0,8.31E-19,2.21E-02,1.80E-02,1.07E-02,1.24E-02,2.29E-03,0,4.42E-18,4.79E-03,0,1.09E-17,4.91E-04,3.02E-02,3.75E-03,0,2.51E-02,0.235016335,1.13E-18,2.83E-02,1.48E-19,2.83E-02,0,2.71E-02,7.69E-03,0.125054052,0,0.198178282,0,0,2.01E-02,0,0,2.24E-02,2.24E-02,0.117390967,0.115701185,0.226384973,2.96E-02,0,7.80E-02,0,1.02E-02,0,2089,7336,0,0,4224,5063,0,0,0,0,0,0.59,NA,NA,-1.020872973,-0.703173935,-0.628478858,0.425288773,8.13E-02,-0.455588047,-0.512797008,-0.424064354,0.479794412,-0.336293525,-0.778982613,0.542219472,-0.19937804,0.399632053,3921.613839,4160.530048,8082.143888,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior,Unifocal,IHC staining not done,1,4,IHC staining not done,0,1,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,33,NA,20,22,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,369|694|1052|1422,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Former Therapy|Former Therapy|Former Therapy|Former Therapy,Unknown|Unknown|Unknown|Unknown,No|No|No|No,No|No|No|No,4 or more|4 or more|4 or more|4 or more,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,369.0|694.0|1052.0|1422.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-01967,C3L-01967,No,b1,4,128N,CPT0108750003,Tumor,No,65,Female,Endometrioid carcinoma,G1 Well differentiated,6,164,100,37.18,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,8,Stage I,Not Reported,1.73E-02,CNV_L,No,0.02,MSS,CNV_L,165,WT,WT,WT,WT,WT,0.31592033,0,2.05E-02,2.22E-18,6.38E-19,0,0.100189533,8.00E-03,9.92E-02,0.124124935,2.89E-02,0,4.34E-03,3.56E-19,5.92E-02,6.88E-02,3.62E-03,0.345642662,6.86E-02,0.209937657,4.07E-02,3.65E-02,2.43E-02,6.77E-04,3.29E-18,3.14E-02,0,2.97E-04,3.63E-18,1.70E-03,5.10E-02,8.58E-05,0,4.22E-18,0.19494426,1.85E-21,0.156717472,0.218004461,0.374721933,1.33E-02,0,3.14E-02,0.18246362,0,0.180507056,3.69E-02,3.59E-02,0,1.88E-02,0,5.17E-02,7.32E-04,0,7.61E-02,0.241358829,1.92E-02,1.45E-02,5.57E-02,0,2.67E-02,1.48E-02,25,48,0,0,0,0,0,0,31,0,42,0.16,NA,NA,0.536843247,0.113003379,0.542891843,-0.845478311,2.148028633,-5.41E-02,0.869400448,-0.399336233,-0.451862202,2.176888745,0.825817444,1.298364714,-0.96120472,0.422316303,8031.335145,7301.581729,15332.91687,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not reported,Unknown,United States,Other,Both anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Yes,Self Report|Self Report|Medical Record|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,Yes,Self Report|Self Report|Self Report,Proair|Vitamins|Loratadine,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,0,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,Unknown,Unknown,No,No,4 or more,No,Unknown,Unknown,n/a,Unknown,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
C3L-02119,C3L-02119,No,b1,3,129N,CPT0114340003,Tumor,No,72,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.3,170,110,38.06,Not identified,NA,Seventh Edition (2010),pT1 (FIGO I),pN0,6,Stage I,White,1.516079337,CNV_L,No,0.75,MSS,CNV_L,98,WT,Mutated,WT,Mutated,Mutated,4.04E-02,8.31E-03,2.59E-19,0,5.06E-19,2.41E-03,1.88E-02,2.52E-19,0,1.39E-02,0,5.06E-03,3.35E-03,0,2.46E-02,5.93E-03,7.78E-03,3.36E-02,0,1.32E-02,3.43E-02,3.31E-02,1.59E-02,4.76E-03,0,3.87E-18,3.89E-03,0,1.63E-19,2.78E-02,2.79E-02,4.10E-03,1.60E-18,6.58E-02,1.11E-02,4.61E-03,5.32E-02,1.98E-02,7.30E-02,0,0,6.43E-03,0.152587534,0,0.208113076,0,1.33E-02,9.69E-03,0,5.39E-02,0,4.36E-02,0.105875785,1.90E-02,0.327131538,3.54E-03,1.48E-02,1.92E-02,0,2.28E-02,0,12,33,31,0,0,0,0,0,0,0,0,0.5,NA,NA,-0.476873862,-0.263096241,-0.257920119,-8.61E-02,-0.811554349,-0.685522975,0.23483925,-7.33E-02,-0.851782968,-0.444961258,0.290148182,0.963318943,0.137828906,0.568796003,3653.131273,4716.283529,8369.414802,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,United States,Posterior endometrium,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,Yes,Absent,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,"Napsin A, Pancytokeratin - both negative",NA,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record,"Atorvastatin (Lipitor)|Cholecalciferol, Vitamin D3",NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|No,Living|Living,342|567,No|No,No|No,No|No,Tumor Free|Tumor Free,Unknown|Unknown,Unknown|Unknown,Never|Never,Yes|Yes,No|No,None|None,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,323.0|548.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02121,C3L-02121,No,b3,9,130N,CPT0114100003,Tumor,No,39,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.8,175,105,34.11,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,2.17E-02,CNV_L,No,0.08,MSS,CNV_L,44,WT,Mutated,Mutated,Mutated,WT,3.86E-02,5.71E-03,9.99E-19,0,1.14E-17,0,2.38E-18,1.92E-20,0,3.01E-18,1.52E-17,5.84E-04,1.01E-02,0,0,8.46E-20,9.51E-19,0,2.21E-18,0,0,0,2.50E-03,9.63E-03,0,7.86E-18,9.76E-21,1.58E-18,8.67E-18,2.13E-02,5.75E-03,1.04E-02,0,0.152446734,0.116417636,0,1.02E-02,3.73E-19,1.02E-02,8.48E-02,0,7.33E-02,4.60E-02,0,0.235766049,0,2.99E-02,4.80E-02,0,0,0.106362312,1.67E-02,0.113006634,3.73E-02,0.163206174,3.30E-02,1.25E-02,0,0,0,0,7,16,0,0,3,3,12,0,0,0,0,0.73,NA,NA,-0.16890428,-0.399057258,0.184331649,0.162518682,-1.380936812,-1.127871458,-0.524421057,-0.456343557,0.314030403,-1.442001644,-0.483844297,-1.74904298,-3.72E-02,-0.779539053,2282.601855,2822.843276,5105.445131,Not Examined,Present,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,United States,Other,Both anterior and posterior,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Premenopausal: less than 6 months since LMP AND no prior bilateral oophorectomy AND not on estrogen replacement,Never,None,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,1,12 Months|24 Months,Yes|Yes,Living|Living,417|417,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,No|No,No|No,None|None,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,170.0|170.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02125,C3L-02125,No,b2,8,131C,CPT0197250003,Tumor,No,68,Female,Serous carcinoma,G3 Poorly differentiated,7,165,80,29.45,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,4,Stage III,White,38.83879719,CNV_H,No,1.35,MSS,CNV_H,82,Mutated,WT,WT,WT,Mutated,0.132382395,7.67E-03,2.39E-03,2.65E-19,4.45E-19,8.81E-18,7.59E-18,4.02E-03,0,0,0,0,4.50E-02,0,2.33E-03,0,1.08E-18,3.41E-03,0,1.55E-02,1.71E-02,2.23E-02,1.64E-19,4.32E-03,0,5.72E-19,1.90E-21,1.09E-19,0,2.44E-02,3.79E-02,4.40E-03,1.62E-18,0.106546166,0.228666305,0,2.09E-02,2.67E-03,2.36E-02,4.86E-02,0,7.92E-02,4.82E-02,0,2.96E-02,0,5.75E-02,0,1.64E-02,0,0.121450749,0,0.190494979,0.1760159,0.183873163,0,3.41E-02,0,8.34E-03,6.11E-03,0,14,64,0,0,0,0,0,0,0,0,0,0.47,NA,NA,-1.810015984,0.925194903,-0.19338274,0.296579574,1.628249652,1.562211057,0.741314062,-1.189854714,2.562004207,0.834973613,0.76376946,-8.92E-02,-1.247598295,0.793274634,3640.161195,3809.917664,7450.078858,Not Examined,Present,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,United States,Other,Both anterior and posterior,Multifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Negative,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Overexpression,Yes,Cannot be determined,Yes,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,1,PAX8 - Positive,"P16-positive, Pancytokeratin - no keratin positive metastatic cells identified, GATA-3 - negative",No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record,Yes,Medical Record|Medical Record,enalapril (VASOTEC) |traMADol (ULTRAM),NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,410,Yes,Yes,No,Unknown Tumor Status,Unknown,Unknown,Unknown,Yes,No,1,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,410,n/a,n/a,n/a,n/a,n/a
C3L-02216,C3L-02216,No,b2,6,127N,CPT0104690003,Tumor,No,68,Female,Endometrioid carcinoma,G1 Well differentiated,4.5,160,87,33.98,Present,=50% myometrial invasion,Eighth Edition (2017),pT1b,pN1,18,Stage IIIC1,White,0,CNV_L,No,17.11,MSI-H,MSI-H,854,WT,Mutated,WT,Mutated,Mutated,3.15E-04,3.86E-19,6.03E-19,0,1.16E-17,7.77E-19,4.19E-04,1.61E-03,0,2.08E-19,6.58E-18,0,1.74E-02,0,4.10E-03,8.11E-03,0,0,0,2.55E-02,6.31E-03,2.78E-03,8.70E-03,2.72E-03,3.28E-18,0,2.54E-21,3.38E-19,9.06E-18,7.69E-03,1.92E-02,8.16E-03,0,9.48E-02,6.60E-02,0,8.75E-03,4.06E-03,1.28E-02,1.72E-02,0,9.74E-02,4.99E-02,0,0.206528078,0,1.86E-02,0,0,2.04E-03,4.16E-02,9.62E-03,0,1.37E-02,0.354504454,0.115254986,0,7.36E-02,0,0,0,74,345,0,0,0,0,212,0,0,0,0,0.74,NA,NA,-0.635187668,-0.45532401,0.485969702,0.81716412,-1.391959106,-0.859056651,-1.94398288,0.803064702,-0.333173048,-0.870820866,-1.828703436,-0.954724608,0.267231971,0.140468678,3182.120029,2670.093058,5852.213087,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,1,4,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,NA,NA,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,gabapentin|ambien|plaquenil|tenormin|methotrexate|amLODIPine|AMitriptyline,Breast,Medical Record,Surgery,Yes,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,346|697|1036|1432,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,No|No|No|No,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,346.0|697.0|1036.0|1432.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02347,C3L-02347,No,b2,8,128C,CPT0113850003,Tumor,No,62,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.5,165,112,41.14,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,0,CNV_L,No,9.76,MSI-H,MSI-H,331,WT,Mutated,WT,Mutated,Mutated,0.149283082,1.58E-02,1.02E-19,4.65E-20,7.30E-19,0,4.86E-02,0,2.97E-04,1.44E-02,0,5.17E-03,8.21E-03,0,9.94E-03,1.77E-03,0,6.74E-18,1.03E-18,1.28E-02,1.34E-02,1.26E-02,6.75E-03,2.85E-03,8.15E-05,0,2.29E-03,3.26E-19,1.20E-17,2.95E-02,1.72E-02,1.42E-02,0,9.94E-02,1.30E-02,3.01E-20,2.82E-02,8.85E-04,2.91E-02,3.01E-03,0,8.17E-02,7.36E-02,0,0.212249015,0,6.21E-02,2.04E-02,0,0,2.10E-02,0,0.244709493,5.31E-02,0.194216922,1.92E-02,0,0,2.03E-03,0,1.27E-02,26,61,55,0,0,0,81,0,0,0,0,0.71,Yes,No,-0.50666458,0.61431738,-2.43E-03,0.59694964,3.43E-02,0.112406606,0.345508127,-0.189280113,-0.545306974,-0.157317202,0.365770604,-8.13E-02,-0.328146903,0.424965714,3841.019296,4699.493375,8540.512671,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,NA,NA,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,"amiodarone (PACERONE)|amLODIPine (NORVASC)|aspirin |	buPROPion (WELLBUTRIN SR) |carvedilol (COREG)|Cholecalciferol (VITAMIN D3)|	ELIQUIS|ferrous sulfate|ferrous sulfate|gabapentin (NEURONTIN)|glipiZIDE (GLUCOTROL)|HUMULIN N & R|KLOR-CON |levothyroxine (SYNTHROID)|lovastatin (MEVACOR)|montelukast (SINGULAIR)|sertraline (ZOLOFT)|valsartan-hydrochlorothiazide (DIOVAN-HCT)",NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,323|696|1064|1438,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,3|3|3|3,No|No|No|No,Not Applicable|Not Applicable|Not Applicable|Not Applicable,Complete Remission|Complete Remission|Unknown|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,323.0|696.0|1064.0|1438.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02353,C3L-02353,No,b4,15,129C,CPT0112780003,Tumor,No,80,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,155,75,31.22,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,29,Stage I,White,6.15E-03,CNV_L,No,1.89,MSS,CNV_L,257,WT,Mutated,WT,WT,WT,0.234538444,2.71E-02,1.38E-02,3.58E-18,7.67E-04,3.37E-18,0.11078579,5.46E-03,1.59E-02,5.86E-02,2.30E-19,5.35E-03,2.07E-02,0,3.31E-02,1.25E-02,8.69E-19,6.68E-03,4.42E-18,1.82E-02,6.60E-02,5.49E-02,2.56E-02,8.04E-03,3.09E-20,1.14E-02,3.49E-03,0,2.62E-19,3.64E-02,7.21E-02,2.62E-03,0,7.04E-02,0.149000429,5.15E-03,0.108182427,1.02E-02,0.118383664,0,0,2.69E-02,7.89E-02,0,0.111091904,1.39E-02,5.48E-02,2.65E-02,3.07E-02,0,5.22E-02,0,0.203734855,6.47E-02,0.27981557,2.09E-02,0,2.43E-02,0,0,1.16E-02,29,70,0,0,0,0,74,0,0,0,19,0.29,NA,NA,-0.535372076,0.600107513,3.155340654,4.16E-02,-0.12352169,-0.722810459,0.678545274,-0.4187511,-0.339408721,0.4957856,0.534735804,0.803664177,8.78E-02,-0.518905112,5771.257457,6399.411201,12170.66866,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Posterior endometrium,NA,Unifocal,IHC staining not done,0,6,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Prilosec |aleve|Multiple vitamin|Enoxaparin sodium |Motrin,Melanoma,Medical Record,Surgery,No,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,381|564|954|1359,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,No|No|No|No,No|No|No|No,4 or more|4 or more|4 or more|4 or more,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,381.0|564.0|954.0|1359.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02354,C3L-02354,No,b3,9,127C,CPT0112910003,Tumor,No,55,Female,Endometrioid carcinoma,G1 Well differentiated,4.1,165,80,29.38,Present,=50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,9,Stage IV,White,0,CNV_L,No,0.01,MSS,CNV_L,39,WT,WT,Mutated,Mutated,WT,8.13E-02,6.42E-03,2.79E-03,0,0,0,2.68E-02,1.63E-21,2.19E-03,1.19E-02,1.28E-18,0,5.95E-03,9.25E-19,0,5.63E-18,0,1.04E-17,2.02E-18,1.47E-02,4.00E-03,9.77E-03,0,6.00E-04,0,4.65E-18,3.60E-03,3.71E-19,0,3.68E-02,5.80E-02,1.08E-02,0,4.78E-02,9.11E-03,4.96E-03,8.81E-03,8.03E-18,8.81E-03,0,0,1.01E-02,8.54E-03,0,0.38078971,0,3.62E-02,0,5.02E-02,0,4.04E-02,0,0.142753811,0.110422357,0.183556076,3.86E-03,0,3.31E-02,0,0,0,15,13,0,0,0,0,0,7,0,0,0,0.74,NA,NA,1.362300799,-0.607768574,-0.522481165,-0.79104118,0.73534036,-8.33E-02,-0.738387863,0.834938257,0.147847122,-8.77E-02,-0.492512274,-1.419153354,0.430372758,1.736080971,2798.087024,3782.760715,6580.847739,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,0,4,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R1:  Microscopic residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record,multivitamin,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,327|670|1050|1421,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Unknown Tumor Status|Tumor Free|Tumor Free|With Tumor,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Current Therapy|Former Therapy|Former Therapy|Former Therapy,No|No|No|No,No|No|No|No,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Persistent Disease,No|No|No|Yes,n/a|n/a|n/a|Locoregional Recurrence,n/a|n/a|n/a|Other: Right pericolic gutter mass,n/a|n/a|n/a|1294.0,n/a|n/a|n/a|Yes,n/a|n/a|n/a|No,n/a|n/a|n/a|Yes,n/a|n/a|n/a|No,327.0|670.0|1050.0|1421.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|1335.0,n/a|n/a|n/a|Surgical Resection,n/a|n/a|n/a|R0: No Residual Tumor
C3L-02357,C3L-02357,No,b1,1,128N,CPT0113330003,Tumor,No,54,Female,Endometrioid carcinoma,G2 Moderately differentiated,6,157,106,43,Not identified,NA,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,White,2.510041587,CNV_L,No,0.05,MSS,CNV_L,89,WT,Mutated,WT,Mutated,Mutated,0.126444941,1.33E-02,2.30E-20,0,3.69E-18,1.09E-18,8.40E-02,0,1.06E-18,2.23E-02,0,7.06E-03,0,4.22E-19,3.25E-02,6.13E-03,9.29E-21,1.24E-02,0,2.68E-02,4.55E-02,2.51E-02,3.78E-02,3.34E-03,0,1.78E-02,2.75E-03,2.32E-03,2.85E-18,3.28E-02,2.21E-02,4.44E-03,0,5.62E-02,5.29E-18,0,7.65E-02,9.27E-03,8.58E-02,0,0,0,5.60E-02,0,0.227136013,0,3.61E-02,1.35E-02,0,0,4.91E-02,5.35E-03,0.112874235,3.22E-02,0.254988031,0.144074465,0,0,0,1.87E-02,4.99E-02,26,31,0,0,0,0,0,14,0,0,0,0.18,NA,NA,-0.124245636,9.25E-02,0.77034754,-0.48269097,4.04E-02,-1.113593164,1.02423415,0.333115793,-0.805252687,-0.400049712,1.235153615,1.039434126,0.467279941,0.500780463,4844.001649,5840.577918,10684.57957,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,15,NA,30,58.5,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,albuterol (PROAIR HFA)|Aspirin|Motrin|Omeprazole,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,349|349,No|No,No|No,No|No,Tumor Free|Tumor Free,Unknown|Unknown,Unknown|Unknown,Never|Never,No|No,No|No,2|2,No|No,Not Applicable|Not Applicable,Complete Remission|Complete Remission,n/a|n/a,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,349.0|349.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02382,C3L-02382,No,b4,14,130C,CPT0190700008,Tumor,No,64,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.5,168,107,37.93,Present,<50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN1 (FIGO IIIC1),3,Stage III,White,5.17E-02,CNV_L,No,18.03,MSI-H,MSI-H,581,WT,Mutated,WT,WT,WT,7.43E-02,1.07E-02,0,0,0,0,1.53E-02,1.10E-19,2.94E-19,0,3.13E-18,1.04E-02,1.82E-02,1.63E-18,6.80E-03,3.02E-03,0,0,0,2.24E-02,1.01E-02,9.23E-03,4.74E-03,1.15E-04,3.06E-18,0,5.35E-03,2.81E-03,4.37E-18,1.72E-19,2.93E-02,1.49E-03,0,6.12E-02,2.18E-02,0,2.03E-02,1.51E-03,2.18E-02,0,0,1.37E-04,0,0,0.373585701,0,9.70E-03,0,0,5.05E-02,0,0,0.116044006,2.37E-02,0.168779456,3.61E-02,5.46E-02,0,6.21E-02,0,0.104740638,15,52,191,0,0,0,0,75,0,0,64,0.27,NA,NA,-0.159240424,1.725697304,8.39E-02,0.402260498,0.284473709,2.096147864,1.42419516,1.032923537,0.7880705,-0.262146321,1.582532969,-0.460392857,0.971265423,1.906322016,3493.014013,4634.052626,8127.066638,Negative for malignancy/normal/benign,Present,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,white,United States,Anterior endometrium,NA,Unifocal,1,0,0,0,0,0,0,0,cM0,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,Unknown,NA,NA,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,25,NA,Unknown,NA,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,aspirin|atorvastatin|vitamin D3|fenofibrate micronized|ferrous sulfate|furosemide|metoprolol tartrate|pantoprazole|potassium chloride,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,360|815|1088,No|No|No,Yes|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Former Therapy|Former Therapy|Former Therapy,Never|Never|Never,Yes|Yes|Yes,No|No|No,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,291.0|746.0|1019.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02384,C3L-02384,No,b2,5,127C,CPT0127980003,Tumor,No,81,Female,Serous carcinoma,G3 Poorly differentiated,2.1,163,58,21.8,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,15,Stage II,White,22.20816427,CNV_H,No,0.49,MSS,CNV_H,74,Mutated,WT,WT,WT,WT,0.150800748,5.60E-02,0,2.53E-18,0,1.15E-02,2.83E-02,9.81E-03,1.37E-02,4.02E-03,6.35E-03,0,6.74E-03,1.78E-18,4.08E-03,0,0,1.60E-02,8.14E-20,0,1.14E-02,2.08E-02,1.04E-03,4.34E-03,6.53E-03,0,2.32E-03,0,0,7.25E-03,2.19E-02,4.29E-02,0,0.138764484,7.83E-02,4.20E-18,5.97E-02,9.03E-03,6.87E-02,7.08E-02,0,0.105325826,0.155680228,0,8.38E-02,0,8.97E-02,0,6.11E-03,0,7.39E-02,0,6.47E-02,0.127723474,0.222159372,0,0,0,0,0,0,10,61,0,0,0,0,0,0,0,0,0,0.2,NA,NA,-1.173315254,0.38104993,-0.339323801,0.228006172,1.453802478,0.352534871,7.52E-02,-0.134404946,-0.872854207,0.405507519,6.20E-02,-0.230264388,-1.223733226,-0.272659945,3592.368124,4176.960813,7769.328937,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not reported,Medical record does not state.,Other: Medical record does not state.,Other,25% anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record,DULoxetine (CYMBALTA|memantine (NAMENDA XR),NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,372|725|907,No|No|No,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,No|No|No,No|No|No,2|2|2,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,326.0|679.0|861.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02389,C3L-02389,No,b3,11,129N,CPT0203040008,Tumor,No,66,Female,Endometrioid carcinoma,G2 Moderately differentiated,5.5,155,103,42.89,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,13,Stage I,White,5.069920133,CNV_L,No,22.34,MSI-H,MSI-H,792,WT,Mutated,WT,Mutated,WT,0.115941548,2.34E-02,7.30E-21,0,4.85E-18,5.69E-18,4.25E-19,1.10E-18,0,1.29E-02,3.23E-18,9.64E-03,2.35E-02,4.70E-18,3.06E-03,1.60E-19,1.80E-19,1.00E-17,0,8.77E-03,1.71E-02,9.21E-03,8.87E-03,9.11E-03,2.27E-19,0,7.71E-03,5.70E-19,2.45E-17,2.14E-03,2.70E-02,1.56E-02,0,7.88E-03,0.236543285,1.79E-18,3.51E-02,5.10E-18,3.51E-02,0,0,0.115006357,0.105195773,0,0.12577489,1.02E-02,0.115195434,0,0,0,7.53E-02,0,5.33E-02,5.15E-02,0.263459463,0,1.53E-02,0,2.45E-02,2.40E-02,2.14E-02,22,134,155,0,0,0,137,122,0,0,0,0.84,NA,NA,-1.490880237,0.334990236,-2.305200076,1.509563344,-9.19E-03,0.718692115,0.178814955,-6.32E-02,1.24029417,-2.023194016,-1.68E-02,-0.602970907,1.296375935,-1.082169211,2125.608228,4362.302181,6487.910409,Positive for malignancy,Not identified,Margins uninvolved by invasive carcinoma,Not reported,Medical record does not state.,Other: Medical record does not state.,Anterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,WT1 negative,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record,Yes,Medical Record|Medical Record|Medical Record,lisinopril (PRINIVIL|hydrochlorthiazide|GLUCOSAMINE,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,412|778,No|No,Yes|Yes,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,None|None,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,351.0|717.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02392,C3L-02392,No,b3,10,127N,CPT0203250008,Tumor,No,58,Female,Endometrioid carcinoma,G1 Well differentiated,1,173,60,19.99,Present,<50% myometrial invasion,Seventh Edition (2010),pT1 (FIGO I),pN0,14,Stage I,White,0,CNV_L,No,0,MSS,CNV_L,42,WT,Mutated,WT,Mutated,Mutated,0.119162713,1.14E-02,0,0,2.16E-18,9.70E-18,0,0,0,3.00E-02,0,1.70E-19,8.61E-03,2.45E-18,2.22E-03,3.87E-02,3.22E-19,8.67E-02,0,7.24E-02,3.67E-02,2.02E-02,2.91E-02,8.95E-04,0,0,9.67E-03,3.80E-03,8.39E-18,8.41E-19,0.115187762,1.16E-02,0,1.33E-02,1.80E-02,9.42E-19,3.67E-02,6.36E-02,0.100282353,7.92E-02,0,1.46E-02,0,0,0.297421448,0,4.48E-02,0,0,7.14E-03,0.153642558,2.55E-02,6.69E-02,0,0.150684184,0,4.15E-02,0,1.08E-02,3.77E-02,7.01E-02,16,22,0,0,0,0,0,0,0,0,0,0.42,Yes,Yes,1.158002193,0.354457106,-6.89E-02,0.904742306,-0.170557405,0.52844758,1.756731819,-0.529442237,0.698834426,0.527759844,1.922361048,-6.67E-02,-5.19E-02,0.909140434,5456.76615,6014.84868,11471.61483,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not reported,Medical record does not state.,Other: Medical record does not state.,Other,100% of anterior and 80% of posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,"Current reformed smoker, years unknown",NA,NA,Unknown,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,lisinopril (PRINIVIL|albuterol sulfate|Furosamide|Loratadine|Metformin|Megestrol,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,407|721,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,Yes|Yes,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,356.0|670.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02399,C3L-02399,No,b1,3,127N,CPT0171090008,Tumor,No,72,Female,Endometrioid carcinoma,G1 Well differentiated,6,160,73,28.52,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,4,Stage I,White,0,CNV_L,No,18.08,MSI-H,MSI-H,658,WT,Mutated,WT,Mutated,Mutated,1.84E-02,2.46E-03,1.90E-20,0,2.85E-19,0,2.55E-18,1.83E-03,5.01E-04,2.83E-19,0,1.70E-03,1.12E-02,0,1.52E-19,6.26E-19,0,0,0,2.68E-02,2.87E-18,0,5.79E-04,9.28E-03,8.01E-19,9.24E-18,7.76E-03,0,1.80E-17,1.44E-02,1.75E-02,1.52E-02,0,3.84E-02,4.15E-02,1.65E-02,8.16E-03,3.13E-19,8.16E-03,5.11E-02,0,0.156291699,2.02E-02,0,0.133542694,0,0,7.87E-02,0,0,2.96E-02,0,6.61E-03,3.27E-03,0.321720414,0,4.93E-02,0,8.25E-02,0,6.73E-02,8,108,240,0,0,0,0,95,0,0,40,0.22,Yes,Yes,0.356523193,-1.177795445,0.955305472,1.571301844,-0.812883679,-1.144946258,-0.419224288,9.95E-02,0.795561739,-1.034651936,-0.327372214,-0.146373798,1.111735452,-0.163999141,2177.415351,2032.120904,4209.536255,Negative for malignancy/normal/benign,Not identified,Cannot be assessed,Not reported,Medical record does not state.,Other: Medical record does not state.,Other,Tumor involves the entire endometrial cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,NA,NA,No,Alcohol consumption history not available,Smoking history not available,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Hydrochlorothiazide |Lisinopril|Metformin (GLUCOPHAGE),NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,388|716|1121,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,Yes|Yes|Yes,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,374.0|702.0|1107.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02403,C3L-02403,No,b3,12,127N,CPT0203150008,Tumor,No,78,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.3,152,73,31.64,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,Stage I,White,2.168436612,CNV_L,No,0.21,MSS,CNV_L,62,WT,Mutated,WT,WT,WT,0,1.32E-18,0,0,2.08E-18,7.23E-18,1.45E-17,5.52E-03,0,1.19E-18,6.61E-18,8.06E-04,2.42E-02,4.13E-18,0,0,0,4.37E-18,0,1.73E-02,9.67E-20,0,4.39E-03,3.72E-03,0,9.28E-19,5.83E-04,0,2.60E-17,1.04E-21,1.92E-02,8.53E-03,0,7.64E-02,0.116689455,9.92E-18,2.48E-03,2.42E-18,2.48E-03,1.09E-02,0,6.97E-02,4.28E-02,0,0.221969431,0,4.16E-02,0,0,0,8.05E-02,5.12E-02,0.186537618,4.27E-03,1.60E-02,0,2.82E-02,0,0.178831222,3.42E-02,3.33E-02,11,23,0,0,0,10,13,0,0,0,0,0.88,NA,NA,0.524381162,-0.743967618,-0.604988673,0.27303969,-2.066452686,-1.428921729,-1.047606387,0.949078836,0.584137212,-1.25762043,-0.950153209,-1.674099253,1.701743818,-1.27778508,1971.012149,1687.928722,3658.940871,Positive for malignancy,Not identified,Cannot be assessed,Not reported,Medical record does not state.,Other: Medical record does not state.,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,NA,NA,No,Lifelong non-drinker,"Current reformed smoker, years unknown",NA,NA,Unknown,NA,Exposure to secondhand smoke history not available,Medical Record,Yes,Medical Record|Medical Record,carbamazepine|hydrochlorthiazide,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|Yes,Living|Living,375|375,Yes|Yes,No|No,No|No,With Tumor|With Tumor,Unknown|Unknown,Unknown|Unknown,Unknown|Unknown,No|No,No|No,Unknown|Unknown,No|No,Persistent Disease|Persistent Disease,Persistent Disease|Persistent Disease,n/a|n/a,Yes|Yes,Distant Metastasis|Distant Metastasis,Liver|Liver,325.0|325.0,No|No,No|No,No|No,No|No,344.0|344.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02408,C3L-02408,No,b3,9,131C,CPT0111720003,Tumor,No,60,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,175,88,28.54,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,2,Stage I,White,3.182216519,CNV_L,No,0.02,MSS,CNV_L,43,WT,Mutated,WT,Mutated,WT,0.115998006,1.11E-02,0,3.38E-18,5.88E-18,5.47E-04,5.09E-02,2.13E-19,2.74E-18,0,0,2.50E-02,1.28E-18,0,7.00E-03,3.73E-02,4.39E-03,1.23E-02,1.07E-18,6.80E-03,5.59E-02,4.33E-02,2.60E-02,1.64E-03,0,1.37E-02,5.61E-19,3.37E-03,4.29E-18,1.55E-02,2.07E-02,3.15E-03,1.15E-18,5.09E-02,1.55E-17,6.55E-20,6.48E-02,2.51E-02,8.99E-02,0,0,2.23E-02,3.30E-02,0,6.01E-02,0,3.23E-02,3.57E-02,0,1.98E-02,0,0,0.491546368,5.58E-03,0.147737178,0,4.94E-04,0,0.116885107,0,3.46E-02,16,26,0,0,0,0,0,0,0,0,0,0.24,NA,NA,0.220732003,0.824924776,0.478561692,1.129040782,-0.51458853,-5.62E-02,1.664753554,1.113795799,-0.516980841,0.109624338,1.936502917,0.943134015,0.147189091,1.046165377,5123.511869,5729.673666,10853.18553,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Uterine Mass,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,NA,NA,NA,NA,Exposure to secondhand smoke history not available,NA,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Multivitamin|Probiotic|Aleve,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|Yes,Living|Living,442|442,No|Unknown,No|Unknown,No|Unknown,Tumor Free|Unknown Tumor Status,Never|Unknown,Former Therapy|Former Therapy,Never|Unknown,No|No,No|No,2|2,No|No,Complete Remission|Unknown,Complete Remission|Unknown,n/a|n/a,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,424.0|424.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02409,C3L-02409,No,b3,9,128C,CPT0111810003,Tumor,No,60,Female,Endometrioid carcinoma,G1 Well differentiated,2,160,98,38.16,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,Stage I,White,8.62E-04,CNV_L,No,4.9,MSS,CNV_L,213,WT,WT,Mutated,Mutated,Mutated,0.127920425,1.90E-02,2.77E-20,0,1.96E-18,0,3.77E-02,2.43E-19,8.74E-19,1.18E-04,2.90E-18,3.50E-03,0,0,6.78E-03,0,0,0,8.79E-18,0,4.10E-03,1.61E-02,1.10E-03,4.66E-04,5.72E-19,4.44E-18,6.24E-03,8.34E-19,1.75E-19,2.03E-02,3.67E-02,1.07E-02,3.92E-19,6.64E-02,1.51E-02,2.65E-02,2.02E-02,0,2.02E-02,1.77E-02,0,0.100500717,0.108031029,0,0.290292754,0,6.15E-02,0,1.58E-02,2.14E-02,1.09E-02,0,2.18E-02,3.83E-02,0.24271605,4.37E-02,2.15E-02,0,1.96E-03,3.86E-03,0,42,21,0,0,0,0,45,0,0,38,18,0.69,NA,NA,1.765120506,0.564339941,-2.352111854,0.254354244,0.560087239,0.560796752,0.372782855,0.63330904,0.983472617,-0.158391359,0.502633446,-0.28393349,0.774743392,1.097352889,3326.749174,4805.566666,8132.315839,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Uterine mass,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,Unknown,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Former Therapy,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Adderall|Dexilant|Tribenzor|Albuterol inhaler|Megestrol Acetate|Potassium Chloride|Melatonin|Multivitamin|Vitamin D3,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|Yes,Living|Living,427|427,No|No,No|No,No|No,Tumor Free|Tumor Free,Former Therapy|Former Therapy,Former Therapy|Former Therapy,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,404.0|404.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02411,C3L-02411,No,b3,10,129C,CPT0111880003,Tumor,No,81,Female,Endometrioid carcinoma,G2 Moderately differentiated,6,155,76,31.63,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,2,Stage I,White,1.741142725,CNV_L,No,30.57,MSI-H,MSI-H,1387,Mutated,Mutated,WT,Mutated,Mutated,7.38E-02,1.21E-19,0,9.55E-18,1.84E-18,5.97E-18,5.85E-18,0,6.16E-18,1.31E-17,0,0,9.82E-03,0,2.43E-19,3.77E-20,0,0,3.70E-18,5.08E-19,7.20E-03,9.83E-03,0,0,0,0,7.70E-04,3.01E-20,3.76E-18,6.26E-02,3.54E-03,1.17E-02,0,0.103303567,9.27E-03,0,4.80E-03,4.59E-03,9.39E-03,0,8.64E-03,1.43E-02,0,0,0.102083916,0,3.92E-02,1.50E-02,0,1.03E-02,0,0,0.346403092,3.29E-03,8.49E-02,0,2.48E-02,0,0.297429038,1.41E-02,3.96E-02,0,93,340,0,0,0,201,231,0,0,143,0.72,NA,NA,-0.653334298,1.426061946,0.606151999,2.487905238,-0.677717126,1.085715164,1.932674343,6.49E-02,-0.154000378,-0.773704446,2.079873501,-1.686194991,1.788934529,0.352786302,2763.797411,3784.427922,6548.225333,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,United States,Other,Uterine Mass,Unifocal,0,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",25,28,10,1.5,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Aleve|Altrace|AmLODIPine Besylate|Calcium|Famotidine|Multivitamin|Ocuvite|Aspirin|Simvastatin,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|Yes,Living|Living,385|784,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,367.0|766.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02412,C3L-02412,No,b1,1,131C,CPT0111950003,Tumor,No,74,Female,Endometrioid carcinoma,G1 Well differentiated,5,152,83,35.79,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,2,Stage I,White,5.18E-02,CNV_L,No,0.15,MSS,CNV_L,78,WT,Mutated,Mutated,Mutated,WT,8.56E-02,5.91E-03,1.67E-20,0,1.12E-17,1.30E-19,1.30E-02,3.82E-18,1.43E-17,3.94E-20,2.98E-18,1.86E-02,4.17E-03,0,1.41E-03,0,2.51E-19,0,4.03E-18,5.05E-03,8.83E-03,9.60E-03,1.47E-02,5.35E-03,1.17E-18,0,3.84E-04,0,2.23E-17,6.85E-03,6.49E-03,5.27E-03,0,9.88E-02,2.14E-02,1.38E-18,1.43E-02,0,1.43E-02,7.27E-03,0,9.77E-03,4.65E-02,0,0.184902803,0,0,5.69E-02,0,8.53E-02,0,4.09E-02,0,1.18E-02,0.422752469,2.58E-03,1.21E-02,6.33E-02,0,5.61E-02,0,28,30,0,0,0,11,0,0,0,0,0,0.55,NA,NA,0.925530522,-0.646528744,-0.176359011,-0.721992448,-8.11E-02,-1.302851061,-0.353073928,8.29E-02,-1.037386416,-1.766782648,-0.351390319,-0.29183766,0.855230241,-0.616219991,2140.034868,3257.757281,5397.792149,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Uterine Mass,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,Unknown,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Former Therapy,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Levothyroxine|Lovastatin|Oxybutynin|Aspirin|Calcium + Vitamin D|Multivitamin|Fish Oil|PreserVision,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,354|656|1110,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Former Therapy|Former Therapy|Former Therapy,Former Therapy|Former Therapy|Former Therapy,Unknown|Unknown|Unknown,No|No|No,No|No|No,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,329.0|631.0|1085.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02449,C3L-02449,No,b3,10,128N,CPT0186720008,Tumor,No,58,Female,Clear cell carcinoma,G3 Poorly differentiated,3.5,163,62,23.34,Present,<50% myometrial invasion,Eighth Edition (2017),pT1a,0,4,IA,Black or African American,NA,NA,Yes,0.04,MSS,POLE,4971,WT,WT,WT,Mutated,Mutated,0.280735109,0.115934873,5.15E-02,2.57E-18,0,1.75E-18,8.87E-02,1.11E-02,0.11887045,0.156832999,0.103774282,3.03E-02,5.12E-02,1.16E-18,7.26E-03,3.12E-03,1.33E-18,0,1.77E-18,1.08E-02,0.121097158,9.21E-02,3.79E-02,5.86E-03,1.65E-03,1.02E-02,2.41E-02,0,1.99E-02,1.98E-02,0.177433185,1.96E-02,6.61E-03,0.159505408,0.253316382,9.39E-03,0.266106727,1.56E-03,0.267667084,2.39E-03,8.38E-03,9.61E-03,0.218345012,0,2.69E-02,4.38E-02,7.79E-02,0,1.08E-02,0,0.192756947,1.64E-02,3.33E-03,0.16084529,0.173853302,3.27E-03,0,4.70E-02,0,0,4.60E-03,189,215,0,0,2288,2259,0,0,0,0,0,NA,NA,NA,-2.504332116,1.04349973,-3.389075924,-0.733873847,2.907446761,2.018156641,1.137366865,-0.153284942,0.560531879,-1.060715759,0.572501364,6.18E-02,1.977527161,-1.708321409,4232.613174,7850.345549,12082.95872,Not Examined,Not identified,Cannot be assessed,Not-Hispanic or Latino,African American,United States,Other,Posterior Endomyometrium,Unifocal,0,0,3,0,0,0,0,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Absent,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record,Yes,Medical Record,Lisinopril,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,461|787|1018|1452,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,461.0|787.0|1018.0|1452.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02468,C3L-02468,No,b2,5,130C,CPT0126000003,Tumor,No,63,Female,Endometrioid carcinoma,G1 Well differentiated,6,157,86,34.82,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,11,Stage I,White,0.110322572,CNV_L,No,0.16,MSS,CNV_L,168,WT,Mutated,WT,WT,WT,7.20E-02,0,0,0,4.46E-18,0,0,6.74E-05,1.32E-02,2.66E-02,0,1.08E-17,2.01E-03,0,4.26E-03,6.64E-02,0,0.303144277,0,0.186393915,8.02E-03,1.40E-02,1.01E-02,0,0,5.01E-18,0,3.44E-19,0,0,1.67E-02,0,0,4.75E-02,0,8.14E-03,1.70E-02,0.191923089,0.208916654,8.43E-02,0,7.23E-02,0.101415408,0,0.265756628,0,2.48E-02,0,0,0,7.62E-02,0,2.49E-02,1.02E-02,0.154901341,7.57E-03,1.81E-02,0.159486207,0,0,0,6,33,53,0,0,0,45,0,0,0,0,0.34,Yes,No,2.530011759,-1.573755029,-0.427557694,-1.155008403,0.163870676,-1.891298456,-0.548637648,-0.659051556,-0.620247876,0.966082411,-0.420254571,0.240475841,-4.85E-02,-0.45084239,5934.88564,4821.034666,10755.92031,Not Examined,Present,Margins uninvolved by invasive carcinoma,Hispanic or Latino,Caucasian,United States,Other,Anterior and Posterior Endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Smoking history not available,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,1,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,Unknown,Unknown,No,Yes,Unknown,Unknown,Unknown,Unknown,n/a,Unknown,n/a,n/a,n/a,n/a,n/a,n/a,n/a,1,n/a,n/a,n/a,n/a,n/a
C3L-02545,C3L-02545,No,b3,10,127C,CPT0113060003,Tumor,No,55,Female,Endometrioid carcinoma,G1 Well differentiated,20,175,134,43.76,Present,=50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pN2 (FIGO IIIC2),9,Stage III,White,1.309762883,CNV_L,No,0.18,MSS,CNV_L,50,WT,WT,Mutated,Mutated,Mutated,0,2.42E-18,1.21E-18,4.27E-18,2.16E-18,0,1.11E-17,0,2.33E-18,1.26E-17,0,0,2.42E-02,0,0,2.21E-03,0,3.57E-17,0,8.88E-03,0,0,3.83E-04,1.46E-03,0,1.09E-17,2.00E-03,1.38E-18,3.59E-19,0,1.25E-18,6.04E-03,1.24E-17,3.17E-02,1.80E-18,0,9.74E-04,1.10E-03,2.08E-03,0.13244133,0,6.20E-02,0,0,0.276946099,0,7.19E-02,0,0,0,5.66E-02,5.73E-02,2.87E-02,0,0.106734243,0,7.98E-02,0,6.13E-02,5.94E-02,6.89E-03,14,34,0,0,0,0,0,0,0,0,0,0.62,Yes,No,-1.035116488,1.384020416,-1.590689016,1.422513221,-0.974504776,1.021570706,-1.223645756,0.505641544,-0.471251062,-1.733072855,-0.97792523,-1.808847395,1.594489641,1.278755187,1096.432541,1618.092058,2714.524599,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,3,4,IHC staining not done,3,13,IHC staining not done,6,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,25,NA,10,15,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,"Advair Diskus|Lasix |Lisinopril|Zyrtec|Actos|Tylenol extra strength|MetroCream topical cream|Nystatin cream |ProAir HFA|Lipitor|CeleBREX 200 mg| Motrin IB 200 mg|Prevacid 30mg|Zofran 4 mg|Protonix 40 mg |triamcinolone 0.1% Cream|Tylenol 8 Hour 650 mg oral tablet,|Glucophage 850 mg oral tablet",NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,356|686|1069|1432,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,356.0|686.0|1069.0|1432.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02555,C3L-02555,No,b1,2,127N,CPT0128370003,Tumor,No,71,Female,Endometrioid carcinoma,G1 Well differentiated,4,157,137,55.3,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,White,0.321691537,CNV_L,No,0,MSS,CNV_L,29,WT,Mutated,WT,Mutated,WT,9.10E-02,0,2.35E-19,0,0,0,5.19E-03,0,1.55E-19,1.02E-02,7.07E-19,0,7.04E-03,2.15E-03,1.09E-02,2.79E-02,2.20E-03,0.221278411,0,0.10293007,8.28E-03,1.23E-02,2.62E-03,6.99E-03,0,4.16E-03,0,2.87E-03,0,4.10E-03,1.28E-02,0,0,3.13E-02,2.97E-02,0,2.36E-02,0.138481455,0.162087047,0,1.31E-02,4.17E-02,6.22E-03,0,0.271539543,0,1.98E-02,3.24E-03,0,0,7.06E-02,0,6.78E-02,3.06E-02,0.214448819,2.77E-02,4.10E-02,0.109887591,0,0,8.23E-02,6,8,0,0,0,0,0,0,0,11,0,0.28,NA,NA,0.730573088,0.2194551,0.904615117,-0.773859855,0.600982588,-0.336610101,0.877717236,0.776917366,-0.742086405,0.909248452,0.986073372,0.732167066,-0.910661952,0.548064114,5856.975157,4881.545196,10738.52035,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Aspirin|Cozaar|Toprol-XL,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Deceased,323|685|1059|1421,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,No|No|No|No,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,323.0|685.0|1059.0|n/a,n/a|n/a|n/a|Other : Acute Respiratory Failure,n/a|n/a|n/a|1421.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02557,C3L-02557,No,b3,12,130N,CPT0128610003,Tumor,No,60,Female,Endometrioid carcinoma,G3 Poorly differentiated,3.5,173,62,20.69,Not identified,NA,Seventh Edition (2010),pT1a (FIGO IA),pN0,0,Stage I,White,22.0323639,CNV_H,Yes,0.28,MSS,POLE,10579,Mutated,Mutated,Mutated,Mutated,Mutated,0.220211953,5.10E-02,1.69E-02,5.55E-19,6.69E-04,1.24E-18,1.21E-02,1.31E-02,8.83E-03,3.60E-02,8.54E-03,1.50E-02,1.25E-02,3.11E-18,1.05E-02,8.92E-20,3.37E-18,5.82E-18,7.98E-19,0,7.25E-02,5.25E-02,2.65E-02,2.73E-03,0,0,1.17E-03,0,1.21E-18,2.28E-02,9.78E-02,3.28E-02,0,0.111273874,0.382940999,1.22E-02,9.75E-02,2.95E-18,9.75E-02,1.76E-02,0,7.00E-02,0.15254295,0,6.31E-02,5.22E-02,9.29E-02,0,5.22E-03,0,0.104300943,0,4.25E-02,0.116217161,0.28169176,0,0,0,0,0,1.74E-03,499,638,0,0,5226,4189,0,0,0,0,0,0.26,Yes,Yes,-1.423493372,-0.150835025,-0.981849085,1.746109297,1.274855061,0.46070137,-1.254264295,-1.456454739,0.255014024,-1.441478311,-1.543809731,-1.0709663,0.808796046,-3.59E-02,2769.3066,5475.036872,8244.343472,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Both anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,8,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,Yes,Cannot be determined,Yes,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,p16 & p53: Neoplastic cells demonstrate patchy positivity,Pancytokeratin stain: no tumor cells are identified,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Aspirin|Ferrous sulfate|Metformin|Novolin N Relion,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,335|654|1042|1375,No|No|No|No,No|No|No|No,No|No|No|No,Unknown Tumor Status|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,3|3|3|3,No|No|No|No,Not Applicable|Not Applicable|Not Applicable|Not Applicable,Unknown|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,335.0|654.0|1042.0|1375.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02602,C3L-02602,No,b3,12,127C,CPT0113910003,Tumor,No,57,Female,Endometrioid carcinoma,G3 Poorly differentiated,4.2,173,101,33.75,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,4,Stage I,White,1.32E-03,CNV_L,No,26.59,MSI-H,MSI-H,832,WT,WT,WT,Mutated,Mutated,3.34E-19,5.10E-04,3.76E-19,0,6.26E-19,0,0,4.44E-19,3.62E-19,4.89E-20,3.03E-18,4.75E-03,5.87E-03,0,4.90E-20,1.19E-02,0,6.60E-18,0,2.55E-02,3.24E-04,3.85E-20,7.84E-03,5.28E-03,7.01E-18,0,0,2.38E-20,5.72E-19,3.21E-02,2.44E-03,1.07E-02,1.56E-17,9.92E-02,0.152285652,0,4.07E-03,5.96E-03,1.00E-02,0,0,7.02E-02,1.38E-02,0,0.110649004,0,9.53E-02,0,0,0,0.133048471,4.63E-03,4.78E-02,0,0.333095274,0,8.90E-02,9.45E-02,0,8.02E-03,0,0,111,351,0,0,0,0,76,0,0,67,0.57,NA,NA,-1.087374265,0.396265585,-0.37634493,-0.991307533,-0.927092155,-0.242996616,-1.262112281,0.66364367,-1.543802576,-1.215483159,-1.233692111,-1.935854835,0.824210479,-1.660052003,1652.649136,1906.465199,3559.114335,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,4,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record,Yes,Medical Record,Vitamin D 2000,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,329|692|1010|1431,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,No|No|No|No,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,329.0|692.0|1010.0|1431.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3L-02741,C3L-02741,No,b1,2,128N,CPT0188190004,Tumor,No,59,Female,Endometrioid carcinoma,G1 Well differentiated,4.2,155,109,45.34,Present,<50% myometrial invasion,Eighth Edition (2017),pT1a [IA],pN0,3,pT1a [IA],White,0,CNV_L,No,0.01,MSS,CNV_L,78,WT,Mutated,Mutated,Mutated,Mutated,0.126942286,2.15E-02,1.71E-02,0,0,2.07E-18,3.35E-02,3.02E-03,2.14E-02,6.28E-02,0,6.40E-03,7.92E-03,1.60E-19,5.97E-03,0,7.52E-04,6.65E-18,6.97E-19,9.47E-03,3.51E-02,2.66E-02,1.44E-02,2.66E-03,0,1.50E-18,6.43E-03,9.63E-21,0,0,6.27E-02,7.23E-03,0,3.31E-02,0.100821553,1.10E-02,5.82E-02,3.32E-18,5.82E-02,2.68E-02,0,3.61E-02,5.27E-02,0,0.280410779,1.16E-02,5.20E-02,0,2.63E-02,0,4.09E-02,0,4.53E-02,8.59E-02,0.201740993,5.55E-02,0,0,0,3.42E-02,5.05E-02,17,32,21,0,0,0,0,0,0,0,0,0.46,Yes,Yes,0.394003455,-0.260573858,0.954144865,-0.1668009,0.595689226,0.273563673,0.532828325,0.731187029,0.373708248,-0.416185648,0.578089144,0.159976594,-0.218940957,1.024427815,4333.180519,5202.11138,9535.291899,Not Examined,Present,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Endometrium,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Lantus|Metformin|Allopurinol|Simvastatin|Metoprolol|Vitamin D,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,414|750,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Former Therapy|Former Therapy,Never|Never,Yes|Yes,Yes|Yes,1|1,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,371.0|707.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-02744,C3L-02744,No,b2,6,128N,CPT0188370003,Tumor,No,73,Female,Serous carcinoma,G3 Poorly differentiated,3.2,157,82,32.92,Present,<50% myometrial invasion,Eighth Edition (2017),pT1a [IA],pN0,2,pT1aN0,White,13.89818603,CNV_H,No,0.64,MSS,CNV_H,72,Mutated,Mutated,WT,WT,WT,0.138868154,3.44E-02,3.30E-03,0,3.52E-19,6.03E-03,0,5.85E-19,3.31E-03,1.25E-03,4.72E-18,0,6.03E-03,0,3.64E-03,8.74E-19,5.07E-20,2.35E-19,0,0,1.59E-02,2.95E-02,1.56E-03,9.53E-03,2.97E-03,0,1.09E-02,0,0,4.19E-02,3.62E-02,1.53E-02,8.20E-18,4.62E-02,9.80E-02,7.17E-03,4.45E-02,5.54E-19,4.45E-02,0,0,2.77E-02,0.116519696,0,0.135637399,0,0.127290393,0,0,0,5.12E-02,6.19E-03,8.33E-02,0.138718106,0.272059461,0,1.69E-02,0,2.19E-02,2.63E-03,0,17,52,0,0,0,0,0,0,0,0,0,0.81,NA,NA,-0.591102835,-0.607538601,-1.592816372,-0.269396188,1.790264105,3.63E-02,-0.305010908,-0.603350865,0.753250993,-1.048370597,-0.641485937,-0.90309894,-0.150361494,7.96E-02,2676.453008,3594.013095,6270.466102,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,Other: Unknown,Other,Endometrium,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Positive : 10 %,Negative,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Overexpression,Yes,Cannot be determined,Yes,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,4 or more,p16 - Overexpression,Ki-67 - 80%,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Lisinopril|Hydrochlorothiazide|Lovastatin,NA,NA,NA,NA,Yes,2,12 Months,Yes,Living,455,No,Yes,No,Unknown Tumor Status,Never,Former Therapy,Never,Yes,No,4 or more,No,Unknown,Unknown,n/a,Unknown,n/a,n/a,n/a,n/a,n/a,n/a,n/a,407,n/a,n/a,n/a,n/a,n/a
C3L-02746,C3L-02746,No,b2,6,130N,CPT0188270004,Tumor,No,66,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.8,160,98,38.26,Present,=50% myometrial invasion,Eighth Edition (2017),pT1b,pN0,2,Stage IB,White,5.79E-03,CNV_L,No,0.15,MSS,CNV_L,66,WT,Mutated,WT,WT,WT,6.95E-02,1.26E-02,6.15E-20,0,0,2.10E-18,0,0,2.16E-19,7.09E-03,0,5.92E-03,7.51E-03,4.94E-19,3.67E-04,2.48E-19,0,1.60E-18,0,3.99E-02,8.80E-03,5.85E-03,1.19E-02,1.07E-03,0,0,7.08E-03,0,1.74E-18,5.57E-18,9.68E-03,8.33E-03,0,9.51E-03,9.31E-02,8.07E-03,1.52E-02,9.23E-19,1.52E-02,1.92E-02,0,0.124264868,7.12E-02,0,0.157472456,0,8.32E-02,0,0,0,3.95E-02,1.20E-02,2.82E-02,0,0.278203367,0,7.26E-02,0,4.20E-02,2.23E-02,4.98E-02,22,38,0,0,0,0,0,0,0,0,0,0.52,Yes,Yes,0.728367234,1.16830713,1.152749632,-0.407007597,0.657242715,0.899014175,5.75E-02,1.238954416,0.607780177,-0.486863626,9.67E-02,-0.535969293,-0.328143904,6.61E-02,3458.857808,3687.508458,7146.366266,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Endometrium,Unifocal,0,0,1,0,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self Report|Self Report|Self Report,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Alpha Lipoic Acid|Aspirin |Calcium|Cinnamon|Cranberry|Januvia|Metformin|Vitamin B-12|Vitamin C|Vitamin E,NA,NA,NA,NA,Yes,2,12 Months,Yes,Living,313,Yes,No,No,Unknown Tumor Status,Never,Never,Never,Yes,No,2,No,Unknown,Unknown,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,288,n/a,n/a,n/a,n/a,n/a
C3L-02747,C3L-02747,No,b2,6,129N,CPT0188480004,Tumor,No,66,Female,Endometrioid carcinoma,G2 Moderately differentiated,0,160,74,28.85,Present,<50% myometrial invasion,Eighth Edition (2017),pT1a [IA],pN0,2,Stage IA,White,0.16469716,CNV_L,No,0.02,MSS,CNV_L,79,Mutated,Mutated,Mutated,WT,WT,4.12E-02,1.05E-22,8.70E-04,4.52E-18,0,4.80E-18,2.41E-02,9.86E-03,5.64E-02,7.24E-02,0,0,1.75E-02,4.40E-18,4.51E-03,8.37E-03,1.84E-18,0.132000137,0,4.81E-02,0,1.00E-03,9.73E-04,2.88E-03,1.71E-18,0,2.58E-03,0,4.18E-19,0,3.99E-02,7.99E-03,1.47E-18,0,0.122991193,1.71E-03,4.25E-02,7.17E-02,0.114212713,6.42E-02,0,9.01E-02,5.63E-02,0,0.241969113,0,8.69E-02,0,9.07E-02,0,2.89E-02,0,5.58E-02,3.88E-02,0.15366573,2.64E-04,5.30E-02,1.25E-02,0,1.59E-02,1.09E-02,16,37,0,0,0,0,18,0,0,0,0,0.23,NA,NA,0.556301124,-3.46E-02,2.356294556,-0.900618903,0.195743885,7.99E-02,-7.87E-02,0.506302618,-0.775327931,0.533758841,-0.189949983,-0.638969563,-1.566650249,0.740481676,4853.985643,4050.826376,8904.812019,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Endometrium,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Current Therapy,None,NA,NA,Yes,Lifelong non-drinker,"Current reformed smoker, more than 15 years",19,28,5,2.3,Exposure to secondhand smoke history not available,Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Progesterone |Thyroid TABS|Vitamin D,Basal Cell Cancer,Self-reported and Medical Record,Other(Mohs treatment),Yes,Yes,2,12 Months,Yes,Living,355,No,No,No,Tumor Free,Former Therapy,Never,Never,No,No,None,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,321,n/a,n/a,n/a,n/a,n/a
C3L-02800,C3L-02800,No,b3,11,129C,CPT0186900008,Tumor,No,62,Female,Endometrioid carcinoma,G2 Moderately differentiated,8,160,44,17.36,Present,=50% myometrial invasion,Eighth Edition (2017),1b,1,7,IIIC1,Not Reported,0,CNV_L,No,0.04,MSS,CNV_L,77,WT,Mutated,WT,Mutated,WT,0.13088719,5.54E-02,2.39E-20,0,3.10E-18,5.36E-18,2.03E-02,5.60E-19,5.80E-19,1.30E-02,1.86E-18,3.28E-03,0,4.58E-19,4.00E-03,0,2.91E-03,0,0,2.51E-02,9.02E-02,5.21E-02,4.67E-02,8.00E-03,4.24E-03,3.04E-02,1.26E-02,4.66E-03,1.83E-18,0,3.64E-02,1.13E-02,0,2.48E-02,0,6.41E-03,0.130438247,2.67E-19,0.130438247,0,4.00E-02,6.39E-02,3.20E-02,0,0.191386648,0,2.59E-05,0,0,2.46E-03,7.08E-02,2.80E-02,0,0,0.393414602,0,4.46E-02,9.10E-03,0,4.87E-03,0.119450398,34,35,0,0,0,0,0,0,0,0,0,0.34,NA,NA,0.916979191,0.328143467,-0.133290382,1.07839776,0.800271123,-0.184025007,1.53154745,2.035646258,0.126621444,-0.617025882,1.690917707,1.075984327,0.427187422,0.207440286,4542.005739,5923.57068,10465.57642,Not Examined,Not identified,Cannot be assessed,Not reported,Patient did not disclose,Other: Patient did not disclose,Other,"anterior and posterior endomyometrium, lower uterine segment",Unifocal,3,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Absent,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Coumadin|Toprol XL|Lasix,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,333|782|1099,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Never|Never|Never,Yes|Yes|Yes,No|No|No,4 or more|4 or more|4 or more,No|No|No,Unknown|Unknown|Unknown,Complete Remission|n/a|n/a,n/a|Complete Remission|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,333.0|782.0|1099.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02802,C3L-02802,No,b1,3,130N,CPT0174890008,Tumor,No,56,Female,Endometrioid carcinoma,G1 Well differentiated,5.6,170,118,40.75,Present,<50% myometrial invasion,Eighth Edition (2017),pT2 (FIGO II),pN0,5,Stage II,White,NA,NA,No,0.01,MSS,NA,62,WT,Mutated,WT,WT,WT,7.50E-02,3.73E-02,0,0,1.84E-18,7.48E-19,0,3.96E-19,0,1.54E-04,1.16E-18,3.11E-02,2.01E-03,0,6.91E-03,4.59E-03,0,3.39E-02,0,7.58E-02,5.46E-03,7.47E-03,1.24E-02,6.88E-03,0,5.58E-18,1.16E-02,9.66E-19,8.41E-19,3.07E-18,2.87E-02,4.08E-03,0,1.94E-02,5.12E-02,2.00E-02,3.77E-02,1.95E-02,5.72E-02,0,0,0.101281922,3.00E-02,0,0.279683089,0,2.80E-02,0,0,3.21E-02,3.27E-02,1.36E-02,0,1.16E-02,0.350116517,4.78E-02,0,7.33E-02,0,0,0,17,37,0,0,0,0,0,0,0,0,0,NA,Yes,Yes,0.775085641,-1.558194899,-0.390610225,-1.030024653,-0.513403734,-1.015309655,-0.415125526,0.732860877,-0.243031102,-0.346188022,-0.464713404,0.311253083,-0.350183655,-0.646846385,4250.972659,4203.374447,8454.347106,Atypical and/or suspicious,Not identified,Cannot be assessed,Not-Hispanic or Latino,Caucasian,Other: TSS did not collect this information.,Other,Anterior and posterior endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,3,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,1,NA,NA,Unknown,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,Unknown,Unknown,Unknown,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Lisinopril|Metformin|Paroxetine,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|Yes,Living|Living|Living,404|690|844,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown Tumor Status|Unknown Tumor Status|Unknown Tumor Status,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,Yes|Yes|Yes,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|n/a,n/a|n/a|Unknown,Unknown|Unknown|Unknown,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,404.0|690.0|844.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02894,C3L-02894,No,b2,8,129C,CPT0196790004,Tumor,No,67,Female,Serous carcinoma,G3 Poorly differentiated,9,170,124,42.75,Present,<50% myometrial invasion,Eighth Edition (2017),pT3b,pN1,1,IVB,White,32.26682434,CNV_H,No,0.47,MSS,CNV_H,31,Mutated,WT,WT,WT,Mutated,0.116052251,3.07E-03,0,0,0,4.91E-18,6.54E-19,0,3.55E-03,2.64E-02,9.10E-20,2.03E-03,1.44E-02,0,9.05E-03,4.18E-03,6.22E-03,3.08E-18,4.12E-18,4.47E-02,1.96E-02,1.19E-02,6.14E-03,1.44E-02,7.20E-19,2.91E-04,1.05E-03,0,8.45E-18,6.31E-02,1.75E-02,1.37E-02,4.12E-03,2.67E-02,7.72E-02,3.53E-02,3.75E-02,2.09E-03,3.96E-02,1.87E-02,0,3.92E-02,4.22E-03,0,0.389947278,1.24E-02,3.43E-02,0,0,1.82E-02,3.76E-02,0,0,0.125831425,0.308898825,8.39E-03,2.21E-03,0,0,0,0,0,10,13,0,0,6,0,0,0,0,0,0.5,NA,NA,-0.302656356,-1.89215291,1.717822789,5.69E-02,1.634944881,-2.429994437,-0.345932677,-0.717609346,1.553613754,-0.920875207,-0.557953488,-0.147590392,0.335801798,-1.614018749,3864.565935,4180.945317,8045.511252,Positive for malignancy,Not identified,Margin(s) involved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Anterior endometrium,NA,Unifocal,IHC staining not done,1,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,R2:  Macroscopic residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Overexpression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,None,Ki-67 is increased,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Allopurinol|Neurontin|lisinopril |toprol XL|multivitamin,NA,NA,NA,NA,Yes,1,12 Months,No,Deceased,428,Yes,Yes,No,With Tumor,Unknown,Unknown,Unknown,No,No,None,No,Persistent Disease,Patient Deceased,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Other : Serous carcinoma of uterine,431,n/a,n/a,n/a
C3L-02953,C3L-02953,No,b4,14,129N,CPT0161590008,Tumor,No,56,Female,Endometrioid carcinoma,G1 Well differentiated,3.5,160,83,32.42,Not identified,NA,Seventh Edition (2010),pT1a (FIGO IA),pN0,0,Stage I,White,3.002217572,CNV_L,No,0.04,MSS,CNV_L,50,WT,Mutated,WT,Mutated,WT,2.31E-02,7.82E-03,6.78E-03,6.67E-19,7.14E-18,1.22E-17,2.04E-18,3.33E-03,1.26E-19,8.50E-03,5.55E-18,9.18E-03,3.82E-02,4.19E-19,2.20E-03,9.63E-19,1.58E-19,5.59E-03,0,5.43E-02,2.76E-04,0,6.97E-03,3.88E-03,2.69E-18,0,6.96E-03,0,0,0,7.73E-03,1.12E-02,0,7.74E-02,0.141421964,0,9.45E-03,2.80E-03,1.22E-02,1.99E-02,0,0,0,0,0.403147937,0,0,0,4.34E-02,0,8.87E-02,0,0,4.23E-02,0.197120605,0.101290754,1.55E-02,6.24E-02,0,2.62E-02,0,18,30,0,0,0,0,0,0,0,0,0,0.25,NA,NA,-0.809465177,-1.892438555,0.368169932,-1.520651544,-0.325254897,-2.145732302,-0.732143709,-0.576884602,-0.264900823,-1.028471118,-0.744663868,-0.435615665,0.207689789,-0.978108343,2859.960218,3016.273958,5876.234176,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Hispanic or Latino,Hispanic,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,0,0,IHC staining not done,0,5,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,4 or more,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Flonase|lisinopril |imitrex,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,464|652|1063,No|No|No,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Never|Never|Never,Yes|Yes|Yes,No|No|No,4 or more|4 or more|4 or more,No|No|No,Not Applicable|Not Applicable|Not Applicable,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,464.0|652.0|1063.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-02990,C3L-02990,No,b2,6,131N,CPT0238260003,Tumor,No,67,Female,Serous carcinoma,G3 Poorly differentiated,5.3,155,53,22.2,Present,=50% myometrial invasion,Eighth Edition (2017),pT1b,pN1,3,IB,White,15.39006414,CNV_H,No,1.17,MSS,CNV_H,72,Mutated,WT,WT,WT,WT,7.91E-02,2.84E-02,3.56E-03,2.10E-18,1.63E-19,7.55E-19,5.20E-18,1.10E-02,2.39E-19,3.62E-03,2.84E-18,8.89E-19,1.94E-02,6.46E-19,0,1.90E-03,2.14E-19,1.28E-02,1.59E-17,1.64E-02,1.64E-02,2.42E-02,2.07E-03,1.02E-03,2.11E-03,0,5.55E-03,5.78E-19,0,1.12E-02,3.43E-02,6.71E-03,1.18E-02,7.66E-02,0.179428212,0,3.05E-02,9.26E-03,3.98E-02,2.33E-03,0,2.33E-04,5.97E-02,0,0.249125649,1.67E-02,2.25E-02,0,2.69E-02,0,6.90E-02,0,0,0.108754988,0.29473712,0,8.08E-02,0,4.80E-02,0,2.11E-02,23,47,0,0,0,0,0,0,0,0,0,0.79,NA,NA,-1.136808914,-0.18967163,-2.065544496,-1.377735401,0.626819451,0.784653339,-0.705770149,-1.190684684,0.328633076,-0.327609874,-0.981983691,-1.717230186,-0.673944479,-0.457005729,3038.314743,3320.857845,6359.172588,Not Examined,Not identified,Cannot be assessed,Not-Hispanic or Latino,Caucasian,United States,Other,Endomyometrium - posterior and anterior,Multifocal,1,1,0,0,0,0,0,0,IB,R0:  No residual tumor,Positive : % Not available,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,"CD10=possible stroma, Ki-67 proliferative, Her2neu negative, P16 positive, Wilms Tumor positive, Beta-Catenin Positive, PTEN positive",NA,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",23,63,Unknown,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Medical Record|Medical Record,Naproxen|Valtrex|Evista|Melatonin|Magnesium Oxide|Calcium Citrate D3,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,274,Yes,Yes,No,Unknown Tumor Status,Former Therapy,Unknown,Never,No,No,None,No,Not Applicable,Not Applicable,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,251,n/a,n/a,n/a,n/a,n/a
C3L-03143,C3L-03143,No,b4,15,127N,CPT0234080003,Tumor,No,67,Female,Serous carcinoma,Other: Not specified.,6,165,76,27.79,Present,<50% myometrial invasion,Eighth Edition (2017),pT3b,Not assessed,Unknown value,IVB,Asian,48.06698584,CNV_H,No,0.74,MSS,CNV_H,80,Mutated,WT,WT,WT,WT,0.164961528,4.83E-02,6.25E-03,1.15E-18,0,7.38E-18,0,3.71E-03,0,6.37E-03,0,1.19E-02,3.88E-02,0,4.46E-03,2.56E-03,4.75E-19,3.44E-18,2.30E-18,2.07E-02,8.89E-02,6.63E-02,6.30E-02,1.19E-02,0,5.68E-03,4.51E-03,0,3.32E-18,1.21E-02,3.07E-02,2.06E-02,1.97E-02,0.156393402,0.121081541,0,0.106185887,1.28E-03,0.107466999,5.61E-03,0,5.93E-02,1.44E-02,0,0.156323105,0,2.81E-02,8.87E-03,0,0,6.09E-02,4.56E-03,0.1251209,3.23E-02,0.484311913,0,1.50E-03,1.13E-02,0,0,7.51E-03,18,58,0,0,0,0,0,0,0,0,0,0.24,Yes,No,-1.795173579,-0.242445775,-1.823740404,-0.325799406,0.280835724,-0.917153033,-0.338774305,-2.406594955,0.661974435,-1.186250662,-0.492380375,-0.5718681,1.742996723,-1.638259025,3480.166403,5296.123459,8776.289862,Not Examined,Not identified,Margin(s) involved by invasive carcinoma,Not-Hispanic or Latino,Indian,Other: India,Anterior endometrium,NA,Multifocal,IHC staining not done,0,Unknown value,IHC staining not done,0,Unknown value,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Unknown,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record,No,NA,NA,Breast,Medical Record,"Radiation,Surgery",Yes,Yes,2,12 Months|24 Months,No|No,Living|Living,389|767,Yes|Yes,Yes|Yes,No|No,With Tumor|With Tumor,Unknown|Unknown,Unknown|Unknown,Former Therapy|Former Therapy,Yes|Yes,Yes|Yes,2|2,No|No,Unknown|Unknown,Persistent Disease|Persistent Disease,n/a|n/a,No|Yes,n/a|Distant Metastasis,n/a|Other: retroperitoneal lymph nodes and left axilary lymph node,n/a|585.0,n/a|No,n/a|Yes,n/a|No,n/a|No,389.0|767.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-03264,C3L-03264,No,b4,13,131C,CPT0225010003,Tumor,No,73,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.5,160,91,35.43,Present,=50% myometrial invasion,Eighth Edition (2017),pT1b (FIGO IB),pN0,17,Stage IB,White,3.684774312,CNV_L,No,13.39,MSI-H,MSI-H,773,Mutated,Mutated,WT,Mutated,Mutated,0.26994991,8.37E-02,1.74E-02,7.77E-18,0,0,3.05E-02,2.20E-03,3.46E-02,7.49E-02,2.19E-02,1.68E-03,2.71E-02,0,7.36E-03,0,0,5.08E-19,0,1.02E-19,0.14831925,9.96E-02,7.29E-02,5.61E-03,3.21E-05,5.49E-03,7.90E-03,7.70E-03,4.61E-18,9.22E-03,0.121754587,2.86E-02,3.94E-02,0.134016256,0.272077579,0,0.195172954,4.93E-19,0.195172954,0,1.76E-03,4.31E-02,0.182054303,0,1.80E-02,7.74E-02,5.12E-02,1.48E-02,0,0,8.77E-02,0,5.52E-02,0.141830531,0.197392313,0,0,4.59E-02,0,0,8.37E-02,69,16,0,0,0,0,143,124,0,169,64,0.54,NA,NA,-2.200524627,1.135158314,-1.546455211,0.494836154,2.795392137,1.031519067,2.063841158,-2.164076062,2.171478151,-1.515637629,1.695372992,0.372870976,1.037453216,-1.942804878,3734.259429,7173.677855,10907.93728,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Caucasian,United States,Posterior endometrium,NA,Unifocal,IHC staining not done,0,12,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Atenolol|Diltiazem HCL|Hydrochlorothiazide|Meloxicam|Metformin|Toviaz|Voltaren (topical)|Vytorin|Xarelto|Xiidra|Docusate Sodium|Polyethylene Glycol|Potassium Chloride|Senna,Melanoma,Medical Record,Unknown,Unknown,Yes,2,12 Months|24 Months,No|No,Living|Living,507|847,Yes|Yes,No|No,No|No,Unknown Tumor Status|Unknown Tumor Status,Unknown|Unknown,Unknown|Unknown,Unknown|Unknown,Yes|Yes,No|No,2|2,No|No,Unknown|Unknown,Unknown|Unknown,n/a|n/a,Unknown|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,507.0|847.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-03467,C3L-03467,No,b1,4,128C,CPT0188610003,Tumor,No,73,Female,Serous carcinoma,G3 Poorly differentiated,3.2,160,83,32.59,Present,=50% myometrial invasion,Eighth Edition (2017),pT2 [II],pN1 [IIIC1,5,Stage IIIC1: T1-3/N1/M0,White,44.08377525,CNV_H,No,0.22,MSS,CNV_H,57,Mutated,WT,WT,WT,WT,3.32E-02,4.02E-02,1.28E-20,1.54E-18,5.93E-18,6.21E-18,6.35E-19,1.15E-18,1.45E-19,0,1.29E-17,0,1.36E-02,2.28E-03,4.62E-20,0,0,0,1.90E-02,1.65E-02,1.23E-03,2.17E-03,9.99E-03,1.79E-02,6.40E-03,2.14E-18,1.50E-02,2.53E-21,8.70E-18,1.80E-19,0,6.56E-03,0,1.28E-02,9.18E-02,6.49E-18,3.96E-02,1.77E-03,4.13E-02,0.128349982,0,1.40E-02,0.106646197,0,0.124215886,0,7.69E-02,0,0,0,2.63E-02,7.18E-03,5.29E-02,2.24E-02,0.20326056,1.23E-03,1.95E-02,7.26E-02,0.113727205,2.60E-02,4.89E-03,21,32,0,0,0,0,0,0,0,0,0,0.24,NA,NA,-0.73986979,-6.77E-02,-3.18E-02,-0.945841428,1.09690119,0.712829537,0.680169252,-0.979397066,-1.112269404,0.336409659,0.638153991,-0.159035122,-0.935291549,0.285347859,3473.636966,3185.651842,6659.288808,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Endometrium,Unifocal,1,1,7,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Former Therapy,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Famotidine|Levothyroxine Sodium|Lexapro|Vitamin B12|Vitamin D,NA,NA,NA,NA,Yes,2,12 Months,Yes,Living,410,No,Yes,No,Tumor Free,Former Therapy,Former Therapy,Never,No,No,2,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,383,n/a,n/a,n/a,n/a,n/a
C3L-03589,C3L-03589,No,b3,9,130C,CPT0188710003,Tumor,No,59,Female,Endometrioid carcinoma,G2 Moderately differentiated,0.7,173,130,43.48,Not identified,NA,Eighth Edition (2017),pT1a [IA],pN0,4,Stage IA,White,0,CNV_L,No,24.9,MSI-H,MSI-H,762,WT,Mutated,WT,Mutated,WT,5.45E-02,1.10E-02,0,0,0,1.29E-17,8.15E-19,0,1.23E-18,2.02E-18,8.40E-18,3.63E-20,3.09E-02,8.92E-18,3.51E-03,5.66E-21,2.46E-18,0,2.58E-18,9.83E-03,8.67E-03,6.39E-03,3.75E-03,1.81E-03,0,5.81E-19,5.59E-03,7.06E-19,4.29E-17,1.54E-02,3.29E-02,1.51E-02,3.91E-18,5.61E-02,0.146281241,0,1.66E-02,1.26E-20,1.66E-02,4.93E-02,0,5.94E-02,4.50E-02,0,0.146977081,2.45E-02,4.97E-02,0,0,0,3.40E-02,0,0.125292068,6.68E-02,0.138192484,5.25E-03,0,0,0.166581636,1.71E-02,7.19E-02,0,115,238,0,0,0,0,127,0,0,103,0.5,NA,NA,-0.356254436,0.949837004,0.732015304,0.344629367,-0.336280134,1.364646756,1.918183314,-0.307795601,0.35610709,-0.921718338,1.796789357,-1.247110478,2.065531641,5.10E-02,2482.930503,4395.756138,6878.686641,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,White,United States,Other,Endometrium,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Loss of nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of nuclear expression,Cannot be determined,No,Present,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,14,58,Unknown,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Esomeprazole Magnesium|Levothyroxine |Simvastatin,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|Yes,Living|Living,427|883,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Unknown|Unknown,Yes|Yes,No|No,None|None,No|No,Complete Remission|Complete Remission,Unknown|Unknown,n/a|n/a,Unknown|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,417.0|873.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-05571,C3L-05571,No,b4,16,131N,CPT0275270003.1,Tumor,No,58,Female,Serous carcinoma,G3 Poorly differentiated,8.2,165,86,31.48,Present,=50% myometrial invasion,Eighth Edition (2017),1b,1a,14,-1,Black or African American,17.9472104,CNV_H,No,0.09,MSS,CNV_H,42,Mutated,WT,WT,WT,Mutated,0.114268749,5.35E-03,1.15E-20,0,3.46E-18,9.53E-19,0,4.21E-03,0,4.60E-19,0,3.97E-18,7.08E-03,0,1.94E-03,2.80E-20,3.98E-19,5.25E-18,0,5.70E-02,1.51E-02,1.88E-02,8.26E-03,3.66E-03,0,0,2.35E-03,2.32E-19,5.04E-18,7.90E-03,3.39E-02,1.23E-03,0,5.10E-02,0.148970878,0,1.73E-02,2.70E-18,1.73E-02,5.48E-02,0,7.14E-03,7.03E-03,0,0.222205039,0,3.44E-02,2.00E-02,0,5.87E-02,0,2.49E-02,7.91E-02,4.01E-02,0.274873476,0,8.01E-02,0,1.94E-02,6.02E-02,1.69E-02,18,20,0,0,0,0,0,0,0,0,0,0.21,NA,NA,-1.384619954,-0.314596071,-1.131237614,0.41941826,2.268785111,0.304576868,-0.13962301,-1.0273441,1.154439286,-0.551835445,-0.184775839,-0.463593241,0.806508233,0.519192186,2886.147055,3651.024917,6537.171972,Negative for malignancy/normal/benign,Not identified,Cannot be assessed,Not-Hispanic or Latino,Black,United States,Posterior endometrium,NA,Multifocal,0,0,4,0,0,0,0,0,Staging Incomplete,R0:  No residual tumor,Positive : 65 %,Positive : 2 %,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record,Yes,Medical Record|Medical Record|Medical Record,Celebrex|guaifenesin|naproxen,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|Yes,Living|Living,298|449,Yes|Yes,Yes|Yes,Yes|No,Tumor Free|With Tumor,Never|Never,Former Therapy|Former Therapy,Never|Never,No|No,No|No,2|1,No|Unknown,Complete Remission|Persistent Disease,Complete Remission|n/a,n/a|Persistent Disease,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,298.0|449.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3L-05571-b1,C3L-05571,Yes,b1,4,131C,CPT0275270003,Tumor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-05848,C3L-05848,No,b1,1,129C,CPT0288750003,Tumor,No,70,Female,Serous carcinoma,G3 Poorly differentiated,-2,165,53,19.3,Present,<50% myometrial invasion,Eighth Edition (2017),pT3a,pN0,2,IVB,White,23.02237376,CNV_H,No,0.13,MSS,CNV_H,190,Mutated,WT,WT,WT,Mutated,0.133982091,1.83E-02,6.14E-03,0,3.43E-18,3.22E-19,1.03E-02,3.83E-03,0,2.47E-19,0,1.46E-19,3.06E-02,5.40E-20,1.11E-02,3.50E-03,2.23E-19,0,8.39E-03,2.12E-02,4.08E-02,3.28E-02,1.15E-02,2.96E-03,9.85E-21,1.20E-02,6.68E-03,5.90E-03,0,0,2.13E-02,1.08E-03,0,0,0.23338744,1.62E-18,6.07E-02,1.75E-03,6.24E-02,0,0,4.49E-02,3.29E-02,0,0.209211775,0,4.59E-02,0,0,0,7.64E-02,0,3.31E-02,3.01E-02,0.247757337,4.39E-02,3.65E-02,0,9.03E-02,2.64E-02,8.27E-02,4,119,0,62,0,0,0,0,0,0,0,0.23,NA,NA,2.62E-02,1.056713158,-5.22E-02,-1.322776134,0.177598276,0.662110775,1.510200793,-0.162670933,0.9932458,0.442598882,1.480251765,0.922565198,-1.654268392,1.045739467,4756.659794,5475.906105,10232.5659,Not Examined,Not identified,Cannot be assessed,Not-Hispanic or Latino,White,Other: Unknown,Other,Endometrium,Unifocal,0,0,0,0,0,0,0,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Cannot be determined,No,Absent,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,calcium carbonate/vitamin D3 |Naproxen|Propranolol |ibuprofen,NA,NA,NA,NA,Yes,2,12 Months,No,Deceased,153,No,Yes,No,With Tumor,Never,Unknown,Never,No,No,2,No,Persistent Disease,Persistent Disease,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,Other : Endometrial Carcinoma,153,n/a,n/a,n/a
C3L-05849,C3L-05849,No,b3,10,131N,CPT0288830003,Tumor,No,64,Female,Serous carcinoma,G3 Poorly differentiated,95,165,80,29.35,Present,=50% myometrial invasion,Eighth Edition (2017),pT2,PN2a,6,IIIC2,Black or African American,15.89601897,CNV_H,No,0.01,MSS,CNV_H,59,WT,WT,WT,WT,WT,0.401764688,0.124726736,4.84E-02,1.37E-02,1.39E-02,2.96E-18,0.138651888,0,2.17E-02,6.00E-02,0,3.38E-02,2.59E-02,0,2.70E-02,5.99E-02,1.27E-19,5.25E-02,6.08E-20,6.29E-02,0.129562923,0.108230892,3.49E-02,3.94E-03,2.63E-02,0.121764701,1.93E-02,0,1.48E-19,2.94E-02,8.28E-02,8.09E-03,2.83E-03,0,0.152181899,4.43E-02,0.295071247,6.13E-02,0.356335552,2.21E-02,0,1.49E-02,4.36E-02,5.21E-03,0.257167925,3.77E-02,0,0,0,3.91E-02,0,1.16E-02,0.138619362,7.64E-02,0.273111105,0,2.31E-02,0,4.13E-02,4.02E-03,1.21E-02,21,35,0,0,0,0,0,0,0,0,0,0.18,Yes,No,2.57E-02,1.008324896,0.471269094,-0.759199592,2.307381318,0.73200949,2.19771132,0.604381722,0.10293743,0.185554515,1.98110734,2.310609056,-0.581266888,-0.113105162,6400.839955,8045.434992,14446.27495,Negative for malignancy/normal/benign,Present,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,Black,United States,Other,Endometrium,Unifocal,IHC staining not done,2,16,IHC staining not done,12,Unknown value,IHC staining not done,0,Staging Incomplete,R0:  No residual tumor,Positive : 80 %,Positive : 80 %,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Intact nuclear expression,Loss of expression,Yes,Absent,Yes,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,p16 - Diffusely reactive,Ki-67 highlights 70-80% of tumor,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,amLODIPine|Cabergoline|Calcium carb-mag oxide-vit D3 |Citalopram|Potassium|RaNITIdine |TraZODone,NA,NA,NA,NA,Yes,2,12 Months,No,Living,385,No,Yes,No,Tumor Free,Never,Never,Never,Yes,Yes,1,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,373,n/a,n/a,n/a,n/a,n/a
C3N-00155,C3N-00155,No,b4,15,129N,CPT0104820003,Tumor,No,57,Female,Endometrioid carcinoma,G1 Well differentiated,0,165,126,46.28,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,0,Stage I,NA,0,CNV_L,No,0.84,MSS,CNV_L,175,WT,Mutated,WT,Mutated,Mutated,9.04E-02,1.04E-02,4.28E-19,1.99E-18,6.03E-18,0,0,0,0,0,0,7.75E-04,0,4.17E-18,6.60E-03,4.04E-03,5.37E-19,0,0,3.62E-02,2.42E-02,2.56E-02,8.79E-03,2.96E-03,3.61E-19,0,5.73E-03,1.39E-02,5.82E-18,2.85E-02,2.48E-02,5.47E-03,0,0.116365435,2.04E-03,0,3.87E-02,4.71E-03,4.34E-02,0,0,3.89E-02,8.17E-03,0,0.219529533,0,1.56E-02,1.87E-02,0,0,0.128373163,0,8.14E-02,1.38E-02,0.201141274,4.56E-02,3.43E-03,0,3.45E-02,0,0.190958924,10,52,72,0,0,0,0,0,0,0,0,0.17,NA,NA,-0.374553388,-0.289790261,1.121605755,-0.312409698,0.263218036,-1.451544947,0.786626642,0.235738782,0.431825143,-0.186178109,0.811559247,0.696742021,0.134654558,-2.37E-02,4354.35758,4945.367245,9299.724825,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Ukraine,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,18,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,Unknown,n/a,Unknown,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
C3N-00520,C3N-00520,No,b2,7,131C,CPT0115000004,Tumor,No,58,Female,Endometrioid carcinoma,G1 Well differentiated,4,154,75,31,Present,=50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,8,Stage III,NA,0.388013171,CNV_L,No,0.01,MSS,CNV_L,39,WT,Mutated,Mutated,WT,WT,2.74E-02,0,7.46E-20,5.96E-20,3.38E-18,5.07E-19,2.35E-02,0,7.96E-19,0,3.36E-19,4.76E-03,0,0,2.36E-03,0,2.12E-18,7.51E-02,0,8.67E-02,9.14E-04,4.32E-03,2.33E-03,5.25E-03,1.45E-18,0,1.75E-19,3.38E-19,1.30E-19,9.22E-03,4.16E-03,1.85E-02,5.13E-18,7.26E-03,3.33E-18,0,5.68E-03,3.82E-02,4.39E-02,5.10E-02,0,0.118470449,3.79E-02,0,0.248511895,0,8.87E-02,0,0,0,3.56E-02,1.12E-02,4.18E-03,0,0.294056151,6.02E-02,0,5.02E-02,0,0,0,11,24,0,0,0,0,0,0,0,0,0,0.5,NA,NA,3.415209041,-0.56644536,0.164344889,-0.382919656,-1.122017538,-0.353273327,-1.091400146,0.61448874,-0.53563564,0.859388667,-0.860110525,-0.754691908,-0.876800191,0.616814696,4178.702317,3528.21591,7706.918227,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,NA,Yes,Medical Record|Medical Record|Medical Record,citrafleet|fragmin|kalipoz,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Deceased,120|638|974|1169,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|With Tumor,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,No|No|No|No,No|No|No|No,1|1|1|1,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|Persistent Disease,n/a|n/a|n/a|n/a,No|No|No|Yes,n/a|n/a|n/a|Distant Metastasis,n/a|n/a|n/a|Liver,n/a|n/a|n/a|1124.0,n/a|n/a|n/a|No,n/a|n/a|n/a|No,n/a|n/a|n/a|Yes,n/a|n/a|n/a|No,132.0|650.0|986.0|n/a,n/a|n/a|n/a|Malignant Neoplasm,n/a|n/a|n/a|1239.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-00732,C3N-00732,No,b2,7,127C,CPT0089600003,Tumor,No,56,Female,Endometrioid carcinoma,G1 Well differentiated,2.2,168,107,38.09,Not identified,NA,Seventh Edition (2010),pT1a (FIGO IA),pN0,16,Stage I,White,4.70E-03,CNV_L,No,0.05,MSS,CNV_L,55,WT,WT,Mutated,WT,Mutated,3.37E-02,2.83E-19,3.45E-04,5.27E-18,1.06E-18,1.54E-21,1.94E-02,1.15E-02,2.99E-02,4.19E-02,3.38E-18,2.59E-18,8.99E-03,1.63E-03,3.42E-03,1.73E-02,0,0.102854363,0,9.45E-02,2.99E-03,6.79E-03,1.68E-03,6.43E-03,7.62E-19,2.39E-03,0,1.54E-04,0,2.57E-03,6.77E-03,6.35E-03,0,2.29E-02,1.26E-02,1.68E-02,3.02E-02,6.01E-02,9.03E-02,5.81E-02,0,2.14E-02,4.12E-02,0,0.335995816,1.30E-02,0,0,2.17E-02,0,3.03E-02,3.33E-02,5.94E-02,6.76E-04,0.183489103,0,5.60E-03,0.172183947,0,2.35E-02,0,14,36,0,0,0,0,0,0,0,0,0,0.74,Yes,No,1.281583094,0.344033172,0.792653576,-0.851252327,-2.04783258,1.267562224,-0.537584745,1.140270672,-0.18848291,0.968124511,-0.408493069,-0.90066271,-0.992093506,2.390558613,4748.579197,3968.887673,8717.46687,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,white,United States,Anterior endometrium,NA,Multifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Perimenopausal: 6-12 months since last menstrual Period,Never,None,see below comment,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,albuterol|Duloxetine |insulin aspart|insulin glargine|meloxicam|pantoprazole|Ranitidine|simvastatin,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,411|795|1126|1393,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,None|None|None|None,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,365.0|749.0|1080.0|1347.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-00750,C3N-00750,No,b4,16,127C,CPT0265110003,Tumor,No,44,Female,Endometrioid carcinoma,G2 Moderately differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,White,4.069838891,CNV_L,No,0.03,MSS,CNV_L,122,WT,Mutated,Mutated,WT,WT,5.91E-04,0,1.96E-20,0,7.54E-18,0,0,0,0,0,1.79E-19,0,3.18E-03,7.77E-18,0,1.67E-18,1.57E-19,7.76E-03,8.65E-18,0,0,0,0,1.68E-03,5.45E-18,0,0,0,5.32E-18,7.51E-03,1.31E-02,1.97E-03,0,8.75E-02,6.41E-02,0,1.12E-03,6.00E-03,7.12E-03,0,0,3.45E-03,6.14E-03,0,0.282786595,0,0,7.64E-03,0,9.49E-02,0,0,0.313552183,0,0.21834091,0,7.32E-02,0,0,0,0,37,57,0,17,0,0,0,0,0,0,0,0.4,NA,NA,-0.560139313,0.799378482,0.345423557,2.295443066,-0.706807355,0.772592175,-0.346099661,1.473413909,1.838931664,5.65E-02,-1.10E-02,-1.185084524,1.204169953,0.738238381,2901.657976,2816.021258,5717.679233,NA,NA,NA,Hispanic or Latino,Hispanic or Latino,Other: Unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-00753,C3N-00753,No,b4,14,127C,CPT0129640003,Tumor,No,51,Female,Endometrioid carcinoma,G3 Poorly differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Asian,5.439517525,CNV_L,No,23.27,MSI-H,MSI-H,1855,WT,Mutated,WT,Mutated,Mutated,0.248709586,6.63E-02,7.99E-03,2.86E-03,2.08E-20,1.11E-18,7.44E-03,8.90E-03,2.77E-02,2.68E-02,1.48E-02,3.33E-02,2.31E-02,0,2.19E-02,9.14E-03,1.14E-18,1.06E-02,5.35E-19,1.21E-02,3.64E-02,3.96E-02,1.17E-02,9.26E-04,1.28E-18,2.60E-03,0,0,0,2.29E-02,7.79E-02,1.32E-02,9.71E-18,0.113754093,0.207907802,0,0.103872701,1.14E-02,0.115266428,3.03E-02,0,5.79E-02,0.109810609,0,0.152099328,6.13E-02,8.53E-02,0,0,1.98E-02,1.43E-02,0,8.99E-02,8.95E-02,0.230033669,0,1.65E-02,0,2.99E-02,0,1.34E-02,0,42,710,0,0,0,0,0,262,0,381,0.28,NA,NA,-1.166468405,1.359253342,-0.549850734,-0.117554452,1.899269333,1.326601228,0.773041072,0.10522105,0.147770966,9.95E-02,0.705746679,-0.136648547,0.47250482,8.26E-02,4933.254317,6033.839712,10967.09403,NA,NA,NA,Not-Hispanic or Latino,Non-Hispanic,Other: unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-00755,C3N-00755,No,b2,7,130C,CPT0129520003,Tumor,No,42,Female,Endometrioid carcinoma,G1 Well differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not Reported,0,CNV_L,No,0,MSS,CNV_L,31,WT,Mutated,WT,Mutated,Mutated,1.88E-02,4.03E-03,0,8.55E-19,6.90E-18,3.67E-02,7.13E-02,1.49E-18,0,1.91E-20,0,3.25E-02,2.95E-18,0,1.00E-02,0,3.19E-02,7.43E-02,0,1.23E-02,4.09E-19,7.68E-04,1.50E-03,6.88E-03,8.69E-18,0,0,0,6.51E-19,6.78E-02,1.77E-02,6.61E-03,0,2.35E-02,0,0,3.52E-02,3.87E-02,7.39E-02,3.37E-02,0,7.68E-02,0.102958021,0,0.364702102,0,1.27E-02,7.07E-03,0,5.21E-02,0,5.63E-03,5.47E-02,9.28E-03,5.54E-02,3.49E-02,2.23E-02,0.114542263,0,0,5.32E-02,5,10,0,0,2,5,5,0,0,0,0,0.21,NA,NA,0.317408249,0.909689511,1.35503569,-0.596165032,-0.472720313,-1.34E-02,0.274011505,0.650156366,-1.078573686,1.91E-02,0.5196641,0.597370721,-0.380419227,0.797239601,3799.267126,4355.661811,8154.928937,NA,NA,NA,Hispanic or Latino,Hispanic or Latino,Other: unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-00859,C3N-00859,No,b4,16,130N,CPT0116010004,Tumor,No,60,Female,Other,G2 Moderately differentiated,9,170,121,41,Present,=50% myometrial invasion,Eighth Edition (2017),pT3b,pN0,5,Stage IIIB,NA,2.03E-03,CNV_L,No,0.01,MSS,CNV_L,85,WT,WT,Mutated,WT,WT,5.07E-02,0,3.43E-20,1.68E-18,1.43E-18,0,0,0,3.57E-18,0,0,0,0,0,0,3.77E-03,0,0.147814991,0,3.37E-02,1.85E-03,1.50E-02,0,5.89E-03,0,0,0,0,5.68E-18,6.13E-19,1.92E-02,8.06E-03,0,5.64E-02,9.50E-02,0,5.16E-03,7.99E-02,8.50E-02,0,0,6.99E-02,4.36E-02,0,0.166125082,0,8.13E-02,0,2.13E-02,0,7.75E-02,4.08E-02,0,1.80E-02,0.346618089,0,5.73E-02,7.76E-02,0,0,0,30,52,0,0,0,0,0,0,0,0,0,0.35,NA,NA,-0.355841341,0.949596302,0.509884697,0.344707027,7.43E-02,0.829933884,-0.501319963,1.379621481,0.790181976,0.634357178,-0.2743769,-0.293629283,0.264688355,-0.430693492,4213.747375,3389.428758,7603.176133,Negative for malignancy/normal/benign,Not identified,Cannot be assessed,NA,Caucasian,Poland,Fundus,NA,Multifocal,0,0,0,0,0,0,0,0,0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,4 or more,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Offtensin|Tritace|Clexane|Exacyl|cyclonamine|Potassium Chloride|fortrans,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,377|722|1056|1440,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,4 or more|4 or more|4 or more|4 or more,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a|n/a,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,392.0|737.0|1071.0|1455.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-00860,C3N-00860,No,b4,15,128C,CPT0116140004,Tumor,No,67,Female,Endometrioid carcinoma,G1 Well differentiated,5.5,154,76,32,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,NA,2.16E-03,CNV_L,No,0.04,MSS,CNV_L,97,WT,Mutated,WT,WT,Mutated,3.96E-02,0,0,5.59E-19,1.38E-17,1.16E-02,5.34E-03,1.05E-18,9.96E-19,0,0,1.78E-02,2.00E-04,0,7.17E-03,1.42E-02,1.59E-19,3.14E-02,0,7.35E-02,0,3.64E-04,3.80E-03,7.39E-03,0,0,3.71E-19,0,1.50E-18,1.24E-02,1.76E-02,1.79E-03,3.86E-18,5.11E-02,2.07E-18,0,9.71E-03,2.28E-02,3.25E-02,0,2.04E-02,6.12E-02,4.07E-02,0,0.256280046,0,0,1.42E-02,0,0,5.78E-02,4.53E-04,4.17E-02,7.67E-03,0.396138995,1.81E-02,3.86E-03,7.01E-02,0,0,1.13E-02,15,39,0,0,0,12,20,0,0,0,0,0.45,NA,NA,0.663451845,-1.042030566,0.261304497,-1.286492731,-0.609085537,-1.379859068,-0.580944902,1.044305932,-0.291931793,-0.480919047,-0.294376313,0.96234935,-0.962555868,-0.250919023,3751.168781,3712.832239,7464.00102,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Absent,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Nebicard|Vanatex HCT|Fragmin|Potassium Chloride|fortrans,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,351|451,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,364.0|464.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-00872,C3N-00872,No,b3,11,130N,CPT0116250004,Tumor,No,75,Female,Endometrioid carcinoma,NA,5.5,158,74,29.64,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,6,Stage I,NA,0,CNV_L,No,0.05,MSS,CNV_L,60,WT,Mutated,WT,Mutated,WT,7.26E-02,1.97E-02,0,0,8.19E-18,3.12E-18,4.45E-02,6.47E-04,7.72E-03,8.32E-03,0,7.96E-04,2.12E-03,0,3.18E-03,3.99E-19,0,2.10E-02,0,3.23E-02,1.24E-20,2.52E-04,4.25E-03,5.53E-03,0,1.02E-17,4.54E-03,0,9.92E-18,3.62E-02,1.02E-02,4.00E-02,6.16E-18,6.82E-02,5.63E-05,1.13E-02,2.41E-02,1.05E-02,3.46E-02,1.66E-02,0,0.157788327,0.127586723,0,0.205252977,0,4.06E-02,0,0,2.66E-02,0,6.66E-03,0.195866958,2.12E-02,0.136866067,0,0,0,6.51E-02,0,0,15,21,0,0,0,8,13,0,0,0,0,0.26,Yes,No,0.529870461,-0.269327231,0.954137734,1.055162237,-0.83937678,-0.765850621,-0.298832009,0.342006037,4.76E-02,-0.214148673,-0.213604886,0.277916899,0.107628576,-7.73E-02,3109.754015,3623.267678,6733.021693,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Other,Uterine cavity,Multifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,399|651|1106|1554,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,411.0|663.0|1118.0|1566.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01007,C3N-01007,No,b1,2,130C,CPT0095100003,Tumor,No,59,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.5,164,92,34,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,4,Stage I,NA,0,CNV_L,No,7.81,MSI-H,MSI-H,1075,Mutated,Mutated,Mutated,Mutated,Mutated,0.126893776,3.37E-02,7.71E-03,1.67E-18,0,0,2.01E-02,2.38E-03,1.60E-02,4.23E-02,0,4.58E-19,0,1.94E-19,3.46E-03,1.02E-18,0,0,0,9.63E-03,1.42E-02,9.47E-03,1.30E-02,4.31E-03,2.61E-03,2.89E-03,1.04E-02,2.52E-03,1.01E-17,2.27E-02,2.67E-02,1.31E-02,0,5.48E-02,0.129531956,1.54E-02,5.14E-02,5.10E-19,5.14E-02,1.92E-03,0,3.09E-02,5.85E-02,0,0.221617916,0,7.77E-02,0,7.21E-04,0,5.70E-02,0,0.1428905,0.123243905,0.125879396,3.05E-04,0,0,6.27E-02,9.09E-03,8.75E-02,409,154,454,0,0,0,0,0,0,0,0,0.7,NA,NA,-0.160785511,-0.928428143,-2.30E-02,0.660467572,1.092692701,-0.545833911,0.345920518,-0.731912121,9.64E-02,-1.218773649,0.316729301,-0.378349943,0.207863952,0.625548468,2972.189086,4667.48303,7639.672116,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : 70 %,Positive : 50 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Bisocard|Axtil|Aldac|Concor|Hydroxyzin|Fragmin,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,364|364,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Unknown|Unknown,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,376.0|376.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01008,C3N-01008,No,b1,3,127C,CPT0095130004,Tumor,No,68,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,156,98,40,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,Stage I,NA,0,CNV_L,No,0.16,MSS,CNV_L,91,WT,Mutated,Mutated,WT,WT,4.80E-02,5.13E-03,0,2.66E-18,2.25E-18,1.07E-18,0,4.87E-04,1.57E-19,8.22E-03,7.01E-18,1.18E-02,1.35E-02,5.94E-03,2.78E-03,2.39E-19,1.39E-18,0,1.21E-18,1.64E-02,2.89E-03,5.78E-03,7.59E-04,5.50E-03,0,3.87E-18,3.16E-03,1.53E-19,3.71E-18,2.21E-02,1.63E-02,9.91E-04,0,2.86E-02,0.10970217,1.50E-03,1.09E-02,1.20E-19,1.09E-02,0,0,2.19E-02,5.18E-02,0,0.261957218,0,0,0,0,3.47E-02,5.64E-02,1.47E-02,4.50E-02,3.82E-03,0.276429343,6.89E-02,4.03E-02,0.124152219,0,0,0,30,56,0,0,0,0,0,0,0,0,0,0.84,NA,NA,0.189670667,0.266224453,-1.693862585,-0.210503442,-0.403409309,0.750945395,-0.912400656,0.454799384,2.131324119,-0.17124993,-0.611319975,-1.270733903,1.098963889,0.990166908,2920.666306,3286.44014,6207.106445,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,0,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 90 %,Positive : 50 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,Ki67 positive 40%,NA,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,20,NA,20,48,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record,Bespres|Polocard|Clexane,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,347|318,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Unknown|Unknown,Never|Never,Yes|Yes,No|No,1|1,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,371.0|342.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01079,C3N-01079,No,b1,2,131N,CPT0211120004,Tumor,No,77,Female,Endometrioid carcinoma,G1 Well differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.19E-02,CNV_L,No,0.27,MSS,CNV_L,56,Mutated,WT,WT,WT,WT,8.68E-02,0,0,6.04E-19,0,0,2.51E-02,4.41E-03,0,2.24E-02,9.63E-19,0,2.45E-02,0,5.64E-03,2.45E-02,5.71E-19,0.104588958,6.58E-18,0.100437458,7.48E-03,4.16E-03,9.49E-03,2.43E-03,0,0,0,5.97E-20,0,0,1.40E-02,1.40E-02,4.55E-18,1.73E-02,0.115950423,0,1.04E-02,6.90E-02,7.94E-02,4.81E-02,0,0.100444197,0,0,0.32654871,0,5.06E-03,0,5.34E-02,0,5.23E-02,4.26E-04,2.91E-02,3.41E-02,0.220740066,2.64E-02,2.91E-03,7.92E-02,0,0,2.13E-02,13,30,0,0,0,0,11,0,0,0,0,1,NA,NA,0.680457885,1.045625842,1.572270619,0.379230172,-0.920658346,1.537915387,-0.243829645,-0.98072042,-1.617707419,0.251512131,-0.295053867,-0.200529493,-0.185502919,0.728184302,4836.138544,3845.676546,8681.815089,NA,NA,NA,NA,Caucasian,Ukraine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01171,C3N-01171,No,b3,10,128C,CPT0095190003,Tumor,No,82,Female,Endometrioid carcinoma,G2 Moderately differentiated,4,164,88,32,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,NA,0,CNV_L,No,18.81,MSI-H,MSI-H,685,Mutated,Mutated,WT,Mutated,Mutated,0.111760853,1.93E-02,4.43E-03,3.30E-19,2.38E-21,1.33E-19,1.03E-02,8.39E-03,1.04E-02,1.73E-02,0,8.99E-03,1.92E-02,0,6.55E-03,8.34E-03,0,0,5.48E-18,1.13E-02,1.42E-02,1.45E-02,4.88E-03,1.30E-03,1.48E-18,1.03E-02,7.66E-03,1.86E-04,1.72E-18,7.80E-03,2.93E-02,3.39E-03,0,5.65E-02,0.145371868,0,4.16E-02,4.17E-03,4.58E-02,0,0,6.39E-02,0.150286416,0,0.130687333,0,8.47E-02,1.26E-02,0,0,7.15E-02,1.09E-02,0.120323693,8.21E-02,0.132281152,8.38E-03,0,0,9.64E-02,0,3.59E-02,48,12,134,0,0,0,126,92,0,0,60,0.59,Yes,No,-0.674945537,1.373998424,-3.64E-02,1.228499994,1.368713733,1.441871718,1.457994086,0.375543651,1.1153636,-0.1715209,1.317100488,0.189389964,-0.122353855,1.268667507,3989.733683,5208.547429,9198.281112,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Multifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 70 %,Positive : 50 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,glucophage|sotahexal|Diuver|cardura|milurit|atoris|hyzaar forte|Polocard,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,492|596|1009,No|No|No,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,Yes|Yes|Yes,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,505.0|609.0|n/a,n/a|n/a|Cardiovascular Disorder,n/a|n/a|1035.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-01172,C3N-01172,No,b2,8,131N,CPT0095230003,Tumor,No,57,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.5,165,80,29,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,1,Stage I,NA,0,CNV_L,No,20.34,MSI-H,MSI-H,553,Mutated,Mutated,WT,Mutated,Mutated,1.47E-19,8.06E-03,8.59E-04,9.18E-19,5.36E-18,0,7.82E-19,1.00E-19,0,0,3.70E-18,1.98E-03,2.91E-02,0,0,0,0,0,0,1.70E-02,1.14E-03,2.69E-19,0,2.25E-04,2.09E-21,0,5.78E-03,1.14E-19,0,5.12E-02,1.30E-02,6.40E-03,1.77E-18,9.11E-02,6.21E-02,0,6.28E-03,3.38E-20,6.28E-03,0,0,9.63E-03,2.72E-02,0,0.317302471,0,7.37E-02,0,0,0,2.35E-04,5.18E-02,0.149642383,2.74E-02,7.01E-02,1.82E-03,5.85E-02,0,0.134244772,1.54E-02,6.30E-02,35,67,92,0,0,0,95,99,0,0,0,0.83,NA,NA,-0.946346098,0.625565314,-1.265186151,1.570568446,-0.437061472,1.262791341,0.684931362,-0.874411812,0.500136872,-1.360868182,0.801243699,-2.136479043,2.218294711,0.800431099,1771.707456,3149.409592,4921.117048,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,0,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 60 %,Positive : 50 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Normal,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record,Yes,Medical Record,Fragmin,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,555|709|961|1479,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,No|No|No|No,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,568.0|722.0|974.0|1492.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01341,C3N-01341,No,b1,4,131N,CPT0095280003,Tumor,No,64,Female,Endometrioid carcinoma,G2 Moderately differentiated,5,168,95,33,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,9,Stage I,NA,9.78E-04,CNV_L,No,0,MSS,CNV_L,66,WT,Mutated,WT,Mutated,Mutated,8.64E-02,1.87E-02,6.33E-21,9.73E-19,6.85E-20,6.53E-19,7.82E-03,1.84E-19,2.75E-18,1.43E-02,4.32E-19,1.37E-02,7.24E-03,0,4.12E-03,1.53E-03,1.94E-19,4.93E-03,2.11E-18,2.49E-02,8.86E-03,8.82E-03,4.71E-04,1.02E-03,5.18E-19,2.79E-04,2.78E-03,7.02E-20,1.77E-18,1.13E-03,2.93E-02,8.05E-03,1.00E-19,7.09E-02,7.08E-03,0,2.20E-02,4.65E-03,2.67E-02,0,3.62E-03,0.10405177,4.75E-02,0,0.156197673,0,6.11E-02,0,0,0,0.123430266,9.08E-02,0,3.38E-03,0.263868097,2.58E-02,7.42E-02,3.96E-02,0,0,6.60E-03,27,32,0,0,0,0,0,0,0,0,0,0.66,NA,NA,0.478038492,0.102807066,0.239316893,3.78E-02,-0.283586538,0.603740038,8.86E-02,1.517526455,-9.23E-04,-0.251237819,0.331323806,0.163221202,-0.476046881,-0.253778156,3896.851759,4284.434815,8181.286574,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Multifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : 70 %,Positive : 50 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Berotec|Tezeo|Cipronex|Fragmin,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,343|343,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,353.0|353.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01342,C3N-01342,No,b1,1,130C,CPT0088140003,Tumor,No,68,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.6,164,95,35,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,11,Stage I,NA,0,CNV_L,No,0.03,MSS,CNV_L,59,WT,Mutated,Mutated,WT,WT,4.83E-02,2.29E-03,1.25E-19,0,8.32E-18,0,2.65E-02,0,9.06E-21,6.77E-04,0,1.06E-19,1.35E-03,2.31E-18,5.66E-21,0,2.19E-18,0,0,5.08E-03,9.75E-04,3.45E-03,1.07E-03,4.50E-03,3.48E-19,1.95E-18,2.58E-03,0,7.04E-18,8.99E-03,8.73E-03,8.96E-03,0,7.73E-02,3.45E-02,0,5.18E-03,6.51E-04,5.83E-03,0,0,0,4.73E-02,0,0.329401231,0,0,3.76E-02,0,0,0.110133339,7.10E-03,0,5.30E-02,0.249179947,0,2.93E-02,9.22E-02,0,0,4.49E-02,18,28,0,0,0,0,0,0,0,0,0,0.92,NA,NA,0.678806316,8.62E-02,-0.351367591,-0.266862729,-0.524670381,0.507325205,-0.994790741,0.174274834,-0.248611771,-0.28194513,-0.92349606,-0.96983554,1.933994758,0.47664936,2743.521331,2888.741889,5632.263219,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Multifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Concor|Axtil|Ipress Long|Lecalpin|Captopril|Meloxicam,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,233|702|1063|1329,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,242.0|711.0|1072.0|1338.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01344,C3N-01344,No,b2,8,130N,CPT0116340004,Tumor,No,80,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,150,107,47,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,Stage I,NA,4.89E-03,CNV_L,No,0.05,MSS,CNV_L,83,WT,Mutated,Mutated,Mutated,Mutated,6.35E-02,0,1.39E-18,2.55E-18,7.34E-18,0,3.44E-19,0,0,4.41E-18,0,0,0,0,6.07E-20,6.22E-19,8.47E-19,0,6.08E-19,2.54E-02,0,2.68E-03,4.99E-20,1.88E-05,4.28E-19,0,0,4.51E-19,7.65E-18,3.57E-04,2.69E-02,1.75E-03,0,7.77E-02,3.99E-19,9.22E-18,1.25E-05,1.67E-03,1.68E-03,0,0,1.88E-02,1.86E-02,0,0.184320429,0,7.32E-02,0,0,8.96E-03,5.74E-02,7.98E-02,0.106922609,1.56E-02,0.207896215,0,0.123534418,0,3.42E-02,7.49E-03,6.33E-02,36,24,0,16,0,0,0,0,0,0,0,0.65,Yes,No,1.010584357,0.958917619,-0.122092578,0.591618951,1.71548221,0.83661242,0.373454018,1.909639803,-0.407318649,0.19433427,0.53145782,-1.059607454,5.48E-02,1.491327304,2816.325831,3437.612906,6253.938737,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Multifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,oxycordil|diuresin|doxor|Clexane|kalipoz|fortrans|Cipronex|Potassium Chloride,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Deceased,424|654|1011|1011,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,448.0|678.0|1035.0|n/a,n/a|n/a|n/a|Respiratory Disease,n/a|n/a|n/a|1359.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01525,C3N-01525,No,b1,4,129C,CPT0095880003,Tumor,No,77,Female,Endometrioid carcinoma,G2 Moderately differentiated,2,162,101,38.48,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,6.56E-02,CNV_L,No,0.01,MSS,CNV_L,69,WT,Mutated,WT,Mutated,Mutated,0.113347672,0.138089515,7.26E-04,2.62E-02,0,8.19E-04,6.67E-02,3.50E-03,1.89E-02,1.32E-02,1.31E-19,3.48E-02,7.21E-03,0,1.22E-02,1.58E-02,0,1.90E-02,3.28E-20,5.74E-02,9.95E-03,1.08E-02,8.24E-03,9.63E-03,2.18E-02,2.38E-02,2.43E-02,2.24E-02,1.02E-19,4.41E-02,3.23E-02,1.70E-02,0,9.39E-03,4.00E-02,0,0.15660197,1.74E-02,0.174028141,6.38E-03,6.54E-02,6.88E-02,6.37E-02,0,0.338442194,0,1.62E-02,3.19E-02,0,1.67E-02,5.76E-03,0,3.46E-02,2.58E-02,0.159190306,0,6.96E-03,0,1.46E-02,0,0.145579711,22,38,0,0,0,0,0,0,0,0,0,0.24,NA,NA,0.968455041,0.116985024,0.586825416,-1.830026394,0.652835063,-0.358812128,1.262459572,1.604640792,-1.190027371,7.66E-03,1.127224327,2.7023317,-2.335287933,1.259273466,4455.437792,5641.829234,10097.26703,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 50 %,Positive : 30 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,Cytokeratin 7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,221|678,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,No|No,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,206.0|663.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01526,C3N-01526,No,b1,2,129N,CPT0096010003,Tumor,No,66,Female,Other,G1 Well differentiated,1.5,163,120,45.17,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,9,Stage I,NA,1.44E-02,CNV_L,No,0.18,MSS,CNV_L,46,WT,Mutated,Mutated,WT,Mutated,4.79E-02,8.74E-03,2.18E-03,8.02E-18,0,1.50E-02,2.25E-02,8.64E-04,8.43E-04,1.38E-02,4.71E-18,1.20E-02,1.30E-02,1.30E-03,1.40E-04,3.54E-19,1.04E-03,7.72E-18,1.41E-17,4.30E-03,1.20E-02,1.28E-02,2.26E-03,8.05E-03,0,0,4.29E-03,3.69E-19,0,3.37E-02,7.09E-02,1.35E-02,3.66E-18,6.71E-02,5.27E-02,8.39E-03,2.05E-02,4.04E-18,2.05E-02,2.07E-02,0,2.84E-03,0.112389797,0,0.253080028,0.109388855,2.77E-03,0,0,0.140858162,0,4.29E-02,1.87E-02,6.00E-02,0.168718426,1.14E-02,0,0,4.26E-02,1.37E-02,0,11,18,12,0,0,0,0,0,0,0,0,0.75,NA,NA,-0.602082745,-0.32923972,0.335663418,-0.711535885,2.75E-02,0.266371451,-0.389968954,0.170962117,0.524567535,-0.974226972,-0.49249463,-0.756494607,-0.616693079,0.192387266,2830.616714,3480.307943,6310.924657,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 25 %,Positive : 45 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,Cytokeratin 7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,206|663,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,206.0|663.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01529,C3N-01529,No,b3,10,130C,CPT0097440003,Tumor,No,70,Female,Endometrioid carcinoma,G2 Moderately differentiated,2,161,77,29.71,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,NA,1.420667785,CNV_L,No,0.28,MSS,CNV_L,77,Mutated,WT,WT,Mutated,Mutated,6.98E-03,4.57E-03,0,0,2.18E-18,4.33E-03,0,0,2.53E-18,0,1.41E-18,6.17E-03,3.70E-04,8.82E-03,3.04E-19,1.52E-18,4.88E-19,0,0,1.98E-02,4.35E-18,1.53E-19,0,1.55E-02,2.79E-18,5.69E-18,2.68E-03,5.93E-19,0,5.64E-02,2.14E-02,2.04E-02,1.78E-18,4.84E-02,6.97E-02,0,1.34E-02,7.58E-19,1.34E-02,0,0,6.18E-03,4.62E-02,0,0.283628823,0,0,5.17E-03,0,3.31E-02,1.99E-02,2.27E-02,0.372928636,1.85E-03,0.191768164,0,6.01E-03,0,0,1.05E-02,0,15,39,0,0,0,0,17,0,0,0,0,0.8,NA,NA,-0.350698157,-1.787253484,0.375408379,-0.430807066,-0.988606273,-1.114672298,-1.083843371,-0.533844894,-0.259319555,-0.962619281,-1.003937609,-0.156204933,0.935634718,-1.285862678,1635.195132,2630.987183,4266.182316,Not Examined,Present,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 80 %,Positive : 90 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,CK7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months,Yes,Living,27,Unknown,Unknown,Unknown,Unknown Tumor Status,Unknown,Unknown,Unknown,Unknown,Unknown,2,Unknown,Unknown,Unknown,n/a,Unknown,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a,n/a
C3N-01761,C3N-01761,No,b3,9,128N,CPT0116710003,Tumor,No,69,Female,Endometrioid carcinoma,G3 Poorly differentiated,4.5,162,72,27,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,12,Stage I,NA,2.000247062,CNV_L,No,22.53,MSI-H,MSI-H,624,WT,Mutated,WT,Mutated,WT,7.35E-02,9.41E-03,0,7.30E-18,1.35E-18,9.69E-19,3.91E-19,5.84E-20,2.64E-18,0,2.77E-18,2.02E-03,1.06E-02,0,9.71E-23,2.61E-03,4.00E-19,0,2.79E-18,2.06E-02,0,6.01E-04,4.02E-04,1.98E-04,3.67E-18,2.57E-17,0,0,6.10E-18,2.31E-02,1.01E-02,2.14E-02,0,0.148230371,0.133913,2.43E-18,6.41E-03,1.31E-03,7.71E-03,4.92E-02,0,0.108184728,0.122038116,0,0.221708232,0,0.118366604,0,0,0,5.94E-02,7.06E-03,4.36E-02,0.112296479,9.26E-02,0,0,0,8.40E-03,3.56E-03,5.36E-02,58,71,0,0,0,0,160,65,0,0,53,0.69,NA,NA,-0.594911418,1.032012483,-1.096912147,1.401428603,0.9708803,1.339458804,0.157450776,-0.785718131,1.358407618,-1.262712613,-9.68E-03,-0.903377582,0.971890694,-0.277578463,2707.093154,4003.392608,6710.485762,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Multifocal,0,0,1,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,Vimentine positive,NA,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,Unknown,NA,20,NA,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Bisocard|milurit|effox long|diuresin|Fragmin|fortrans|kalipoz,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,244|839|979|1338,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|With Tumor|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Unknown|Never,Yes|Yes|Yes|Yes,No|No|No|No,1|1|1|1,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,Yes|Yes|Yes|Yes,New Primary Tumor|New Primary Tumor|New Primary Tumor|New Primary Tumor,Other: Kidney|Other: Kidney|Other: Kidney|Other: kidney,113.0|113.0|113.0|113.0,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,No|No|No|No,264.0|859.0|999.0|1358.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,113.0|113.0|113.0|113.0,Surgical Resection|Surgical Resection|Surgical Resection|Surgical Resection,R0: No Residual Tumor|R0: No Residual Tumor|R0: No Residual Tumor|R0: No Residual Tumor
C3N-01764,C3N-01764,No,b2,7,128C,CPT0181320003,Tumor,No,73,Female,Serous carcinoma,G3 Poorly differentiated,6,158,75,30,Present,<50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN0,11,Stage II,NA,14.69558014,CNV_H,No,7.00E-02,MSS,CNV_H,64,Mutated,WT,WT,WT,Mutated,0.190726861,7.55E-02,1.67E-02,3.89E-03,1.96E-03,8.26E-18,3.27E-03,9.01E-03,1.74E-02,1.01E-02,5.00E-03,0,3.07E-02,0,1.14E-02,1.81E-18,0,8.66E-18,0,1.54E-02,3.38E-02,2.26E-02,2.21E-02,1.86E-03,3.26E-03,4.18E-03,1.05E-02,1.17E-20,1.18E-03,9.15E-03,2.42E-02,2.01E-02,9.29E-18,3.68E-02,0.25858588,7.24E-19,9.81E-02,5.24E-18,9.81E-02,7.31E-02,0,4.77E-02,0.108187785,0,0.114452992,3.87E-02,9.76E-02,0,0,0,5.85E-02,4.87E-03,4.11E-02,0.110210276,0.208625266,0,5.27E-02,0,1.94E-02,1.31E-02,1.18E-02,12,36,0,12,0,0,0,0,0,0,0,0.35,NA,NA,-0.286215717,0.380558766,-0.228724485,-0.203270537,2.099036814,8.69E-02,0.859025866,-0.737063438,5.87E-03,-0.429555029,0.62996958,-0.156939859,-2.61E-02,0.838316501,3940.012075,5240.349808,9180.361883,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Other,Isthmus of uterine corpus and cervical canal,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : 10 %,Positive : 10 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,"Ki67 positive 50%, Vimentin positive, SMA negative, CD10 - positive/negative, Desmine- negative, Bcl-2 - negative, EMA - positive/negative, CK7 positive, CK8/18 - positive, CK19 - positive",NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Bisocard|Euthyrox|Fragmin|Fortrans|Natrium kalium|Kalipoz|Aldac,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,386|816|1201|1346,Yes|Yes|No|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,406.0|836.0|1221.0|1366.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01765,C3N-01765,No,b1,4,130C,CPT0116940003,Tumor,No,58,Female,Endometrioid carcinoma,G2 Moderately differentiated,8,158,65,26,Present,=50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pN1 (FIGO IIIC1),6,Stage III,NA,3.70E-03,CNV_L,No,14.61,MSI-H,MSI-H,771,WT,Mutated,Mutated,Mutated,Mutated,0.246545802,1.52E-02,6.86E-03,2.69E-18,0,1.69E-18,4.85E-02,1.17E-02,8.94E-02,0.114629111,4.22E-03,4.72E-03,1.16E-02,0,7.04E-03,0,2.69E-18,3.92E-03,0,1.81E-02,2.25E-03,1.11E-02,6.02E-03,2.77E-03,0,1.79E-18,5.35E-03,0,5.69E-18,1.66E-02,3.23E-02,2.10E-02,1.10E-18,8.01E-02,0.142359302,0,7.78E-02,1.96E-03,7.97E-02,1.97E-02,0,6.14E-02,0.134433128,0,0.261287416,2.98E-03,8.83E-02,4.97E-03,8.31E-02,0,4.02E-02,0,6.18E-02,9.54E-02,0.117614713,0,0,2.87E-02,0,0,0,95,176,0,0,0,0,160,0,72,0,123,0.4,NA,NA,0.138864277,0.316001016,0.692017961,0.825944117,0.30805158,-3.20E-02,-0.799914545,-0.424941507,-0.125753229,0.750546401,-0.955156205,0.173068789,-0.561494049,-5.88E-02,5013.704003,5217.161207,10230.86521,Not Examined,Present,Cannot be assessed,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,0,2,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,metronidazol|Cipronex|Fragmin|kalipoz,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,259|484|988|1352,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,No|No|No|No,No|No|No|No,3|3|3|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,271.0|496.0|1000.0|1364.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01766,C3N-01766,No,b1,2,128C,CPT0226810003,Tumor,No,63,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,165,108,39,Not identified,NA,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,NA,0,CNV_L,No,0.01,MSS,CNV_L,52,WT,Mutated,WT,Mutated,Mutated,9.03E-02,0,0,0,8.36E-19,0,0,2.13E-03,0,8.21E-03,0,0,2.16E-02,2.59E-19,3.61E-03,2.73E-02,2.60E-19,0.143591591,0,0.125117983,3.23E-02,2.27E-02,1.35E-02,1.76E-03,4.41E-18,4.62E-03,0,3.30E-03,1.29E-17,3.01E-03,2.17E-02,0,0,4.92E-02,9.14E-02,0,3.04E-02,9.03E-02,0.12067751,0,0,5.74E-02,3.91E-02,0,0.136205481,0,2.06E-02,0,0,3.28E-02,4.07E-02,6.15E-02,8.77E-03,4.84E-03,0.360359682,4.23E-02,2.23E-02,4.40E-02,6.55E-03,1.93E-02,0.103249658,23,24,0,0,0,0,0,0,0,0,0,0.33,Yes,No,-0.212399685,-0.179274308,0.514966703,-0.1912367,-0.549840059,-1.46E-02,0.326598797,0.865885353,-1.060837629,9.72E-02,0.406557973,0.163027314,-0.82872889,0.756589656,5172.775259,4941.366454,10114.14171,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Euthyrox|Nebilet|Metformax|Gensulin R|Gensulin N|Jardiance|Pramolan|Valsacor|Tertensif SR|Nebilet|Dulsevia,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|Yes,Living|Living,372|520,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,Yes|Yes,3|2,No|No,Complete Remission|Complete Remission,Complete Remission|Unknown,n/a|n/a,No|Unknown,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,372.0|520.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01830,C3N-01830,No,b3,12,128N,CPT0097300003,Tumor,No,73,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.5,163,72,27.1,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,5,Stage I,NA,0.121195139,CNV_L,No,0.11,MSS,CNV_L,67,WT,Mutated,Mutated,Mutated,WT,1.16E-18,2.43E-03,7.51E-20,0,0,1.91E-18,1.98E-18,9.54E-03,1.69E-02,2.20E-02,0,0,6.54E-03,1.87E-18,4.08E-21,1.19E-03,8.84E-19,5.68E-02,1.48E-18,2.47E-02,0,0,7.39E-04,4.06E-03,1.48E-19,2.26E-17,3.67E-03,1.37E-18,0,0,2.56E-02,1.10E-02,8.69E-19,2.09E-02,5.22E-02,0,1.56E-02,2.90E-02,4.46E-02,0,0,8.43E-02,9.39E-02,0,0.191293251,0,0,2.43E-02,0.121978416,0,4.96E-02,0,6.59E-02,3.86E-02,0.156815348,0,2.17E-02,7.53E-02,0,0,7.63E-02,28,34,0,0,0,0,0,0,0,0,0,0.17,NA,NA,1.144298628,-0.244991698,0.277131716,0.359918433,-0.270113667,0.386533568,-0.764118355,7.87E-02,-0.377960293,0.214227381,-0.785101313,5.41E-02,-0.961078663,1.142328869,3244.306649,2922.030539,6166.337188,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 90 %,Positive : 90 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,228|716,Yes|Yes,Yes|Yes,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,Unknown|Unknown,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,192.0|680.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01843,C3N-01843,No,b3,9,127N,CPT0098270003,Tumor,No,68,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.4,164,64,23.8,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN1 (FIGO IIIC1),10,Stage III,NA,0.282470823,CNV_L,No,18,MSI-H,MSI-H,681,Mutated,Mutated,WT,Mutated,Mutated,0.223526843,3.01E-02,1.31E-02,0,4.93E-18,5.83E-18,1.80E-02,3.31E-03,1.33E-02,4.66E-02,0,8.84E-03,2.50E-02,1.01E-18,1.21E-02,0,8.36E-19,9.35E-18,3.42E-18,2.66E-02,2.73E-02,2.74E-02,6.44E-03,5.67E-03,1.34E-19,3.79E-18,5.54E-03,5.42E-19,4.95E-18,3.21E-02,7.54E-02,8.41E-03,0,4.49E-02,0.247032703,8.98E-19,5.90E-02,4.67E-18,5.90E-02,0,0,2.72E-02,0.216393599,0,0.128096267,0,8.38E-02,0,0,0,6.90E-02,3.29E-02,4.84E-02,9.27E-02,0.248276041,1.97E-02,0,3.36E-02,0,0,0,43,13,216,0,0,0,0,152,0,0,71,0.51,NA,NA,4.43E-02,0.144663114,-7.23E-02,5.24E-02,-0.547351059,0.534132119,1.47E-02,-0.311919732,0.56525262,-2.62E-02,2.85E-02,0.137575459,0.701965702,0.115626401,3834.743959,5059.640457,8894.384416,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,1,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 20 %,Positive : 20 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,CK7 - positive; Vimentin - patchy positive;,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,43,NA,10,12.5,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,201|738,Yes|Yes,No|No,No|No,Tumor Free|With Tumor,Never|Never,Never|Never,Never|Never,No|No,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Persistent Disease,n/a|n/a,No|Yes,n/a|Distant Metastasis,n/a|Other: Peritoneal carcinomatosis,n/a|706.0,n/a|No,n/a|No,n/a|Yes,n/a|No,165.0|702.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01847,C3N-01847,No,b1,3,130C,CPT0098920003,Tumor,No,57,Female,Endometrioid carcinoma,G1 Well differentiated,1.4,163,116,43.66,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,3.70E-03,CNV_L,No,0.03,MSS,CNV_L,84,WT,Mutated,WT,Mutated,Mutated,7.60E-02,7.94E-03,8.91E-04,0,0,0,2.50E-02,2.35E-04,1.02E-19,1.14E-02,3.11E-19,1.48E-02,2.61E-02,0,2.80E-03,1.53E-02,4.03E-03,1.17E-18,3.06E-18,4.48E-02,5.96E-03,4.44E-03,5.40E-03,4.90E-04,2.19E-18,4.98E-03,3.19E-03,4.29E-04,0,6.23E-04,4.76E-03,5.31E-04,3.54E-18,4.36E-02,7.69E-02,0,1.78E-02,7.63E-03,2.54E-02,2.28E-03,0,4.47E-03,3.78E-02,0,0.280090609,0,1.52E-02,4.91E-02,0,2.66E-02,0,3.17E-04,2.13E-03,3.85E-02,0.309974614,8.53E-02,1.07E-02,7.10E-02,0,0,6.66E-02,26,33,0,0,0,0,20,0,0,0,0,0.24,NA,NA,-0.203958163,0.354768534,0.697546386,0.636621984,-0.105211027,0.664941363,0.597701371,1.192832327,-0.627929428,-0.384998838,0.566847748,0.695395794,-0.358632918,1.260857813,3847.422934,4238.491726,8085.91466,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 80 %,Positive : 80 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months,Yes,Living,32,No,No,No,Tumor Free,Never,Never,Never,Yes,No,Unknown,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,11,n/a,n/a,n/a,n/a,n/a
C3N-01848,C3N-01848,No,b3,12,131C,CPT0099050003,Tumor,No,68,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.3,160,77,30.08,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,NA,0.254035118,CNV_L,No,3.44,MSS,CNV_L,320,WT,Mutated,WT,Mutated,WT,7.70E-02,1.36E-02,0,2.58E-18,0,2.32E-18,8.62E-03,4.51E-19,5.40E-19,0,5.49E-19,2.80E-19,5.58E-03,0,2.69E-03,2.80E-02,1.23E-18,1.04E-02,0,5.98E-02,1.12E-02,1.14E-02,8.93E-03,3.32E-03,0,2.41E-18,4.92E-03,0,7.35E-20,2.34E-02,7.03E-03,2.29E-02,0,3.13E-02,0.131746335,0,2.05E-02,1.92E-02,3.98E-02,1.53E-02,0,0.138733616,8.36E-02,0,0.263437163,0,2.35E-02,1.45E-02,0,1.72E-02,0,0,6.49E-02,5.09E-02,0.285224525,1.38E-02,1.10E-02,0,4.72E-03,8.52E-04,1.25E-02,8,35,113,0,0,0,0,50,0,0,27,0.2,NA,NA,1.139570918,-0.531494785,-0.962600331,2.147275985,-9.99E-02,-0.502091483,-0.188633044,-0.891483434,-0.156879223,0.417927495,-6.95E-02,0.412675045,-0.163980249,-0.799125931,4904.734919,4328.776721,9233.51164,Not Examined,Present,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 15 %,Positive : 15 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,2,CK7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,193|709,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,2|2,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,172.0|688.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-01871,C3N-01871,No,b4,13,130C,CPT0117010004,Tumor,No,77,Female,Endometrioid carcinoma,G2 Moderately differentiated,2.4,149,80,36,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,1.09E-03,CNV_L,No,10.85,MSI-H,MSI-H,683,WT,Mutated,WT,Mutated,Mutated,6.25E-02,3.82E-03,0,9.99E-19,0,7.50E-19,1.12E-02,0,0,1.26E-02,0,8.23E-03,8.10E-03,0,1.39E-02,2.33E-19,1.07E-19,0,2.79E-18,2.14E-02,3.31E-03,7.85E-03,2.88E-03,3.68E-03,4.70E-18,0,1.15E-03,7.57E-19,2.61E-18,2.08E-03,2.21E-02,7.01E-03,2.44E-18,3.25E-02,0.118236283,8.15E-19,1.65E-02,2.14E-04,1.67E-02,3.86E-02,0,0.100928794,0.135339536,0,0.122688657,5.80E-02,9.27E-02,0,9.91E-03,0,1.77E-02,0,3.71E-02,4.53E-02,0.302402469,1.76E-02,0,0,9.55E-03,2.79E-03,9.40E-03,0,47,294,0,0,0,0,91,0,0,74,0.27,NA,NA,0.302900335,0.516058367,0.292252452,1.083780096,-1.083293559,0.476643996,-0.47464658,0.42683152,-6.25E-02,-0.164209424,-0.388869335,-0.35724918,0.36279121,1.213801812,3831.676349,4112.023105,7943.699453,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Yes,Self Report|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,co-valsacor|kalipoz|Fragmin|Citrafleet|Iporel,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,243|684|963|1412,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,3|3|3|3,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,253.0|694.0|973.0|1422.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01873,C3N-01873,No,b4,16,127N,CPT0117230003,Tumor,No,71,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,164,81,30,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,3,Stage I,NA,1.38E-02,CNV_L,No,0.03,MSS,CNV_L,59,WT,Mutated,Mutated,WT,WT,8.33E-02,1.05E-02,1.14E-18,0,5.14E-18,7.84E-03,1.99E-02,0,1.58E-19,0,0,4.95E-03,0,0,0,4.90E-03,4.86E-19,1.28E-18,0,3.43E-03,7.45E-03,1.37E-02,3.29E-03,6.46E-03,0,9.67E-19,4.38E-03,0,7.33E-18,4.05E-02,2.96E-02,1.70E-02,4.03E-18,1.53E-02,2.32E-02,2.23E-03,1.63E-02,2.45E-03,1.87E-02,0,0,0.173787939,0.114182112,0,0.116560122,0,4.27E-02,3.14E-02,0,3.82E-03,4.17E-02,4.45E-02,0.156313502,4.00E-02,0.140850526,0,0,0,8.17E-02,0,1.26E-02,15,18,0,0,0,0,16,0,0,0,0,0.75,NA,NA,0.106481953,0.43067387,-0.9722897,1.06846311,-0.216816855,0.300596224,0.470600851,0.290423913,0.552485217,-0.815837183,0.521103887,-0.243989694,0.206061519,1.169256133,2190.410018,4249.679464,6440.089482,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Amlopin|Euthyrox|Metocard|Lorista H|Fragmin,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,361|606|959|1325,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,375.0|620.0|973.0|1339.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01874,C3N-01874,No,b4,16,129C,CPT0117300003,Tumor,No,84,Female,Endometrioid carcinoma,G1 Well differentiated,2.5,158,76,30,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,1.800134566,CNV_L,No,0.12,MSS,CNV_L,58,WT,Mutated,Mutated,Mutated,Mutated,1.52E-02,1.17E-18,2.86E-18,3.41E-18,1.45E-18,0,1.56E-17,0,6.10E-18,1.23E-17,1.05E-18,1.33E-18,0,1.19E-18,1.00E-19,0,0,1.82E-17,0,0,0,7.99E-20,1.07E-19,1.14E-02,0,1.96E-17,3.50E-03,0,6.22E-17,3.22E-02,1.59E-02,1.58E-02,2.29E-18,6.37E-02,2.03E-19,4.50E-19,7.62E-03,9.13E-18,7.62E-03,0,0,7.05E-02,6.17E-02,0,0.142400803,0,9.16E-02,3.51E-02,0,0,2.84E-02,2.52E-02,6.77E-02,0,0.340888389,0,5.24E-02,8.43E-02,0,0,0,13,17,0,0,0,0,24,0,0,0,0,0.92,Yes,No,0.244211136,-1.414841471,-0.925858253,-0.153620361,-0.502347154,-1.089310841,-2.733835426,-0.859543811,-0.500990905,-0.608425221,-2.485675847,-1.325090731,1.86172286,-0.201595836,1021.173704,1322.951831,2344.125535,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Insulatard|Mixtard|Fragmin|nitrendypina|Tarcefoksym|Potassium Chloride,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Deceased,398|817|1027|1027,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,3|3|3|3,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,410.0|829.0|1039.0|n/a,n/a|n/a|n/a|Respiratory Disease,n/a|n/a|n/a|1267.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01875,C3N-01875,No,b1,2,127C,CPT0117370004,Tumor,No,66,Female,Endometrioid carcinoma,G1 Well differentiated,3.5,165,67,24,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,4.90E-02,CNV_L,No,13.51,MSI-H,MSI-H,432,WT,Mutated,WT,Mutated,Mutated,9.06E-02,4.35E-03,3.23E-19,9.90E-18,0,0,0,0,0,8.78E-18,1.24E-18,1.64E-02,6.04E-03,4.24E-18,0,3.92E-18,6.19E-18,1.67E-17,4.29E-18,2.73E-02,4.62E-19,1.29E-03,5.24E-03,4.99E-03,1.80E-19,2.29E-17,2.03E-03,1.90E-18,3.49E-19,1.98E-02,1.10E-02,4.26E-03,1.19E-18,8.04E-02,3.62E-02,7.16E-19,6.23E-03,1.03E-17,6.23E-03,0,0,1.24E-02,0.157910704,0,0.246611062,0,6.92E-02,2.93E-04,0,0,5.50E-02,0.100858138,0,2.02E-02,0.241064221,3.03E-02,3.34E-02,0,6.70E-03,4.79E-03,2.13E-02,5,45,262,0,0,0,0,0,0,0,0,0.82,NA,NA,-1.363689812,-4.89E-02,-1.529508912,-0.553215043,-0.634025083,0.390767965,-0.119760407,-0.111178363,0.344065615,-1.171730701,-7.18E-02,-0.597194535,1.768138045,0.172848677,2183.985888,3574.391886,5758.377774,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Other,left side of uterine cavity,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Self-reported and Medical Record,Yes,Medical Record,citrafleet,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,48,No,No,No,Tumor Free,Never,Never,Never,No,No,2,No,Complete Remission,Complete Remission,n/a,Unknown,n/a,n/a,n/a,n/a,n/a,n/a,n/a,66,n/a,n/a,n/a,n/a,n/a
C3N-01876,C3N-01876,No,b4,15,128N,CPT0117440003,Tumor,No,65,Female,Endometrioid carcinoma,G2 Moderately differentiated,6,160,76,29,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,11,Stage I,NA,0,CNV_L,No,30.86,MSI-H,MSI-H,1200,WT,Mutated,Mutated,Mutated,WT,0.121096139,2.94E-03,0,4.68E-18,0,1.44E-18,0,3.85E-03,0,0,1.70E-18,0,9.28E-03,0,4.75E-03,1.14E-18,0,3.16E-18,4.08E-18,0,2.45E-03,8.54E-03,3.41E-03,8.83E-03,0,5.97E-18,0,0,2.59E-17,2.46E-02,5.26E-02,2.27E-02,7.02E-03,0.145036196,0.153952945,3.74E-18,1.26E-02,3.12E-18,1.26E-02,1.21E-02,0,8.37E-02,0.113594656,0,0.170929985,2.97E-02,0.129824121,0,3.77E-02,0,4.75E-02,0,0.122970951,7.81E-02,0.167485468,3.59E-03,0,2.75E-03,0,0,0,4,128,256,0,0,0,257,110,119,0,0,0.66,NA,NA,0.559073275,0.680713095,-0.752155232,0.647809148,-0.702791641,0.933029185,-0.500273297,0.931540716,1.020084157,-0.395834595,-0.375792936,-0.910458356,0.450531888,0.578826112,2723.908546,4237.496025,6961.404571,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,0,0,3,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Lokren|Vanatex|Lexotan|Acard|fragmin|Fortrans,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,392|683|1071|1509,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,409.0|700.0|1088.0|1526.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-01877,C3N-01877,No,b2,8,127N,CPT0117510003,Tumor,No,73,Female,Endometrioid carcinoma,G2 Moderately differentiated,8,163,100,37,Present,=50% myometrial invasion,Seventh Edition (2010),pT3b (FIGO IIIB),pN2 (FIGO IIIC2),17,Stage III,NA,5.61E-03,CNV_L,No,11.86,MSI-H,MSI-H,726,WT,Mutated,WT,Mutated,Mutated,0.177404359,3.49E-02,7.77E-04,0,4.02E-18,5.17E-19,6.30E-02,0,1.63E-02,1.90E-02,1.99E-18,3.61E-03,1.62E-02,5.18E-19,7.60E-03,2.04E-02,1.97E-03,4.46E-02,2.95E-18,6.93E-02,1.09E-02,9.92E-03,1.08E-02,1.00E-02,5.72E-04,3.74E-03,7.22E-03,6.81E-20,1.08E-19,3.98E-02,2.16E-02,2.29E-02,6.13E-20,6.77E-02,4.62E-02,6.13E-03,5.70E-02,3.42E-02,9.11E-02,0,2.63E-02,0.114976296,5.65E-02,0,0.298018221,0,5.30E-02,0,0,4.07E-03,8.95E-03,8.79E-03,4.93E-02,7.36E-02,0.172018072,6.28E-02,0,6.47E-02,0,0,6.91E-03,10,145,147,0,0,0,127,114,0,0,0,0.17,NA,NA,-3.17E-02,1.77E-02,3.37E-02,-0.659912822,-1.29076585,-0.103905023,7.33E-02,-0.816857239,-0.29263442,0.376151556,-0.11418628,0.238528748,-0.47811667,0.441443599,4764.458571,5173.015659,9937.47423,Not Examined,Not identified,Margin(s) involved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,4,4,5,1,1,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,Unknown,NA,20,NA,Yes,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Atrovent|Flutixon|Enarenal|Zafiron|fragmin|Cipronex|Metronidazol|Fortrans,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,397|678|678,No|No|No,Yes|Yes|Yes,No|No|No,With Tumor|With Tumor|With Tumor,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,3|3|3,No|No|No,Persistent Disease|Persistent Disease|Patient Deceased,Persistent Disease|Persistent Disease|Patient Deceased,n/a|n/a|n/a,Yes|Yes|No,Distant Metastasis|Distant Metastasis|n/a,Other: vaginal cuff and paraortic lymph nodes|Other: rectum and paraortal lymph nodes|n/a,195.0|604.0|n/a,No|No|n/a,No|No|n/a,Yes|Yes|n/a,No|No|n/a,412.0|693.0|n/a,n/a|n/a|Uterine Corpus Cancer,n/a|n/a|912.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-01878,C3N-01878,No,b2,5,129C,CPT0117560003,Tumor,No,59,Female,Endometrioid carcinoma,G2 Moderately differentiated,10.5,170,106,36,Present,=50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN2 (FIGO IIIC2),6,Stage II,NA,0.6351284,CNV_L,No,20.15,MSI-H,MSI-H,837,WT,Mutated,WT,Mutated,Mutated,0.199708337,2.28E-02,8.86E-03,0,1.19E-18,0,5.52E-02,8.07E-21,3.10E-04,4.05E-02,0,4.42E-02,1.95E-02,1.98E-18,2.88E-02,4.75E-19,1.20E-18,0,1.93E-18,7.79E-03,2.89E-02,2.82E-02,5.85E-03,5.89E-04,0,2.20E-03,3.47E-18,0,2.38E-18,1.85E-02,6.86E-02,1.76E-02,5.34E-18,4.04E-02,0.151555088,3.31E-02,5.57E-02,2.37E-19,5.57E-02,7.27E-03,0,1.94E-02,0.125281925,0,0.214293137,0,3.11E-02,2.34E-02,0,0,8.62E-02,1.21E-02,0.160409928,4.09E-02,0.244346272,1.44E-02,0,0,1.61E-02,4.78E-03,0,25,74,285,0,0,0,0,203,0,0,0,0.55,Yes,No,-0.181577593,1.397289792,0.635311483,1.162459583,-0.616480681,0.98083274,0.669498781,0.829350251,0.762932699,0.239677216,0.519901832,1.391960865,0.982448781,-0.881420623,5148.669003,5726.274774,10874.94378,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,IHC staining not done,1,24,IHC staining not done,1,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,"ER(+), PR(+), p53(-), panCK, CK7, p16, CK5/6",NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record,Bisopromerck|metformax,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,162,Yes,Yes,No,Tumor Free,Never,Never,Never,Yes,Yes,2,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,188,n/a,n/a,n/a,n/a,n/a
C3N-01879,C3N-01879,No,b2,8,127C,CPT0226860003,Tumor,No,67,Female,Endometrioid carcinoma,G1 Well differentiated,4,164,104,38,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,Stage I,NA,0,CNV_L,Yes,7.00E-02,MSS,POLE,2239,Mutated,Mutated,WT,Mutated,Mutated,0.137455678,4.02E-02,1.41E-02,3.66E-18,9.86E-20,0,4.28E-02,0,7.38E-03,6.30E-02,9.25E-18,7.35E-03,1.82E-02,0,8.02E-03,1.48E-03,0,9.46E-18,0,1.38E-02,3.08E-02,2.14E-02,1.09E-02,6.56E-06,3.93E-03,1.22E-02,1.30E-02,4.87E-03,3.27E-18,1.98E-02,6.48E-02,2.11E-02,0,3.09E-02,4.58E-02,2.86E-02,6.91E-02,7.39E-04,6.98E-02,1.35E-02,0,2.50E-02,7.75E-02,0,0.227319109,9.34E-02,6.00E-02,0,0,0,1.57E-02,0,0.173488158,0.106049337,0.129079703,7.92E-03,0,5.35E-03,0,0,6.57E-02,169,126,0,0,492,1440,0,0,0,0,0,0.55,NA,NA,-0.152512497,1.429161576,1.091894133,3.201166668,-6.38E-02,1.536337968,1.483652505,-0.92167649,0.836126569,-0.909618405,1.498413183,0.17598968,0.142423981,1.59541048,4156.428126,5829.00019,9985.428316,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self Report|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Euthyrox|Atoris|Aldan,NA,NA,NA,NA,Yes,1,12 Months,Yes,Living,489,No,No,No,Tumor Free,Never,Never,Never,Yes,No,2,No,Complete Remission,Unknown,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,489,n/a,n/a,n/a,n/a,n/a
C3N-01880,C3N-01880,No,b4,14,131N,CPT0244510003,Tumor,No,68,Female,Endometrioid carcinoma,G2 Moderately differentiated,6,157,76,30,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,13,Stage I,NA,5.74E-03,CNV_L,No,2.46,MSS,CNV_L,169,WT,Mutated,WT,WT,Mutated,0.174442329,3.33E-02,1.16E-02,5.53E-18,0,1.28E-18,3.50E-02,9.48E-04,1.97E-02,2.47E-02,4.55E-18,5.53E-03,1.97E-02,6.66E-03,1.89E-02,1.03E-02,0,3.13E-18,0,5.43E-02,3.95E-02,2.55E-02,2.40E-02,1.30E-02,1.30E-19,3.38E-18,1.06E-02,0,0,1.46E-02,3.16E-02,1.82E-02,0,3.81E-02,3.68E-02,2.32E-02,8.29E-02,5.16E-03,8.81E-02,6.19E-03,0,6.65E-02,6.73E-02,0,0.242474543,0,3.09E-02,0,1.56E-02,0,1.82E-02,0,9.68E-02,0.105584982,0.275675943,5.71E-03,0,6.92E-02,0,0,0,26,43,0,0,0,0,55,0,0,0,0,0.56,NA,NA,0.70910867,-1.400986602,2.046975559,2.73E-02,-2.65E-03,-1.50845047,0.203122598,3.34E-02,-0.623237411,-0.769186317,0.191999416,0.755493383,-0.607070106,-0.259883536,4534.7251,5118.019807,9652.744907,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,0,0,5,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record,Yes,Medical Record|Medical Record,Imovate|Vit B2,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,411|745|1074|1531,No|No|No|Yes,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,No|No|No|No,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,411.0|745.0|1074.0|1531.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02012,C3N-02012,No,b1,4,130N,CPT0115470003,Tumor,No,69,Female,Endometrioid carcinoma,G2 Moderately differentiated,3,173,126,42.11,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,30,Stage I,White,0,CNV_L,No,0.13,MSS,CNV_L,39,WT,Mutated,Mutated,Mutated,WT,0.10837779,2.33E-02,0,0,0,0,2.77E-02,0,3.69E-19,1.66E-02,4.50E-19,1.87E-19,6.36E-03,0,3.77E-03,5.12E-03,0,0,5.32E-19,3.07E-19,1.03E-02,1.17E-02,5.31E-03,4.45E-03,0,0,4.26E-03,4.59E-19,0,2.99E-02,2.66E-02,1.32E-02,0,9.35E-02,0.104035137,3.39E-03,2.79E-02,2.56E-03,3.04E-02,2.38E-03,6.60E-03,0.100506775,2.23E-02,0,0.193876697,0,0.114171638,1.65E-02,8.98E-04,0,0.103761073,3.46E-02,6.48E-02,2.79E-02,0.182560871,8.04E-03,2.33E-02,0,4.64E-02,3.03E-03,4.85E-02,9,24,0,0,0,0,0,0,0,0,0,0.31,NA,NA,-0.530721444,1.171436913,-0.331317798,0.100828289,0.158560762,0.533353021,1.460192614,-0.436046742,0.655455465,-0.683019213,1.427569954,-0.314388587,0.463815547,-9.64E-02,3396.330521,4983.009654,8379.340175,Atypical and/or suspicious,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,white,United States,Other,Involves anterior and posterior,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,aspirin|lipitor|temovate|docusate|hydroxychloroquine|levothyroxine|metaprolol,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,398|762|1126|1490,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Unknown|Unknown|Unknown|Unknown,Unknown|Unknown|Unknown|Unknown,Yes|Yes|Yes|Yes,No|No|No|No,1|1|1|1,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,378.0|742.0|1106.0|1470.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02027,C3N-02027,No,b2,7,127N,CPT0133400008,Tumor,No,55,Female,Endometrioid carcinoma,G3 Poorly differentiated,1.5,161,62,23.92,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,Stage I,NA,0.836262984,CNV_L,No,29.19,MSI-H,MSI-H,1588,Mutated,Mutated,WT,Mutated,Mutated,0.13465926,1.32E-02,6.68E-03,1.39E-18,0,2.20E-18,1.18E-02,1.20E-02,0,1.22E-03,1.57E-18,3.73E-03,2.35E-02,3.44E-19,3.51E-03,0,0,0,0,2.73E-03,2.85E-02,2.99E-02,6.40E-03,3.08E-03,0,0,2.52E-03,0,4.50E-18,1.53E-02,5.43E-02,3.77E-03,0,9.58E-02,0.191302974,4.18E-18,3.22E-02,0,3.22E-02,1.70E-02,0,2.71E-02,4.57E-02,0,0.236501993,3.10E-02,5.83E-02,0,1.41E-02,0,4.11E-02,2.91E-03,0.120051349,0.191009379,0.194287952,0,0,9.09E-03,0,0,1.19E-02,281,255,0,0,0,0,406,263,0,0,0,0.22,NA,NA,-1.620645881,1.030313371,-1.867447847,1.518661251,-1.110265741,0.865446114,0.804264842,-0.359433287,1.926234681,0.573562232,0.55489661,-1.086838292,4.40E-02,-0.319440063,3784.602642,4222.588922,8007.191565,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 80 %,Negative,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - patchy positive; ER - 80% (+++); PR - negative;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,498|874,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,No|No,No|No,Unknown|Unknown,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,440.0|816.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-02028,C3N-02028,No,b1,3,128N,CPT0133600003,Tumor,No,68,Female,Endometrioid carcinoma,G3 Poorly differentiated,1.3,160,103,40.23,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,Stage I,NA,0.94592098,CNV_L,No,16.98,MSI-H,MSI-H,854,WT,Mutated,WT,Mutated,Mutated,0.137349875,6.08E-03,1.45E-02,8.40E-19,2.55E-18,0,1.54E-03,1.23E-02,4.24E-02,4.63E-02,0,0,3.00E-02,1.67E-18,1.97E-02,2.67E-02,0,8.72E-02,3.34E-18,0.171591381,1.98E-02,1.96E-02,5.55E-03,3.66E-03,3.12E-18,0,7.02E-03,3.97E-19,5.56E-18,8.39E-19,4.58E-02,9.70E-03,0,6.20E-03,0.29710689,2.24E-19,6.11E-02,6.08E-02,0.121915215,1.82E-02,0,2.64E-02,0.155186169,0,0.173452888,6.00E-02,6.69E-02,0,1.17E-02,0,2.01E-02,0,0.110151944,0.100243419,0.165907003,0,0,0,6.10E-02,1.98E-02,1.10E-02,0,51,377,0,0,0,0,109,0,0,93,0.16,NA,NA,0.650007282,-8.93E-02,-0.188888952,2.38E-02,-8.43E-02,0.377410318,0.783005019,0.421413623,0.896518726,0.700052389,0.673144646,1.335396533,-1.52790344,0.469251306,6118.023607,5850.288699,11968.31231,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 60 %,Positive : 20 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - patchy positive; ER - 60%; PR - 20%;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02030,C3N-02030,No,b1,4,127C,CPT0133770008,Tumor,No,62,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.4,163,131,49.31,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,Stage I,NA,0,CNV_L,No,12.53,MSI-H,MSI-H,509,WT,Mutated,Mutated,Mutated,WT,2.01E-18,1.47E-19,0,7.53E-18,2.96E-18,0,0,2.19E-19,3.11E-19,5.32E-18,0,0,5.55E-03,0,7.17E-19,1.19E-18,1.21E-18,2.32E-02,0,1.48E-04,0,6.33E-19,0,2.21E-02,0,1.63E-18,6.42E-03,0,0,4.27E-02,3.72E-03,1.38E-02,0,3.09E-02,0.106855103,2.14E-19,1.47E-02,1.37E-02,2.85E-02,1.84E-02,0,0.100547164,5.72E-03,0,0.174504876,0,0,6.92E-02,0,9.15E-02,0,0,0.326854429,0,8.54E-02,0,3.66E-02,0,9.12E-02,0,0,24,64,187,0,0,0,0,54,0,0,50,0.66,NA,NA,1.156356082,1.50100684,0.652103028,1.076495637,-2.130746153,1.268860898,0.252439451,0.981173532,0.283160486,1.172658794,0.448894477,1.278679606,-0.978229726,1.82680905,3771.888795,2333.565376,6105.454171,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,0,0,cM0,R0:  No residual tumor,Positive : 70 %,Positive : 60 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - patchy positive; ER - 70%; PR - 60%,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,270|808,Yes|Yes,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|No,Unknown|Unknown,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,284.0|822.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-02061,C3N-02061,No,b1,2,129C,CPT0134310008,Tumor,No,67,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.7,150,92,40.89,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,Stage I,NA,6.67E-03,CNV_L,No,9.86,MSI-H,MSI-H,461,WT,Mutated,WT,WT,Mutated,0.157836188,1.89E-02,1.43E-02,0,1.80E-19,2.43E-18,2.64E-03,9.82E-03,2.36E-02,1.44E-02,0,0,2.41E-02,1.64E-21,7.12E-03,1.83E-03,7.89E-19,8.53E-02,0,9.94E-02,2.51E-02,1.67E-02,2.32E-02,6.63E-03,5.50E-20,6.31E-19,1.09E-03,5.16E-19,1.74E-18,1.28E-02,3.10E-02,6.42E-03,0,1.04E-02,0.236886499,1.24E-02,5.42E-02,4.45E-02,9.87E-02,3.31E-02,0,2.37E-02,0.124598703,0,0.136362416,0,8.90E-02,0,0,0,4.00E-02,4.89E-02,1.00E-02,0.104041445,0.285313298,4.09E-02,0,5.32E-02,0,1.08E-02,0,57,92,106,0,0,0,92,0,0,0,0,0.46,NA,NA,-0.728045563,-0.762015393,1.433484996,-1.264967724,0.558911407,-0.579144556,-0.84279916,-0.800823869,-0.694694164,0.421685753,-1.117976774,0.161634387,-0.155458633,-0.233454158,5779.035657,5011.711958,10790.74761,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Endometrium,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 90 %,Positive : 75 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - positive;,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months,Yes,Living,54,No,No,No,Tumor Free,Never,Never,Never,Yes,No,Unknown,No,Complete Remission,Complete Remission,n/a,No,n/a,n/a,n/a,n/a,n/a,n/a,n/a,17,n/a,n/a,n/a,n/a,n/a
C3N-02062,C3N-02062,No,b1,1,127C,CPT0134500003,Tumor,No,67,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.3,160,83,32.42,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,0,CNV_L,No,7.00E-02,MSS,CNV_L,73,Mutated,Mutated,WT,Mutated,WT,1.17E-17,1.49E-18,2.43E-03,0,0,0,0,1.08E-02,4.99E-19,5.69E-03,0,9.25E-19,2.89E-02,0,2.42E-03,2.39E-18,0,0,3.02E-17,8.12E-02,2.69E-18,0,9.24E-04,6.94E-03,1.81E-18,0,4.98E-05,0,7.50E-18,4.26E-03,1.72E-02,6.72E-03,2.10E-17,9.40E-02,0.155266913,2.80E-18,6.24E-03,1.22E-18,6.24E-03,0,0,5.31E-02,0,0,0.391955364,0,0,0,0,0,1.96E-02,2.33E-03,0.228128164,5.70E-03,0.246055203,0,1.44E-02,0,1.22E-02,2.65E-02,0,30,36,0,0,0,0,0,0,0,0,0,0.81,NA,NA,-1.698677482,-2.136668882,-0.630072864,0.691906107,-1.301949188,-1.120022429,-1.170332152,-0.782234354,6.70E-02,-1.006483662,-0.921356697,-1.658597955,1.560987255,-0.375566557,1892.523803,1697.25622,3589.780024,Not Examined,Present,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 70 %,Positive : 60 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,CK7 - positive; Vimentin - positive; Estrogen - 70% (+++); Progesterone - 60% (++);,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02244,C3N-02244,No,b1,2,131C,CPT0128960003,Tumor,No,62,Female,Endometrioid carcinoma,G2 Moderately differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Not Reported,0,CNV_L,No,0,MSS,CNV_L,48,WT,Mutated,WT,Mutated,WT,9.60E-02,3.63E-02,7.51E-20,2.84E-19,0,2.01E-02,2.74E-02,0,1.04E-03,1.25E-02,0,2.80E-02,8.75E-20,0,1.08E-02,1.90E-02,6.24E-03,8.89E-02,6.45E-19,4.95E-02,2.25E-03,3.05E-03,7.21E-03,5.95E-03,0,0,4.43E-03,2.45E-20,3.38E-19,4.59E-02,1.40E-02,1.04E-02,2.64E-18,3.48E-02,1.44E-04,0,4.17E-02,5.39E-02,9.57E-02,0,5.09E-02,0.122627402,0.109951525,0,0.185850046,0,2.91E-02,1.98E-02,0,0,8.04E-02,5.54E-04,2.79E-02,7.51E-03,0.222394331,6.12E-02,5.95E-03,5.61E-02,0,0,1.97E-02,19,23,0,0,0,0,0,0,0,0,0,0.18,NA,NA,-0.107676348,9.76E-02,0.835401632,-1.123126051,0.169083077,-0.558616744,0.477976782,1.10908511,-0.128160498,0.58329071,0.591609536,1.259272706,-0.747330076,0.646962999,4754.892256,5088.957186,9843.849442,NA,NA,NA,Hispanic or Latino,Hispanic or Latino,Other: unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02247,C3N-02247,No,b1,3,131N,CPT0265300003,Tumor,No,68,Female,Endometrioid carcinoma,G2 Moderately differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unknown,NA,NA,No,7.93,MSI-H,MSI-H,728,WT,Mutated,WT,Mutated,WT,0.253732935,1.87E-02,3.08E-02,0,1.20E-03,4.99E-18,0.103786136,1.89E-03,4.08E-02,7.66E-02,3.74E-20,1.77E-02,2.23E-02,0,2.66E-02,1.26E-02,7.65E-19,0.157565663,0,0.143572972,3.21E-03,4.38E-03,1.46E-02,6.88E-03,0,0,3.10E-03,1.65E-20,3.06E-18,4.78E-03,1.20E-02,1.80E-02,2.73E-18,1.41E-17,0.158750667,3.25E-03,6.49E-02,8.67E-02,0.151643366,0,1.51E-02,1.03E-02,5.37E-02,0,0.31424386,0,0,0,0.165699366,0,0,0,0,0.109844507,0.209919838,6.39E-02,0,5.74E-02,0,0,0,9,64,316,0,0,0,0,92,0,0,72,NA,NA,NA,0.842084468,-1.627463096,-0.356452521,-1.418094345,0.396804101,-1.283228813,-0.169078372,-1.152918335,-0.350436708,-9.69E-02,-0.381885703,1.097287551,-0.5286894,5.67E-02,5290.709291,5725.192064,11015.90136,NA,NA,NA,Hispanic or Latino,Hispanic or Latino,Other: unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02249,C3N-02249,No,b3,10,130N,CPT0129080003,Tumor,No,64,Female,Endometrioid carcinoma,G2 Moderately differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,White,0,CNV_L,No,0.06,MSS,CNV_L,63,WT,Mutated,Mutated,Mutated,Mutated,5.57E-02,0,5.59E-19,0,1.39E-18,6.01E-18,1.15E-17,4.21E-19,0,0,8.26E-19,4.56E-18,6.59E-03,0,2.06E-19,5.80E-03,3.39E-18,3.39E-03,3.44E-18,4.51E-02,0,4.97E-03,3.63E-19,0,2.93E-18,1.10E-17,9.93E-19,2.57E-18,7.36E-18,2.96E-02,2.86E-03,7.70E-03,1.17E-18,6.30E-02,4.14E-03,0,1.73E-17,5.23E-03,5.23E-03,0,0,6.12E-02,3.15E-03,0,0.324678703,0,0,0,0,4.20E-02,0,0,0.353641598,6.00E-04,0.155729002,0,3.77E-02,0,1.90E-02,0,2.27E-03,2,24,33,0,0,0,0,0,0,0,0,0.74,NA,NA,-2.45E-02,1.129819654,0.518511803,3.22E-02,-0.524796529,1.285313111,0.188739199,-3.77E-02,-3.73E-02,0.555652879,0.529770126,-1.208466992,0.666095782,1.677119566,3546.884365,3299.669416,6846.553781,NA,NA,NA,Hispanic or Latino,Hispanic or Latino,Other: unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02253,C3N-02253,No,b4,14,128N,CPT0128770003,Tumor,No,53,Female,Endometrioid carcinoma,G2 Moderately differentiated,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,White,0,CNV_L,Yes,0.15,MSS,POLE,4219,Mutated,Mutated,WT,Mutated,Mutated,0.128769896,2.68E-02,0,2.00E-18,0,3.01E-03,5.52E-02,9.37E-04,6.90E-04,1.47E-02,5.11E-18,1.32E-19,1.97E-18,1.02E-18,2.87E-03,4.53E-18,3.21E-18,1.90E-18,7.86E-19,1.08E-02,3.79E-03,9.47E-03,6.78E-03,5.26E-03,0,0,6.26E-03,3.52E-19,1.33E-17,6.69E-02,2.84E-02,2.27E-02,0,0.100519471,1.63E-02,4.28E-03,2.63E-02,3.22E-18,2.63E-02,2.14E-02,0,5.23E-02,0.110794303,0,0.185194989,0,0.109066725,2.28E-02,0,6.96E-03,3.95E-02,1.94E-02,8.68E-02,8.13E-02,0.156586588,0,0,0.105098029,0,2.63E-03,0,224,117,0,0,1999,1869,0,0,0,0,0,0.76,NA,NA,-0.572640528,-0.221503713,-0.785765328,-0.165927255,1.69308959,-0.224887438,-0.193014583,-1.434108645,-7.85E-02,-1.141704929,-0.248593204,-0.941148449,1.025463306,0.17829777,2333.912514,4295.831047,6629.743562,NA,NA,NA,Not-Hispanic or Latino,Non-Hispanic,Other: unknown,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02271,C3N-02271,No,b1,3,128C,CPT0181670008,Tumor,No,58,Female,Endometrioid carcinoma,G2 Moderately differentiated,0.7,158,121,48,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,4,Stage I,NA,0,CNV_L,No,0,MSS,CNV_L,31,WT,Mutated,WT,WT,Mutated,6.48E-02,1.68E-02,0,0,0,4.30E-18,3.30E-02,0,0,1.05E-02,5.00E-18,3.08E-02,3.14E-03,1.34E-18,9.52E-03,2.47E-03,1.52E-21,9.94E-18,5.68E-18,2.76E-02,5.43E-03,1.42E-03,7.09E-03,1.03E-02,3.11E-18,7.62E-03,2.38E-03,1.62E-02,5.29E-18,6.52E-18,3.00E-02,2.40E-03,0,4.60E-02,2.96E-02,1.06E-03,4.39E-02,1.23E-03,4.52E-02,3.64E-02,0,5.67E-02,1.36E-02,0,0.276595024,0,1.41E-03,2.26E-02,0,0,8.68E-02,0,6.51E-02,1.72E-02,0.201748072,0,2.38E-02,0,1.79E-02,2.63E-02,0.153909886,9,21,0,0,0,0,0,0,0,0,0,0.25,Yes,No,-1.51E-04,0.747834004,1.239876315,0.394066094,0.997235066,0.80395918,1.218001135,1.504681034,1.20863107,-0.658134259,1.146738531,0.761140661,-0.58700222,1.159577578,3984.425899,5296.834209,9281.260107,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,4 or more,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Self-reported and Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Formetic|Vanatex|Adipine|Citrafleet,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,320|700|1063|1328,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,4 or more|4 or more|4 or more|4 or more,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,335.0|715.0|1078.0|1343.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02274,C3N-02274,No,b2,5,128C,CPT0182380004,Tumor,No,80,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,158,84,33,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,Stage I,NA,0.161135217,CNV_L,No,38.49,MSI-H,MSI-H,1368,WT,Mutated,WT,Mutated,WT,0,0,0,2.26E-18,0,8.38E-18,1.80E-17,0,0,4.24E-18,3.17E-18,0,2.11E-02,0,1.72E-18,2.30E-03,1.68E-18,5.28E-18,0,1.73E-21,0,0,1.83E-04,1.30E-04,0,0,1.26E-18,1.01E-18,4.26E-17,2.47E-03,9.03E-03,2.12E-02,1.98E-20,5.46E-02,0.129406267,1.74E-17,8.64E-05,1.15E-03,1.24E-03,1.09E-02,0,0,0,0,0.231365004,0,1.11E-02,2.09E-02,0,5.55E-02,0,0,8.53E-02,2.12E-03,0.138203005,0.135116782,5.15E-02,0,0.161245324,5.50E-03,9.12E-02,0,108,425,0,0,0,0,248,0,0,208,0.6,Yes,No,-0.960910833,-0.35442055,-1.037890741,1.675003725,-1.144594546,7.85E-02,-3.47E-03,-0.563620465,0.314217582,-0.942210883,0.202177414,-1.276107442,1.452148315,-1.168394001,1718.934353,2235.34997,3954.284324,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Lokren|Siofor|Diured|Simvasterol|Lacipil|Vivace,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Deceased,316|615|977|971,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,With Tumor|Tumor Free|Unknown Tumor Status|Unknown Tumor Status,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Persistent Disease|Complete Remission|Unknown|n/a,n/a|n/a|n/a|Unknown,Yes|Yes|Yes|Yes,Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,Brain|Brain|Brain|Brain,258.0|258.0|258.0|279.0,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,No|No|No|No,No|No|No|No,316.0|615.0|977.0|n/a,n/a|n/a|n/a|Cerebrovascular Disorder,n/a|n/a|n/a|1102.0,279.0|279.0|279.0|279.0,Surgical Resection|Surgical Resection|Surgical Resection|Unknown,RX: Presence of Residual Tumor cannot be assessed|RX: Presence of Residual Tumor cannot be assessed|RX: Presence of Residual Tumor cannot be assessed|RX: Presence of Residual Tumor cannot be assessed
C3N-02296,C3N-02296,No,b3,9,129C,CPT0181750004,Tumor,No,83,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.7,150,90,40,Present,=50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pNX,0,Stage II,NA,0,CNV_L,No,17.56,MSI-H,MSI-H,514,WT,Mutated,WT,WT,WT,2.78E-02,5.13E-03,6.67E-20,0,7.87E-18,1.68E-03,6.63E-03,0,1.17E-18,3.05E-18,0,3.98E-19,0,0,5.99E-04,3.51E-19,3.03E-05,1.73E-04,0,1.84E-02,0,0,4.99E-04,1.38E-02,2.39E-20,0,7.49E-03,0,2.32E-19,6.17E-02,1.20E-02,7.64E-03,0,5.47E-02,6.49E-04,8.83E-03,1.30E-02,8.64E-05,1.31E-02,1.87E-02,0,2.57E-03,1.62E-02,0,0.181637678,0,4.45E-02,5.99E-02,0,0,5.67E-02,0,0.402025819,7.70E-03,0.124040119,0,0,0,7.88E-02,0,7.09E-03,37,100,172,0,0,0,0,79,0,0,0,0.85,Yes,No,1.31E-02,-0.317137185,-0.312541962,1.433738033,-0.161056638,-0.797784762,5.44E-02,-0.704653894,1.024086467,-0.80926426,0.234668224,0.606228964,1.094910038,-0.780992912,2602.18226,3024.123206,5626.305465,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Euthyrox|Siofor|Diuresin|Lisiprol|Simvacard,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Deceased,448|750|974|974,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|With Tumor|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Persistent Disease|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|Yes|Yes|Yes,n/a|Locoregional Recurrence|Locoregional Recurrence|Locoregional Recurrence,n/a|Other: vaginal cuff|Other: vaginal cuff|Other: vaginal cuff,n/a|750.0|750.0|750.0,n/a|No|Yes|Yes,n/a|No|No|No,n/a|No|No|No,n/a|No|No|No,448.0|750.0|974.0|n/a,n/a|n/a|n/a|Respiratory Disease,n/a|n/a|n/a|1268.0,n/a|n/a|817.0|817.0,n/a|n/a|Surgical Resection|Surgical Resection,n/a|n/a|R0: No Residual Tumor|R0: No Residual Tumor
C3N-02298,C3N-02298,No,b3,10,131C,CPT0181540008,Tumor,No,83,Female,Endometrioid carcinoma,G1 Well differentiated,4,160,75,29,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,4,Stage I,NA,NA,NA,No,0,MSS,NA,56,WT,Mutated,WT,WT,WT,3.10E-02,2.66E-02,0,0,2.64E-18,0,8.37E-03,1.35E-18,0,2.79E-02,0,1.35E-02,1.45E-02,0,2.58E-03,6.83E-19,0,9.93E-18,0,5.07E-02,5.67E-04,2.74E-19,6.28E-03,8.96E-03,6.38E-19,5.79E-19,1.08E-02,2.65E-19,3.22E-18,1.09E-17,1.69E-02,1.28E-02,6.99E-20,0,2.24E-02,0,2.58E-02,5.31E-18,2.58E-02,4.38E-02,0,4.85E-03,0.141005068,0,0.172691468,0,0,4.35E-02,1.43E-02,0,0,0,0,1.29E-02,0.280991343,1.14E-02,1.50E-02,0.215700909,0,0,4.40E-02,14,34,0,0,0,0,0,0,0,0,0,NA,NA,NA,0.559241776,-0.540152595,0.970245124,1.000307016,-0.780444474,0.369785978,0.174319739,0.76700818,1.01E-02,-1.335195364,0.182926199,-0.703083495,1.340662281,0.239093334,3230.255382,3577.007665,6807.263047,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,clexane|Nitrendypina|Betaloc|Atoris|Nolpaza|Doxar|Tritace|Heparegen,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,378|625|987|1450,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,No|No|No|No,No|No|No|No,2|2|2|2,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,378.0|625.0|987.0|1450.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02302,C3N-02302,No,b3,11,131C,CPT0181610003,Tumor,No,69,Female,Endometrioid carcinoma,G1 Well differentiated,6.5,160,78,30,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,16,Stage I,NA,2.12E-02,CNV_L,No,0.01,MSS,CNV_L,76,WT,Mutated,Mutated,Mutated,Mutated,5.97E-02,5.82E-03,0,0,0,0,1.93E-18,8.94E-20,0,9.27E-03,3.07E-18,0,4.21E-03,4.50E-20,9.11E-03,0,1.87E-03,1.85E-19,0,8.57E-02,1.96E-02,1.74E-02,1.18E-02,2.56E-03,0,1.35E-02,5.54E-03,6.12E-03,0,2.21E-02,1.30E-02,6.88E-03,2.94E-19,4.81E-02,6.02E-02,6.01E-03,3.90E-02,2.60E-19,3.90E-02,0,0,0.111216784,0.120963476,0,0.172160335,9.29E-03,6.11E-03,0,0,2.73E-02,0,0,6.57E-02,1.58E-03,0.323537185,2.67E-02,7.57E-03,0,0,3.96E-02,8.83E-02,40,33,0,0,0,0,0,0,0,0,0,0.65,Yes,No,0.865147527,-0.131179063,-0.213954775,-0.478838545,-0.369031154,0.146959813,0.585819275,0.688512187,0.315352122,-0.259014447,0.726497766,1.127427742,-0.33141093,0.709827011,3872.297694,4392.003162,8264.300857,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Ebivol|Diuresin|Karbis|Glucophage 750g,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,503|746|993|1357,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,Yes|Yes|Yes|Yes,Yes|Yes|Yes|Yes,3|3|3|3,No|No|No|No,Complete Remission|Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,503.0|746.0|993.0|1357.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02337,C3N-02337,No,b3,12,128C,CPT0136280003,Tumor,No,70,Female,Endometrioid carcinoma,G2 Moderately differentiated,0.8,164,81,30.12,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,Stage I,NA,0,CNV_L,No,0.04,MSS,CNV_L,57,WT,Mutated,WT,Mutated,WT,3.95E-02,4.23E-03,1.92E-19,0,0,1.19E-02,1.99E-18,3.58E-19,4.59E-03,8.66E-03,0,7.50E-03,0,0,2.90E-04,9.72E-03,0,8.86E-19,3.76E-18,4.45E-02,0,0,2.98E-04,2.15E-02,8.04E-20,6.88E-19,7.69E-03,0,3.32E-18,3.83E-03,1.70E-02,1.11E-02,0,2.57E-02,2.25E-02,1.19E-02,2.04E-02,4.86E-03,2.53E-02,0,2.42E-02,0,0,0,0.378661096,0,5.29E-02,2.82E-02,0,3.70E-02,7.47E-02,3.59E-02,0.184791056,2.53E-02,0.146671385,0,1.13E-02,5.60E-04,0,0,0,16,20,0,0,0,0,16,0,0,0,0,0.34,NA,NA,0.634611046,-0.706436551,-0.655793985,-0.747967565,-0.569300874,-0.398115283,-1.97E-02,-0.318297464,0.822338019,-0.38505721,-3.84E-02,-1.81E-02,-0.534978146,0.156357041,3157.377031,3626.221991,6783.599023,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02372,C3N-02372,No,b2,7,131N,CPT0137140008,Tumor,No,54,Female,Endometrioid carcinoma,G2 Moderately differentiated,1.3,173,90,30.07,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,Stage I,NA,6.32E-02,CNV_L,No,22.4,MSI-H,MSI-H,1310,WT,Mutated,WT,Mutated,WT,0.178237985,9.34E-03,2.67E-02,2.06E-19,3.95E-03,0,4.67E-02,1.07E-02,3.51E-02,5.21E-02,4.64E-03,2.84E-03,2.60E-02,1.55E-20,4.54E-02,3.86E-02,9.84E-03,0.141676588,8.44E-03,0.103320842,3.06E-02,2.71E-02,6.42E-03,1.02E-02,0,4.46E-03,1.54E-03,0,0,4.03E-03,7.93E-02,7.24E-03,0,0,0.359208259,7.91E-03,9.93E-02,0.1003232,0.199631902,4.33E-02,0,5.25E-02,0.106278504,0,0.194169252,4.47E-02,7.03E-02,0,0,0,6.94E-02,7.01E-04,1.53E-02,0.113468193,0.221076784,2.20E-02,3.38E-03,3.23E-02,0,1.62E-03,9.46E-03,374,240,0,0,0,0,383,0,0,0,0,0.17,NA,NA,-0.230424072,-0.118166316,0.795624078,-0.299328933,4.20E-02,-0.27518029,-0.132789313,-0.562002205,0.238820503,0.759833964,-0.335783349,0.774896022,-0.626412557,-0.637548054,6356.338308,5859.178928,12215.51724,Not Examined,Present,Margins uninvolved by invasive carcinoma,NA,Slavonic,Ukraine,Other,Entire uterine cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,NA,NA,NA,NA,NA,NA,Yes,2,12 Months|24 Months,No|No,Living|Living,372|818,No|No,No|No,No|No,Tumor Free|Tumor Free,Never|Never,Never|Never,Never|Never,No|No,No|No,Unknown|Unknown,No|No,Complete Remission|Complete Remission,Complete Remission|Complete Remission,n/a|n/a,No|No,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,341.0|787.0,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a,n/a|n/a
C3N-02436,C3N-02436,No,b4,14,131C,CPT0115530003,Tumor,No,51,Female,Endometrioid carcinoma,G1 Well differentiated,8,160,122,47.47,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,13,Stage I,White,7.67E-02,CNV_L,No,35.64,MSI-H,MSI-H,1253,Mutated,Mutated,WT,Mutated,WT,4.93E-02,2.46E-02,1.13E-19,0,2.30E-19,4.88E-18,5.68E-02,1.46E-03,1.74E-02,5.43E-02,3.13E-03,8.39E-03,2.50E-20,0,4.68E-02,0,4.46E-03,8.24E-18,1.14E-18,1.08E-02,3.04E-02,3.05E-02,1.36E-02,2.95E-03,0,7.53E-18,5.45E-03,1.46E-18,1.43E-17,3.20E-02,4.41E-02,8.30E-03,0,0.136260905,7.79E-02,1.31E-02,8.44E-02,4.12E-18,8.44E-02,0,0,1.57E-02,0.111668301,0,0.227725853,1.06E-02,3.43E-02,7.03E-02,0,3.08E-02,2.81E-02,0,0.107232895,7.35E-02,0.274861568,1.75E-03,0,1.35E-02,0,0,0,178,207,0,0,0,0,275,119,0,0,82,0.48,Yes,No,0.130519566,-0.197965889,0.586393386,-0.469053254,6.58E-02,-1.330719595,-1.093150363,-0.530102096,1.141768576,-1.051315758,-1.326021881,0.446566161,0.707129872,-1.509491247,4096.108384,5571.055976,9667.16436,Atypical and/or suspicious,Not identified,Cannot be assessed,Not-Hispanic or Latino,white,United States,Other,entire endometrial cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Premenopausal: less than 6 months since LMP AND no prior bilateral oophorectomy AND not on estrogen replacement,Never,1,ERG in A12: positive for lymphovascular invasion,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,tylenol|ferrous sulfate|lisinopril-hydrochlorothiazide|potassium chloride CR|zoloft,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,332|740|1103|1502,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Unknown|Unknown|Unknown|Unknown,Never|Never|Never|Never,Yes|Yes|Yes|Yes,No|No|No|No,1|1|1|1,No|No|No|No,Not Applicable|Not Applicable|Not Applicable|Not Applicable,Complete Remission|Complete Remission|Not Applicable|n/a,n/a|n/a|n/a|Not Applicable,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,299.0|707.0|1070.0|1469.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02437,C3N-02437,No,b1,1,128C,CPT0159110003,Tumor,No,61,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.8,163,156,58.87,Present,=50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,27,Stage III,White,0,CNV_L,No,8.52,MSI-H,MSI-H,323,WT,Mutated,Mutated,Mutated,Mutated,5.03E-02,0,5.42E-04,4.89E-18,4.13E-19,0,3.32E-19,4.65E-03,1.04E-02,2.81E-03,0,3.43E-19,3.57E-20,0,3.61E-03,1.72E-19,0,1.43E-17,0,1.67E-02,1.23E-19,0,1.11E-19,4.16E-03,0,0,2.39E-03,0,7.35E-18,2.29E-04,2.42E-02,1.50E-02,2.05E-03,4.23E-02,9.91E-02,1.34E-02,1.21E-02,7.34E-18,1.21E-02,0,1.48E-03,0,2.00E-02,0,0.28938527,0,5.16E-03,7.16E-03,0,0,5.78E-02,0,0.259374602,3.83E-02,0.155608113,2.98E-02,8.39E-02,0,2.84E-02,1.26E-02,1.10E-02,0,51,141,0,0,0,0,36,0,0,0,0.76,NA,NA,0.846722283,-0.101513466,-0.144841051,0.91979873,-0.17787433,0.787821688,0.806534529,0.473683518,1.193911538,-0.651134294,0.672034779,-1.17935931,0.537376115,1.365153275,3061.091476,3498.932238,6560.023713,Negative for malignancy/normal/benign,Not identified,Cannot be assessed,Not-Hispanic or Latino,white,United States,Other,anterior and posterior,Multifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,Prussian blue stain for iron: highlights hemosiderin (control positive); Kinyoun stain for mycobacteria: negative (control positive),NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,aspirin|carvedilol|clonidine|cyproheptadine|furosemide|naproxen sodium|potassium chloride|valsartan,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,308|764|1036,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,No|No|No,2|2|2,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,290.0|746.0|1018.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02595,C3N-02595,No,b4,15,130N,CPT0181810004,Tumor,No,41,Female,Endometrioid carcinoma,G3 Poorly differentiated,10,165,50,18,Present,=50% myometrial invasion,Seventh Edition (2010),pT3a (FIGO IIIA),pN1 (FIGO IIIC1),22,Stage IV,NA,1.371947271,CNV_L,No,26.97,MSI-H,MSI-H,1133,WT,Mutated,WT,Mutated,Mutated,9.03E-02,6.03E-03,7.52E-03,0,3.93E-18,2.97E-19,4.97E-03,5.57E-03,2.10E-04,2.26E-02,3.43E-18,1.76E-03,2.74E-02,2.12E-18,8.13E-03,5.30E-19,1.22E-19,0,1.46E-17,2.58E-02,1.28E-02,7.54E-03,4.20E-03,9.07E-03,0,2.46E-19,4.47E-03,0,0,1.11E-02,1.93E-02,8.40E-03,3.62E-19,2.62E-02,0.164645203,0,2.42E-02,2.65E-19,2.42E-02,4.14E-03,0,0.11398473,4.32E-02,0,0.214473912,0,3.41E-02,0,1.96E-02,0,3.62E-02,0,0.12359541,5.96E-02,0.240601901,3.81E-02,0,0,3.10E-02,1.90E-02,2.24E-02,69,6,424,0,0,0,0,173,0,0,104,0.34,NA,NA,-0.216454753,0.610482789,0.80700581,0.530336339,-0.566719449,0.98811317,0.523465296,6.99E-02,2.71E-02,-0.432048403,0.439976356,-0.620225453,-0.401425309,0.272969203,3858.489953,4137.281022,7995.770975,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Other,Fundus and lower part with isthmus - infiltration of the cervix,Multifocal,IHC staining not done,3,11,IHC staining not done,0,0,IHC staining not done,0,cM1,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Premenopausal: less than 6 months since LMP AND no prior bilateral oophorectomy AND not on estrogen replacement,Never,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Olanzapin|Pantoprazol|Exacyl|Cyclonamine|Hydroxyzinum|Clexane,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,489|721|980,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Unknown|Unknown|Unknown,Never|Never|Never,No|No|No,No|No|No,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,509.0|741.0|1000.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02598,C3N-02598,No,b3,12,131N,CPT0187960004,Tumor,No,60,Female,Endometrioid carcinoma,G2 Moderately differentiated,8,157,54,21,Present,=50% myometrial invasion,Seventh Edition (2010),pT4 ((FIGO IVA),pN2 (FIGO IIIC2),0,Stage IV,NA,3.83E-02,CNV_L,No,6.41,MSI-H,MSI-H,941,Mutated,Mutated,WT,Mutated,WT,9.62E-02,8.72E-05,4.48E-03,0,0,3.57E-18,3.91E-02,6.18E-05,8.79E-04,2.71E-02,1.23E-18,0,1.47E-02,0,8.97E-03,1.66E-02,6.19E-19,7.13E-02,0,3.09E-02,2.13E-02,1.36E-02,8.88E-03,7.09E-21,2.88E-19,1.09E-02,4.35E-03,2.28E-03,5.20E-18,3.30E-03,1.47E-02,6.50E-03,7.17E-18,7.55E-03,8.71E-02,1.87E-03,2.97E-02,4.64E-02,7.61E-02,0,0,4.11E-02,4.24E-02,0,0.291548358,0,1.26E-02,0,0,0,4.02E-02,0,6.08E-02,3.22E-02,0.144917984,9.65E-02,0,0,0.106095108,4.69E-02,8.47E-02,149,35,507,0,0,0,0,194,0,0,0,0.49,NA,NA,0.486631463,1.234906624,-1.228286315,1.321823493,-0.744782971,1.954233069,1.32086742,0.304020926,0.114762218,1.056982929,1.30256427,-0.555580639,1.436945537,1.452465137,5311.754482,4933.694273,10245.44875,Not Examined,Not identified,Margin(s) involved by invasive carcinoma,NA,Caucasian,Poland,Other,"Istmus, cervical canal and fundus and anterior wall of uterine corpus",Unifocal,0,0,6,1,1,1,0,0,cM1,R0:  No residual tumor,Positive : % Not available,Negative,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,Unknown,NA,20,NA,Yes,Self-reported and Medical Record,Yes,Medical Record|Medical Record,Citrafleet|Fragmin,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,267|659|1068,No|No|No,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,No|No|No,No|No|No,2|2|2,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,267.0|659.0|1068.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02631,C3N-02631,No,b3,11,128N,CPT0181960004,Tumor,No,77,Female,Serous carcinoma,G3 Poorly differentiated,8,156,75,30.82,Present,<50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN0,6,Stage II,NA,26.26196116,CNV_H,No,0.86,MSS,CNV_H,64,Mutated,WT,WT,WT,Mutated,0,0,4.91E-19,0,0,0,5.03E-18,8.80E-03,1.00E-17,0,2.21E-18,0,2.05E-02,0,0,6.27E-03,0,2.02E-02,0,0.103686034,0,4.42E-19,2.37E-04,2.88E-19,0,0,8.25E-19,8.38E-19,9.80E-18,3.86E-02,1.06E-02,1.24E-02,7.65E-18,5.82E-02,0.189308078,2.64E-18,1.40E-17,1.38E-02,1.38E-02,0.157999115,0,2.52E-02,4.79E-02,0,6.51E-03,0,0.134292989,0,0,0,7.99E-02,7.69E-04,3.93E-02,0,0.269409935,0,0.20074118,3.79E-02,0,0,0,13,48,0,0,0,0,0,0,0,0,0,0.47,Yes,No,-0.571092058,-1.151372585,-0.862799493,-1.536707086,-0.278985331,-0.542342851,-2.460955649,-1.061078949,0.503625473,-0.398774199,-2.501241837,-2.674330255,0.218722636,-2.383170511,2213.438711,865.788058,3079.226769,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Multifocal,IHC staining not done,0,8,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 5 %,Positive : 5 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,"Vimentin (+)-5%,p16 (+)-95%,CEA(+)-1%, CK5/6(+)-1%",NA,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Self Report|Self Report|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Beto ZK|Atoris|Glucophage |Polpril|Verospiron,Melanoma malignum,Self Report,Surgery,Unknown,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,291|679|1107,No|No|No,Yes|Yes|Yes,No|No|No,Tumor Free|With Tumor|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,Yes|Yes|Yes,1|1|1,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Persistent Disease|n/a,n/a|n/a|Complete Remission,No|Yes|No,n/a|Distant Metastasis|n/a,n/a|Other: abdomen wall near umbilicus|n/a,n/a|679.0|n/a,n/a|No|n/a,n/a|No|n/a,n/a|No|n/a,n/a|No|n/a,291.0|679.0|1107.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02632,C3N-02632,No,b1,1,129N,CPT0182020004,Tumor,No,57,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.8,174,89,29,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,3,Stage I,NA,0,CNV_L,No,0.02,MSS,CNV_L,63,WT,Mutated,WT,Mutated,WT,2.95E-02,3.88E-03,0,4.77E-18,0,0,3.54E-18,0,1.16E-17,5.48E-20,3.48E-17,0,2.80E-03,1.87E-18,9.09E-23,0,0,1.18E-18,0,3.50E-02,8.83E-04,1.83E-04,4.80E-03,7.42E-03,3.50E-18,9.45E-04,6.69E-03,4.08E-02,2.68E-17,0,9.09E-03,6.40E-03,1.50E-18,6.09E-02,3.20E-02,5.30E-19,3.59E-02,5.90E-19,3.59E-02,0,7.20E-03,2.33E-04,8.20E-05,0,0.325105995,0,2.63E-02,2.31E-02,0,0,0.137976343,0,3.03E-02,0,3.59E-02,0,1.20E-02,0,6.40E-02,1.70E-02,0.320842759,18,17,0,0,0,0,22,0,0,0,0,0.56,NA,NA,-0.434784163,-0.24884144,-0.494035294,1.053296563,-0.48604084,-8.09E-02,1.640355071,0.380147841,0.865443951,-0.647115205,1.47754223,-0.37469067,1.152536238,0.877684072,3054.31647,4676.254457,7730.570926,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Euthyrox|Citrafleet|Fragmin|Cipronex|Natrium kalium|Dormicum,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months|48 Months,No|No|No|No,Living|Living|Living|Living,497|859|960|1405,No|No|No|No,No|No|No|No,No|No|No|No,Tumor Free|Tumor Free|Tumor Free|Tumor Free,Never|Never|Never|Never,Never|Never|Never|Never,Never|Never|Never|Never,No|No|No|No,No|No|No|No,Unknown|Unknown|Unknown|Unknown,No|No|No|No,Unknown|Unknown|Complete Remission|Complete Remission,Unknown|Complete Remission|Complete Remission|n/a,n/a|n/a|n/a|Complete Remission,No|No|No|No,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,510.0|872.0|973.0|1418.0,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a,n/a|n/a|n/a|n/a
C3N-02635,C3N-02635,No,b4,13,127N,CPT0182070004,Tumor,No,56,Female,Endometrioid carcinoma,G3 Poorly differentiated,3,150,80,35,Present,=50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN1 (FIGO IIIC1),9,Stage II,NA,13.35596277,CNV_H,No,0.5,MSS,CNV_H,66,WT,Mutated,WT,WT,Mutated,0.115812689,2.67E-02,5.25E-20,5.88E-18,1.58E-19,8.31E-19,4.49E-18,3.86E-19,7.54E-19,0,9.99E-18,0,8.17E-03,0,1.34E-19,6.86E-03,0,6.20E-18,1.23E-18,6.24E-02,2.02E-02,2.33E-02,1.57E-02,1.76E-03,0,0,1.42E-03,0,0,1.28E-03,1.55E-02,3.92E-02,8.63E-18,6.46E-02,0.130536771,0,3.24E-02,3.79E-03,3.62E-02,0,7.52E-03,8.39E-02,3.94E-02,0,0.109467339,0,2.37E-02,0,0,0,3.38E-02,0,9.46E-02,1.41E-02,0.352609746,0,0.143849245,6.03E-02,0,0,3.68E-02,14,14,0,0,0,11,17,0,0,0,0,0.83,Yes,No,-0.728620323,-0.21165115,-6.94E-02,0.210879394,2.078698042,-0.708728998,-0.145974832,0.243789143,0.259294703,-0.791693064,-5.03E-02,-1.681788585,0.429710828,-1.149392898,3589.221054,3933.817101,7523.038154,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,1,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Siofor|enalapril|Vastan,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,330|619|1025,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Unknown|Unknown|Unknown,Never|Never|Never,Yes|Yes|Yes,Yes|Yes|Yes,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|Complete Remission,n/a|n/a|n/a,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,330.0|619.0|1025.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02636,C3N-02636,No,b4,14,127N,CPT0182150003,Tumor,No,72,Female,Endometrioid carcinoma,G1 Well differentiated,5.5,157,83,33,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,3,Stage I,NA,1.163072893,CNV_L,No,0.11,MSS,CNV_L,74,WT,WT,Mutated,Mutated,WT,2.68E-02,0,0,5.37E-20,0,4.48E-18,0,3.39E-03,6.22E-20,2.62E-03,0,1.16E-18,8.70E-03,6.32E-19,5.10E-20,1.77E-03,2.31E-19,6.96E-02,1.55E-18,8.65E-03,2.38E-21,1.75E-03,2.13E-04,1.24E-03,5.66E-19,0,2.47E-03,2.91E-04,0,9.28E-03,5.21E-03,7.97E-03,4.48E-18,3.37E-02,0.106936974,4.45E-18,1.02E-03,3.73E-02,3.84E-02,1.78E-02,0,4.00E-02,5.71E-02,0,0.180180067,0,4.22E-02,3.86E-02,0,0.117838441,0,3.84E-02,3.54E-02,2.36E-02,0.121293967,1.16E-02,4.19E-02,0,0.137790059,9.42E-02,2.20E-03,12,22,0,0,0,9,22,0,0,0,0,0.64,NA,NA,1.098775714,-0.170872415,-0.648246186,1.574011104,-0.398238555,0.467888856,8.84E-02,0.145085363,0.263673245,0.301099209,0.307669417,-4.41E-02,-0.668321467,0.925265962,3856.040287,2842.949468,6698.989755,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Other,Fundus (main tumor) and isthmus (implants),Multifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,Vimentin positive,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Tritace|Clexane|Citrafleet,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,361|676|1096,Yes|Yes|No,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,None|None|1,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,382.0|697.0|1117.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02637,C3N-02637,No,b4,15,131C,CPT0182210004,Tumor,No,53,Female,Endometrioid carcinoma,G2 Moderately differentiated,3,168,138,48,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,Stage I,NA,4.45E-03,CNV_L,Yes,0.18,MSS,POLE,7455,Mutated,Mutated,WT,Mutated,Mutated,0.148903082,8.86E-02,9.68E-03,1.00E-03,0,0,6.56E-03,3.28E-03,0,2.46E-02,1.16E-17,1.67E-02,1.07E-02,0,1.62E-02,2.86E-03,4.92E-18,0,2.54E-19,2.34E-02,1.74E-02,2.30E-02,3.86E-04,1.10E-02,2.04E-02,0,2.83E-02,1.15E-19,1.63E-17,4.73E-02,9.35E-02,1.09E-02,4.24E-18,5.86E-02,0.200077682,1.93E-02,8.88E-02,1.43E-03,9.02E-02,5.41E-02,1.40E-02,1.68E-02,5.74E-02,0,0.154482517,0.101144466,7.98E-02,0,0,6.17E-02,0,0,8.35E-02,7.39E-02,0.207691672,0,0,0,6.11E-02,0,3.43E-02,485,0,0,0,2248,4706,0,0,0,0,0,0.65,NA,NA,-0.153843257,0.180211463,0.195008256,0.890892324,-1.25804392,1.127235908,0.520790353,-1.328790363,0.885768342,-1.117668355,0.266184135,6.17E-02,1.020523657,0.379026749,3953.376146,5441.827192,9395.203338,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 70 %,Positive : 80 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,Yes,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,"EMA (+), Vimentin (+), CD10 (+)",NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,302|687|1135,Yes|No|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,No|No|No,No|No|No,1|1|1,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Patient Deceased,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,302.0|687.0|1135.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02639,C3N-02639,No,b4,14,130N,CPT0182290003,Tumor,No,59,Female,Endometrioid carcinoma,G3 Poorly differentiated,9,157,78,31,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,13,Stage I,NA,31.81337824,CNV_H,No,1.41,MSS,CNV_H,53,Mutated,WT,WT,WT,WT,6.77E-03,0,6.60E-20,4.04E-18,0,0,2.86E-18,8.21E-05,2.71E-18,4.39E-18,0,1.49E-18,1.02E-02,0,1.36E-19,3.02E-03,0,0,0,0.130277113,0,1.13E-03,0,1.51E-20,0,0,0,4.57E-19,6.20E-19,0,1.28E-02,7.74E-03,0,7.78E-03,0.166392433,6.78E-18,2.62E-18,6.05E-03,6.05E-03,2.90E-03,0,3.12E-02,3.13E-02,0,0,0,4.80E-02,0.11176199,0.100421579,1.70E-03,0,3.77E-02,0.109428011,0,5.06E-02,0,0.244140879,0.206347578,0,2.45E-02,0,14,24,0,12,0,0,0,0,0,0,0,0.75,NA,NA,0.767210751,2.36E-03,0.317344385,0.977599381,0.586863491,0.245999258,-1.26931856,0.398623514,1.560387177,-0.402292938,-1.053987618,-0.373247649,0.285155769,-0.823684333,3045.532716,2255.926224,5301.45894,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Multifocal,0,0,6,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : 10 %,Positive : 20 %,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,3,"EMA (+), Vimentin (+), CD10 (-), CK8/18(+),CK5/6(-),bcl2(+),SMA(-),DES(-)",NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Beto ZK|Nitrendypina|Tritace|Signopan|Solpadeine,NA,NA,NA,NA,Yes,1,12 Months|24 Months,No|No,Living|Deceased,294|703,Yes|Yes,Yes|Yes,Yes|Yes,With Tumor|Tumor Free,Never|Never,Never|Never,Never|Never,Yes|Yes,No|Yes,3|1,No|No,Persistent Disease|Persistent Disease,Persistent Disease|Persistent Disease,n/a|n/a,Yes|Yes,Distant Metastasis|Distant Metastasis,"Other: peritoneum, omentum majus, ascites|Other: peritoneum, omentum majus, ascites",324.0|324.0,No|No,No|No,Yes|Yes,No|No,294.0|n/a,n/a|Malignant Neoplasm,n/a|526.0,n/a|n/a,n/a|n/a,n/a|n/a
C3N-02678,C3N-02678,No,b3,11,130C,CPT0182340004,Tumor,No,69,Female,Endometrioid carcinoma,G1 Well differentiated,5.5,164,66,24,Present,=50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN0,8,Stage II,NA,0,CNV_L,No,13.39,MSI-H,MSI-H,482,WT,Mutated,Mutated,Mutated,WT,3.74E-02,2.39E-04,0,1.32E-18,0,1.70E-19,7.54E-03,1.01E-19,1.61E-20,0,0,2.06E-18,2.34E-02,0,2.22E-03,6.29E-03,0,8.00E-03,0,4.63E-02,0,1.57E-04,4.53E-03,5.24E-03,0,0,1.66E-04,5.08E-19,5.37E-18,8.01E-03,2.89E-02,1.30E-02,4.87E-21,2.94E-02,6.51E-02,4.02E-03,5.13E-03,8.38E-03,1.35E-02,1.29E-02,0,0.186416001,0,0,0.299349686,2.43E-02,0,0,0,0,0,2.23E-02,0.283531578,1.28E-02,0.104148659,1.85E-02,0,1.99E-02,0,0,1.59E-02,56,57,0,0,0,0,247,0,0,0,0,0.46,NA,NA,0.931996304,-0.234767653,-0.529491834,0.715090167,-1.207887158,0.438337251,4.22E-02,0.16601276,1.021736144,0.611077934,0.259159624,6.02E-02,0.151047993,1.262981778,3790.01119,3673.92532,7463.93651,Not Examined,Present,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,1,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,Unknown,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Concor|Tulip|Afobam|Zyrtec,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,266|707|580,Yes|Yes|Yes,No|No|No,No|No|No,With Tumor|With Tumor|With Tumor,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,Unknown|Unknown|2,No|No|No,Persistent Disease|Persistent Disease|Complete Remission,Persistent Disease|Persistent Disease|n/a,n/a|n/a|Patient Deceased,Yes|Yes|Yes,Distant Metastasis|Distant Metastasis|Distant Metastasis,Lung|Lung|Lung,266.0|545.0|545.0,No|No|No,No|No|No,Yes|No|Yes,No|No|No,266.0|707.0|n/a,n/a|n/a|Uterine Corpus Cancer,n/a|n/a|598.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02789,C3N-02789,No,b4,13,131N,CPT0186010004,Tumor,No,61,Female,Endometrioid carcinoma,G2 Moderately differentiated,3.5,147,56,25.7,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,17,Stage II,White,NA,NA,No,12.08,MSI-H,MSI-H,420,WT,Mutated,Mutated,Mutated,WT,0.141682818,1.13E-02,0,2.58E-18,0,5.61E-18,1.31E-18,6.96E-03,2.75E-02,4.14E-02,0,2.36E-03,2.05E-02,1.90E-18,4.20E-03,0,0,0,1.70E-18,6.02E-04,3.89E-02,2.44E-02,1.94E-02,1.50E-03,0,2.39E-03,9.87E-03,6.66E-03,0,5.42E-03,3.69E-02,2.11E-03,5.83E-18,1.57E-02,0.183682185,0,6.16E-02,4.00E-19,6.16E-02,0,0,3.47E-03,3.86E-02,0,0.144920809,5.21E-03,2.55E-02,0,2.58E-02,0,2.70E-02,0,8.46E-02,7.32E-02,0.317682796,2.23E-02,0,0,9.71E-02,5.60E-02,7.85E-02,13,16,169,0,0,0,0,58,0,0,48,NA,NA,NA,0.552801952,0.918609667,-3.34E-02,-0.767812714,0.630192871,1.229641589,1.659742073,1.123896171,1.512568695,-0.490776871,1.38183436,-0.651425363,0.749161776,0.274117739,3305.802106,4866.046928,8171.849034,Positive for malignancy,Present,Cannot be assessed,Not-Hispanic or Latino,white,United States,Other,entire cavity,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM1,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,Unknown,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Current Therapy,1,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",20,21,2,0.1,Exposure to secondhand smoke history not available,NA,Yes,Medical Record|Medical Record|Medical Record,calcium carbonate|lysine|Multivitamin,NA,NA,NA,NA,No,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,285|725|1137,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Former Therapy|Former Therapy|Former Therapy,Former Therapy|Former Therapy|Former Therapy,Unknown|Unknown|Unknown,No|No|No,No|No|No,1|1|1,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,255.0|695.0|1107.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02947,C3N-02947,No,b2,8,128N,CPT0158520008,Tumor,No,51,Female,Endometrioid carcinoma,G2 Moderately differentiated,5.5,170,65,22.39,Present,=50% myometrial invasion,Seventh Edition (2010),pT1 (FIGO I),pN0,2,Stage I,White,0,CNV_L,No,30.36,MSI-H,MSI-H,921,Mutated,Mutated,WT,Mutated,Mutated,7.35E-02,2.04E-02,8.11E-03,0,1.88E-20,4.85E-18,3.68E-02,8.23E-03,4.32E-03,0,0,4.71E-03,2.74E-02,0,0,3.40E-03,0,0,0,1.28E-02,7.26E-03,7.76E-03,5.17E-03,4.51E-03,0,0,6.09E-03,0,1.44E-17,1.34E-02,2.71E-02,2.15E-02,0,4.86E-02,0.194891097,3.70E-19,2.43E-02,1.70E-03,2.60E-02,1.69E-02,0,6.58E-02,0.119800608,0,0.232481626,4.00E-02,0.100749453,0,0,0,2.42E-02,6.32E-03,0.168448027,2.04E-02,5.51E-02,0,5.57E-02,0,9.39E-02,1.44E-04,0,60,0,364,0,0,0,0,115,0,0,91,0.57,NA,NA,-1.019201651,1.030815245,-1.253029177,0.700607819,-1.151180079,1.29795756,0.897221983,-0.317105163,1.2015646,-4.09E-02,0.850381647,-0.936510283,-7.70E-02,-0.670449534,3107.034864,4311.345097,7418.379961,Positive for malignancy,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,white,United States,Other,anterior and posterior,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Premenopausal: less than 6 months since LMP AND no prior bilateral oophorectomy AND not on estrogen replacement,Unknown,None,NA,NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,Unknown,NA,5,NA,Exposure to secondhand smoke history not available,Medical Record,Yes,Medical Record|Medical Record,acetaminophen |hydrocodone-acetaminophen,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|Yes,Living|Living|Living,331|856|856,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,No|No|No,No|No|No,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,331.0|856.0|856.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02972,C3N-02972,No,b4,15,131N,CPT0159220008,Tumor,No,74,Female,Endometrioid carcinoma,G2 Moderately differentiated,4.1,152,88,38.08,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN1 (FIGO IIIC1),19,Stage III,White,0,CNV_L,No,0.03,MSS,CNV_L,77,Mutated,Mutated,WT,Mutated,Mutated,0.11022494,6.88E-04,1.55E-19,0,1.54E-19,0,0,3.90E-19,2.32E-18,8.85E-04,9.31E-18,1.26E-02,6.92E-03,1.50E-18,3.79E-03,4.27E-03,4.92E-20,4.07E-18,0,4.22E-02,3.72E-03,7.21E-03,4.05E-03,1.76E-03,0,4.09E-18,5.44E-20,1.11E-03,0,2.97E-18,1.73E-02,8.54E-04,2.02E-19,4.50E-02,4.79E-02,2.55E-19,7.38E-03,2.14E-03,9.52E-03,0,0,8.36E-03,6.10E-02,0,0.245884886,0,4.87E-02,1.69E-02,0,0,7.72E-02,1.21E-02,0,2.99E-02,0.239081182,0,4.08E-02,0,0.118302791,3.62E-02,6.54E-02,30,37,0,0,0,0,0,0,0,0,0,0.26,Yes,Yes,-8.51E-02,1.335986316,0.430705105,0.985335445,1.352598595,1.266359789,1.749552285,1.33586285,0.185018664,-4.60E-02,1.84529309,0.477400599,1.069508234,1.19664878,4104.78479,4741.808055,8846.592846,Negative for malignancy/normal/benign,Not identified,Margins uninvolved by invasive carcinoma,Not-Hispanic or Latino,white,United States,Other,Anterior and Posterior,Unifocal,IHC staining not done,1,3,IHC staining not done,0,0,IHC staining not done,0,Staging Incomplete,RX:  Presence of residual tumor cannot be assessed,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,Unknown,Cytokeratin polytypic: positive ;PAX 8: positive;MOC31: negative;WT-1: negative; Vimentin: positive ; P16: mosaic pattern,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,Exposure to secondhand smoke history not available,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,acetaminophen-codeine|aspirin |ducolax|zyrtec|Vitamin D|celexa|glucotrol|hydrochlorothiazide|lisinopril|magnesium oxide|metformin|metoprolol|multi-vitamin (centrum women)|prilosec|pravachol,NA,NA,NA,NA,Yes,2,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,293|874|1202,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Unknown|Unknown|Unknown,Yes|Yes|Yes,Yes|Yes|Yes,Unknown|Unknown|Unknown,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,251.0|832.0|1160.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02976,C3N-02976,No,b2,7,129C,CPT0188030003,Tumor,No,70,Female,Endometrioid carcinoma,G3 Poorly differentiated,3,162,71,27,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,Stage I,NA,1.93E-03,CNV_L,No,36.12,MSI-H,MSI-H,941,WT,Mutated,WT,Mutated,WT,6.33E-02,5.21E-02,1.05E-03,2.43E-18,0,7.86E-18,3.93E-18,1.20E-02,0,4.02E-19,0,0,5.70E-02,0,1.82E-02,2.09E-03,2.20E-18,6.16E-18,7.10E-19,3.76E-02,7.72E-03,2.86E-03,3.12E-03,4.92E-03,0,2.38E-17,5.80E-03,0,1.32E-17,1.53E-02,3.00E-02,2.63E-02,1.53E-02,0.147520061,0.179113386,2.46E-19,5.53E-02,1.04E-03,5.63E-02,8.60E-02,0,0.155100744,6.62E-02,0,9.28E-02,2.26E-02,0.12414492,0,0,0,8.89E-02,5.80E-03,0,0.125798131,0.206497607,2.62E-02,0,0,0,0,0,47,136,198,0,0,0,251,0,0,0,0,0.87,NA,NA,-1.406703087,-0.838490699,-2.850650419,0.232913116,-1.143521854,3.05E-02,-2.005926455,-0.301137126,1.390983307,-0.79777691,-2.206948571,-0.939906875,1.65E-02,-1.87197721,1502.789371,3084.663181,4587.452552,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,0,6,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Beto 2K|Fragmin|Dormicum|Fortrans|Kalipoz,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,364|670|1076,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,2|2|2,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,381.0|687.0|1093.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02978,C3N-02978,No,b4,16,131C,CPT0244470003.1,Tumor,No,66,Female,Endometrioid carcinoma,G2 Moderately differentiated,5.5,166,87,31,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,11,Stage I,NA,1.414147276,CNV_L,No,20.85,MSI-H,MSI-H,605,WT,Mutated,WT,Mutated,WT,3.49E-02,0,0,0,0,2.10E-17,1.77E-17,0,0,9.12E-19,1.19E-17,0,2.45E-02,5.44E-18,6.77E-20,2.37E-03,4.02E-18,1.66E-18,0,0,1.51E-02,9.18E-03,5.58E-03,2.14E-03,5.04E-20,1.35E-18,2.34E-03,1.37E-03,6.23E-18,2.99E-04,1.25E-02,1.11E-02,3.16E-17,5.13E-02,0.152476144,0,1.24E-02,3.15E-03,1.55E-02,0,0,4.88E-02,0,0,7.28E-02,0,4.28E-02,7.67E-03,0,0,1.06E-02,0,0.345744699,0,0.172960294,0,5.13E-02,0,0.143478492,4.80E-02,5.59E-02,16,0,244,0,0,0,0,86,0,0,69,0.79,Yes,No,0.110689746,-0.349973682,0.346445396,2.104449186,-0.25644425,-0.358640898,1.011673668,-0.676356199,0.862513819,-1.584755312,1.053743805,-1.272417748,2.435781627,-0.40816562,2505.531431,3522.469272,6028.000703,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,0,0,0,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,None,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record,Siofor|Faxolet ER 75|Ketiplet|Bisocard,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,253|665|1045,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Unknown|Never|Never,Never|Never|Never,No|No|No,Yes|No|No,None|None|None,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,253.0|665.0|1045.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02978-b1,C3N-02978,Yes,b3,12,129C,CPT0244470003,Tumor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02979,C3N-02979,No,b2,6,130C,CPT0188100004,Tumor,No,61,Female,Endometrioid carcinoma,G3 Poorly differentiated,4,158,69,27,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,Stage I,NA,6.52E-04,CNV_L,No,30.64,MSI-H,MSI-H,1066,WT,Mutated,WT,Mutated,Mutated,0.186319434,3.23E-02,1.55E-02,0,0,5.86E-18,0,1.77E-02,6.83E-03,1.24E-02,4.67E-03,1.16E-03,2.49E-02,9.95E-19,5.09E-03,6.92E-03,2.33E-18,0,1.44E-17,1.20E-02,3.13E-02,3.85E-02,1.52E-03,8.79E-03,8.35E-20,0,1.25E-02,9.68E-20,0,2.76E-02,0.132744518,3.13E-02,0,0.193014788,0.327562554,7.38E-18,5.62E-02,3.46E-03,5.96E-02,1.32E-02,0,1.78E-02,0.105063395,0,0.168575072,7.18E-02,5.81E-02,0,0,4.96E-02,3.35E-02,0,4.23E-02,0.136629496,0.27830002,0,0,1.73E-03,0,0,2.32E-02,0,181,403,0,0,0,0,203,0,0,0,0.73,Yes,No,-1.558987383,-1.191964141,8.39E-02,0.199729184,-0.519301301,-1.31E-02,-0.282597715,-2.07108605,1.11361067,-1.13035857,-0.702183912,-0.756419985,7.45E-02,-1.467945044,3885.812031,5133.685775,9019.497805,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,0,0,4,0,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,"CK7 - negative, CK19 - negative, Chromogranine - negative, CD10 - negative, Synaptophizine - negative",NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Noliprol forte|Bisocard|Glucophage|vasilip|Fragmin|Citrafleet,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,393|647|976,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,Yes|Yes|Yes,2|2|2,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,435.0|689.0|1018.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-02994,C3N-02994,No,b3,11,131N,CPT0248000003,Tumor,No,68,Female,Clear cell carcinoma,G3 Poorly differentiated,2.5,162,73,27,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,16,Stage I,NA,1.664379605,CNV_L,No,32.2,MSI-H,MSI-H,1321,Mutated,Mutated,WT,Mutated,Mutated,0.228347918,2.20E-02,5.80E-22,1.63E-18,0,1.59E-18,3.70E-02,1.28E-03,0,0,0,2.19E-03,3.72E-02,0,2.41E-03,1.58E-03,5.91E-20,4.35E-18,0,0,7.37E-02,6.10E-02,2.87E-02,0,6.14E-19,1.21E-02,6.61E-03,0,5.07E-18,8.17E-02,4.64E-02,7.29E-03,1.26E-02,0.151115485,0.10084028,0,7.34E-02,3.15E-03,7.66E-02,1.35E-03,0,5.75E-02,5.95E-02,0,0.108649589,2.04E-02,7.76E-02,0,6.94E-03,0,6.12E-02,7.71E-02,7.83E-02,0.100178654,0.272419956,0,3.05E-02,0,1.69E-02,0,3.13E-02,470,177,0,0,0,0,369,0,0,0,0,0.51,NA,NA,-2.131794543,0.996114937,-2.512408626,1.397748065,2.192912044,0.380419575,0.75742671,0.973177248,0.686184746,-0.674988569,0.54577056,-0.317470907,0.509482109,-1.552645943,3840.106201,5653.733119,9493.839321,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Fundus,NA,Unifocal,IHC staining not done,0,1,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Negative,Negative,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,Yes,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,1,EMA (+),NA,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record,No,NA,NA,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,337|725|980,Yes|Yes|Yes,Yes|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,No|No|No,No|No|No,1|1|1,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,337.0|725.0|980.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-03005,C3N-03005,No,b2,5,129N,CPT0247940003,Tumor,No,>=90,Female,Endometrioid carcinoma,G2 Moderately differentiated,4,155,78,32,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,4,Stage I,NA,7.504663231,CNV_L,No,0,MSS,CNV_L,78,WT,Mutated,WT,WT,WT,0.136934637,6.63E-02,4.89E-03,0,0,3.28E-18,7.46E-02,9.11E-20,5.18E-03,2.82E-02,8.07E-19,3.44E-03,4.69E-02,0,1.15E-02,1.51E-02,0,1.45E-02,0,3.15E-02,2.90E-02,2.12E-02,2.06E-02,5.57E-03,3.12E-04,2.42E-04,0,5.78E-20,0,5.50E-03,1.89E-02,6.08E-02,0,3.47E-02,0.132437016,1.10E-19,7.85E-02,1.70E-02,9.54E-02,0,0,6.39E-02,9.01E-02,0,0.219648814,1.06E-02,4.97E-02,9.97E-03,0,7.07E-02,0,9.79E-03,9.54E-02,1.93E-02,0.208454493,5.24E-02,4.04E-02,0,3.38E-02,0,2.59E-02,21,27,0,0,0,0,26,0,0,0,0,0.31,NA,NA,1.09266565,-0.553515684,0.556683753,0.378119839,1.156744063,-1.497099808,0.488121317,0.740961007,0.606740987,0.377499539,0.47328784,1.241677203,-0.114117071,-0.541184904,5460.544855,5773.711888,11234.25674,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,4 or more,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Bisocard|Hygroton|Polocard,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,450|734|857,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,4 or more|4 or more|4 or more,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,450.0|734.0|n/a,n/a|n/a|Respiratory Disease,n/a|n/a|898.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-03415,C3N-03415,No,b2,7,130N,CPT0247910003,Tumor,No,85,Female,Endometrioid carcinoma,G3 Poorly differentiated,4.8,150,52,23,Present,=50% myometrial invasion,Seventh Edition (2010),pT1b (FIGO IB),pN0,5,Stage I,NA,0.146408992,CNV_L,No,32.41,MSI-H,MSI-H,6659,Mutated,Mutated,Mutated,Mutated,WT,0.209530632,1.80E-02,1.15E-02,0,7.17E-19,1.54E-18,7.86E-20,1.08E-02,5.20E-03,2.23E-02,0,1.85E-03,3.77E-02,0,1.62E-02,2.22E-19,1.43E-18,6.92E-18,0,7.01E-04,3.68E-02,1.76E-02,3.25E-02,5.86E-03,0,1.00E-18,3.88E-03,1.98E-18,0,1.65E-02,7.34E-02,2.24E-02,7.77E-03,0.151379251,0.314025643,0,5.47E-02,3.71E-18,5.47E-02,6.94E-03,0,3.52E-02,0.12580074,0,0.118640627,9.70E-02,5.93E-02,0,2.55E-02,0,6.34E-02,0,0,6.95E-02,0.268245225,1.69E-02,0,0,0.101829592,0,1.16E-02,161,314,0,0,0,0,0,0,1939,2445,1221,0.23,NA,NA,-1.136963415,-1.024358542,-2.286263556,1.218158501,-1.23439774,5.22E-02,-2.15E-02,-0.230024824,1.608784387,-2.005919563,-0.474275759,-0.900573473,1.600195685,-1.523080234,2384.810301,4565.22009,6950.030391,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,3,IHC staining not done,0,0,0,0,cM0,R0:  No residual tumor,Positive : % Not available,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,Unknown,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Enarenal|Sustonit|Signopam,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,411|712|870,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,Tumor Free|Tumor Free|Tumor Free,Never|Never|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,Unknown|Unknown|Unknown,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,411.0|712.0|n/a,n/a|n/a|Respiratory Disease,n/a|n/a|1047.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-03417,C3N-03417,No,b4,13,128C,CPT0247880003,Tumor,No,67,Female,Endometrioid carcinoma,G1 Well differentiated,2.7,165,83,30.49,Present,<50% myometrial invasion,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,Stage I,NA,1.04E-02,CNV_L,No,0.64,MSS,CNV_L,60,WT,Mutated,Mutated,Mutated,Mutated,3.73E-02,5.10E-03,1.87E-03,0,0,1.32E-17,1.41E-18,3.53E-03,4.49E-20,1.78E-02,0,1.77E-18,2.36E-02,0,0,0,0,0,6.46E-18,5.80E-03,1.34E-19,9.26E-19,1.96E-03,0,0,1.41E-17,1.39E-03,0,3.10E-18,1.63E-02,3.06E-02,5.60E-03,0,6.02E-02,0.289266356,2.25E-18,3.40E-03,0,3.40E-03,5.66E-02,0,9.17E-02,0.115563316,0,0.246878938,3.77E-02,7.77E-02,0,0,6.79E-02,0,0,0.112992327,6.16E-02,8.37E-02,1.10E-02,0,0,2.18E-02,1.49E-02,0,22,21,0,14,0,0,0,0,0,0,0,0.77,NA,NA,-0.684400881,0.561581065,-1.102347356,-8.92E-02,0.222665419,0.924786309,-1.105861496,-0.786586684,0.280656974,-0.713629763,-1.262334267,-1.974988541,1.698376833,0.241199831,2608.1265,3031.213167,5639.339667,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Posterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Positive : % Not available,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Loss of expression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Unknown,3,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,Medical Record|Medical Record|Medical Record,Yes,Medical Record|Medical Record|Medical Record,Bisoratio|Protevasc|Acard,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Living,346|710|1103,Yes|Yes|Yes,No|No|No,No|No|No,Tumor Free|Tumor Free|Tumor Free,Unknown|Unknown|Never,Never|Never|Never,Never|Never|Never,Yes|Yes|Yes,No|No|No,3|3|3,No|No|No,Complete Remission|Complete Remission|Complete Remission,Complete Remission|Complete Remission|n/a,n/a|n/a|Complete Remission,No|No|No,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,346.0|710.0|1103.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3N-03767,C3N-03767,No,b2,5,128N,CPT0247970003,Tumor,No,66,Female,Serous carcinoma,G3 Poorly differentiated,13,158,62,24,Present,=50% myometrial invasion,Seventh Edition (2010),pT2 (FIGO II),pN0,13,Stage II,NA,34.44230553,CNV_H,No,1.01,MSS,CNV_H,66,WT,WT,WT,WT,WT,7.67E-02,1.43E-02,0,4.98E-03,3.27E-19,8.11E-04,3.17E-02,5.32E-04,0,7.01E-20,3.05E-19,9.28E-03,0,1.42E-03,0,1.81E-02,0,1.06E-17,0,9.18E-03,2.56E-02,1.12E-02,1.70E-02,1.08E-02,2.18E-18,1.78E-03,5.02E-03,3.23E-19,0,3.02E-02,2.38E-02,9.99E-03,2.03E-18,4.92E-02,0.138446294,8.13E-19,3.50E-02,9.04E-03,4.40E-02,2.81E-02,0,2.94E-02,0.131642052,0,0,0,4.53E-03,0.100298365,9.25E-02,2.59E-02,0,2.34E-03,0.206982853,0,0.242741027,0,8.51E-02,0,1.92E-02,4.46E-03,2.68E-02,20,22,0,0,0,0,0,0,0,21,0,0.45,NA,NA,-1.129793055,1.027499579,-1.768589342,1.244398301,-1.277384025,0.623079578,-0.722419304,-0.979551296,-0.566171478,-0.655647341,-0.817136634,-0.858177651,1.45056114,-1.726708429,2578.671466,3457.536356,6036.207822,Not Examined,Not identified,Margins uninvolved by invasive carcinoma,NA,Caucasian,Poland,Anterior endometrium,NA,Unifocal,IHC staining not done,0,0,IHC staining not done,0,0,IHC staining not done,0,cM0,R0:  No residual tumor,Negative,Negative,Cannot be determined,Cannot be determined,Cannot be determined,Cannot be determined,Overexpression,No,Cannot be determined,No,Postmenopausal: greater than 12 months since LMP with no prior Oophorectomy OR Prior bilateral oophorectomy,Never,2,NA,NA,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,NA,NA,NA,NA,No or minimal exposure to secondhand smoke,NA,No,NA,NA,NA,NA,NA,NA,Yes,1,12 Months|24 Months|36 Months,No|No|No,Living|Living|Deceased,491|721|897,Yes|Yes|Yes,Yes|Yes|Yes,No|No|No,With Tumor|With Tumor|With Tumor,Never|Never|Never,Never|Never|Never,Never|Never|Never,No|No|No,No|No|No,2|2|2,No|No|No,Persistent Disease|Persistent Disease|Persistent Disease,Persistent Disease|Persistent Disease|n/a,n/a|n/a|Persistent Disease,Yes|Yes|Yes,Distant Metastasis|Distant Metastasis|Distant Metastasis,Lung|Lung|Lung,491.0|491.0|491.0,No|No|No,No|No|No,No|Yes|Yes,No|No|No,491.0|721.0|n/a,n/a|n/a|Malignant Neoplasm,n/a|n/a|1002.0,n/a|n/a|n/a,n/a|n/a|n/a,n/a|n/a|n/a
C3L-00935-A,C3L-00935,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8.87E-02,0,0,0,4.75E-18,0,4.89E-18,9.67E-03,1.09E-03,9.58E-03,5.63E-18,0,1.54E-02,4.97E-03,5.81E-03,0.120966395,0,0.504130901,1.83E-02,0.409030325,0,0,9.24E-04,0,0,0,0,0,0,0,0,7.02E-18,1.26E-17,5.67E-03,9.89E-02,0,4.60E-03,0.319778855,0.324382239,8.84E-02,0,3.65E-02,4.72E-02,0,0.148954717,0,4.14E-02,0,5.57E-02,0,5.62E-02,0,9.39E-02,4.29E-02,0.144343921,3.27E-02,0,0.211995968,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.211046408,-1.163818206,0.20088871,-1.271131044,0.656300892,-0.905376669,-0.302948854,-1.066028656,-2.124537065,0.943415918,-0.365934904,0.821306291,-1.985280952,-0.355157133,6048.885334,4277.403784,10326.28912,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-01277-A,C3L-01277,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.26E-02,0,6.68E-19,3.42E-19,9.56E-20,6.75E-03,0,1.71E-02,8.33E-03,2.22E-19,2.12E-18,0,1.43E-02,2.30E-03,6.76E-19,0.210487924,1.36E-19,0.732908677,2.56E-02,0.652074717,0,4.40E-03,2.38E-03,1.20E-02,0,6.41E-18,0,0,7.02E-18,3.13E-02,1.88E-17,3.81E-18,2.09E-20,0,4.40E-02,0,1.36E-02,0.489786717,0.503358739,8.42E-02,0,1.23E-02,1.69E-02,0,0.288982746,0,6.66E-03,0,4.17E-02,0,5.03E-02,0,0,3.53E-03,0.248263085,0,7.70E-03,0.239400582,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.414135341,-1.020306365,-0.16799745,-1.532624523,-1.052620735,-0.863345831,-1.625708517,-1.829445817,-0.793469855,1.527938946,-1.844476202,0.504574412,-0.739065574,-1.986846148,6711.035705,4219.232716,10930.26842,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-01639-A,C3L-01639,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9.51E-02,1.27E-18,2.41E-18,6.70E-03,1.27E-17,2.19E-03,6.43E-03,4.98E-03,6.63E-03,1.34E-02,1.43E-18,0,1.03E-02,9.42E-03,1.04E-02,0.140680315,5.28E-03,0.538364102,1.73E-02,0.445838095,0,0,5.73E-03,3.55E-20,2.21E-18,0,7.79E-19,0,4.61E-18,7.45E-03,0,3.96E-18,6.94E-19,1.03E-03,2.07E-02,2.70E-03,1.49E-02,0.352513988,0.367374104,7.97E-02,0,6.61E-02,5.99E-02,0,0.184571918,0,4.02E-02,0,2.33E-02,0,0.105593768,1.80E-03,5.71E-03,4.35E-02,0.177980921,3.66E-02,0,9.61E-02,6.56E-02,0,1.32E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.253623114,0.326370073,0.903270377,-1.10153486,-0.29478359,-0.297765172,0.587509746,-0.290579393,-2.813528775,1.350366552,0.625322857,1.027936076,-1.373760636,0.452931332,6912.831464,5165.054101,12077.88557,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-01967-A,C3L-01967,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,2.51E-18,0,0,0,0,1.75E-02,0,0,0,1.55E-17,1.89E-02,3.71E-03,0,0.194065816,1.68E-18,0.653919656,5.87E-02,0.727097981,4.03E-18,0,0,0,0,1.06E-17,0,0,0,0,2.49E-17,2.26E-18,5.04E-18,0,3.20E-02,5.93E-19,1.09E-17,0.435238368,0.435238368,2.20E-02,0,3.93E-03,5.64E-02,0,0.235822388,0,2.54E-02,0,6.07E-02,0,5.92E-02,0,0,7.13E-03,0.213152393,0,0,0.316206686,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.498955371,-1.794032951,-0.437990693,-1.550438395,-0.501700787,-1.504175763,-1.683139964,-1.677800851,-2.247384885,1.092535941,-1.739202793,5.31E-02,-0.63537576,-1.414576593,6344.945644,3855.2529,10200.19854,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02121-A,C3L-02121,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.60E-02,0,7.87E-18,0,0,0,1.11E-17,4.01E-03,6.23E-03,1.65E-19,3.88E-18,1.68E-17,3.03E-02,9.22E-03,0,0.198581286,6.29E-18,0.600784169,3.40E-02,0.726487652,9.79E-19,9.63E-04,0,1.08E-03,1.29E-18,0,4.16E-18,3.44E-18,7.52E-18,2.15E-19,1.80E-17,1.06E-18,4.55E-18,1.25E-20,3.59E-02,4.92E-18,4.87E-03,0.410394644,0.415266171,0,0,0,2.19E-02,0,8.17E-02,0,0,0,4.96E-02,0,3.65E-02,4.16E-02,0,0,0.286802129,0,1.11E-02,0.470840163,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.029138117,-2.283354488,0.784495524,-1.626815622,-0.568082443,-2.144657328,-2.230521597,-2.521069728,-0.39842562,1.332206765,-2.33375145,0.33630669,-0.968764978,-2.306827196,6867.623231,4085.415341,10953.03857,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02216-A,C3L-02216,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6.76E-02,0,0,2.40E-18,2.13E-17,0,3.95E-18,1.33E-02,4.72E-03,2.61E-03,0,4.06E-18,1.75E-02,4.72E-03,2.93E-03,9.29E-02,0,0.616006359,1.92E-03,0.564808115,0,3.11E-03,2.45E-03,5.75E-22,0,4.78E-18,2.62E-18,3.15E-04,0,3.26E-02,5.49E-18,7.71E-19,0,0,2.06E-03,1.63E-19,5.31E-03,0.361027326,0.366338058,8.05E-02,0,3.61E-02,4.47E-02,0,0.205984969,0,2.51E-02,0,0,0,6.05E-02,6.16E-02,0,1.50E-02,0.224371107,0,3.29E-03,0.217911571,1.62E-02,0,8.61E-03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.129353198,-0.321850488,0.849211729,-1.218297996,-0.404627678,-0.554390972,0.287246403,-0.523223047,-2.125387181,1.425969954,0.182025103,0.766235421,-1.339316658,0.227294681,7125.299823,4777.841893,11903.14172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02347-A,C3L-02347,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.44E-02,0,5.63E-18,2.35E-18,0,0,0,1.15E-02,4.17E-18,2.35E-19,2.26E-18,0,1.58E-02,6.17E-03,1.44E-19,0.251570738,8.02E-19,0.663621454,2.28E-02,0.841734884,3.27E-19,0,0,2.99E-19,0,0,0,0,2.17E-18,2.84E-19,0,7.88E-18,2.50E-17,0,2.51E-02,0,5.28E-18,0.471753809,0.471753809,0,0,9.32E-03,5.91E-02,0,0.185742456,0,0,0,3.04E-02,0,4.88E-02,1.08E-02,0,1.08E-02,0.30523825,4.07E-02,2.76E-03,0.288122833,0,0,8.40E-03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.248399119,-2.079062633,-0.473255663,-1.453244388,-0.26348033,-1.617547424,-1.419313665,-1.297005685,-2.21004854,1.301062732,-1.502534757,0.530110014,-1.494404074,-1.797755369,6770.680361,4164.60188,10935.28224,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02353-A,C3L-02353,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.39E-03,0,2.11E-21,3.39E-19,0,0,2.41E-17,6.05E-03,6.91E-19,3.70E-03,4.66E-18,0,7.02E-03,4.58E-03,2.03E-19,0.196339531,7.09E-18,0.619811332,2.17E-02,0.613034072,2.35E-19,0,0,8.56E-19,0,0,0,0,0,0,1.38E-17,0,0,0,2.30E-02,2.79E-18,6.05E-18,0.417245935,0.417245935,3.46E-02,0,2.64E-02,8.18E-02,0,0.228455458,0,1.61E-02,0,1.36E-02,0,5.06E-02,5.91E-03,0,5.70E-03,0.200181509,0,1.56E-02,0.321051161,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.271352996,-0.967337914,0.47433009,-1.450767193,0.134565201,-0.845521523,-0.713857878,-0.756074638,-2.413510083,1.286906112,-0.647963762,0.673471594,-0.601734164,-0.514545962,6425.985404,3846.190997,10272.1764,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02408-A,C3L-02408,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.131210134,0,0,0,1.98E-17,0,3.07E-03,1.26E-02,1.73E-02,8.71E-03,9.13E-18,0,1.64E-02,0,1.16E-02,0.133147777,9.13E-03,0.612616439,5.34E-02,0.766076189,1.35E-03,4.38E-03,1.16E-02,5.25E-03,1.07E-17,9.38E-03,0,1.94E-04,1.33E-17,0.110667849,4.24E-17,4.45E-20,0,8.63E-19,8.10E-02,7.44E-19,3.61E-02,0.37711775,0.413245881,2.40E-02,0,5.48E-02,7.51E-02,0,0.175123362,0,7.85E-03,0,5.31E-02,0,2.81E-02,1.62E-02,0,3.42E-03,0.236818568,0,4.88E-02,0.220394789,2.98E-02,0,2.64E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.933239197,0.913199637,1.178173157,-0.830313519,-0.12915265,0.646966436,0.94913735,-0.199865835,-1.088330724,1.888357198,0.62417164,1.730456151,-1.551065165,-0.566461594,7925.918641,6126.937728,14052.85637,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02409-A,C3L-02409,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.27E-02,0,0,0,0,1.71E-17,6.17E-20,0,0,2.90E-18,2.31E-17,7.11E-18,1.52E-03,0,2.66E-03,5.09E-02,5.64E-18,0.322699883,0,0.383590369,9.21E-21,1.38E-02,1.48E-03,0,1.84E-18,0,0,0,5.15E-18,0,0,0,8.37E-18,0,2.57E-02,1.28E-18,1.77E-03,0.187915174,0.189685599,2.49E-02,0,7.29E-02,3.27E-02,0,0.159441905,0,0,0,2.36E-02,0,3.64E-02,0,0.271801413,8.48E-03,0.229752271,0,1.25E-02,0,0.105419365,0,2.21E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.9557728,0.548289566,3.41E-04,1.81E-02,-0.345797202,0.519290737,0.860105774,1.302085624,-0.522851349,1.325185321,0.993419738,1.372261072,-0.905048667,1.058334661,6222.880071,5060.837371,11283.71744,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02412-A,C3L-02412,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.215739227,0,0,0,7.75E-18,2.29E-02,3.15E-02,3.75E-03,0,1.45E-02,0,0,5.11E-03,0,1.83E-02,0.131728147,1.69E-02,0.526818772,2.43E-02,0.75770873,0,8.49E-03,3.65E-03,2.12E-03,1.55E-17,1.34E-02,0,4.06E-03,0,2.04E-02,1.28E-18,0,0,1.20E-17,0,0,3.65E-02,0.332106794,0.368611615,0,0,4.10E-02,6.86E-02,0,0.236196429,0,2.53E-03,0,1.36E-02,0,9.36E-02,1.22E-02,0,6.22E-04,0.261489771,0,5.20E-02,0.136986379,3.84E-02,7.78E-03,3.50E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.391845651,1.699940261,-0.116827,-0.776342791,0.14047024,0.94591908,1.106123198,1.513517672,-0.763164399,2.054977063,1.063772836,2.407469148,-1.577275359,-0.439496296,7712.295621,6740.407053,14452.70267,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02468-A,C3L-02468,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4.40E-02,0,0,1.50E-19,2.01E-19,9.38E-18,0,6.12E-03,6.12E-03,3.20E-19,1.01E-18,1.59E-20,1.22E-02,8.23E-03,7.28E-20,6.92E-02,0,0.641342513,1.25E-02,0.56595538,1.10E-18,4.45E-03,1.46E-03,1.39E-18,0,0,0,0,0,1.09E-02,4.26E-18,0,0,2.44E-02,4.23E-02,5.42E-20,4.08E-03,0.358160588,0.362237931,6.26E-03,0,3.40E-03,6.08E-02,0,0.212626096,0,4.29E-02,0,0,3.38E-02,6.22E-02,2.67E-02,0,6.89E-03,0.208514434,0,8.91E-03,0.327089814,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.140236289,-2.88716034,-0.996508995,-1.369861021,-0.904218543,-2.590928371,-2.028762638,-1.785443699,-1.00904764,1.762117684,-2.0353135,0.610363391,-0.662719021,-1.837209585,6558.709881,3764.485072,10323.19495,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02557-A,C3L-02557,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7.24E-02,0,0,0,4.43E-19,0,0,1.66E-02,5.37E-02,3.97E-02,0,0,2.43E-02,0,5.30E-03,0.103708401,0,0.689665295,9.42E-03,0.501280037,3.24E-03,5.47E-03,1.43E-02,2.43E-03,0,0,0,1.10E-20,0,5.43E-02,1.78E-17,0,0,0,7.89E-02,1.47E-02,4.31E-02,0.405916254,0.449001326,0,0,4.09E-02,8.16E-02,0,0.293708179,0,1.05E-03,0,6.00E-02,0,7.65E-02,0,2.37E-02,1.33E-02,0.184846121,0,3.90E-02,0.178316573,0,0,7.03E-03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.151016253,-0.413968182,-0.54664953,-1.436754293,-0.678421068,-0.359791585,-0.688589313,-1.235313253,-1.042289823,1.841018131,-0.756341535,0.531813177,-1.049237752,-0.438256446,6770.994541,5047.086005,11818.08055,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3L-02602-A,C3L-02602,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.99E-02,0,1.01E-17,0,0,3.78E-18,0,6.85E-03,2.87E-19,4.29E-19,9.01E-18,0,2.69E-02,7.70E-03,1.91E-20,0.168002798,0,0.596503979,2.34E-02,0.658958354,2.17E-18,0,0,3.12E-19,0,2.74E-17,0,1.33E-18,4.09E-18,9.92E-19,0,0,0,7.79E-18,2.69E-02,1.00E-19,2.37E-17,0.39488576,0.39488576,3.08E-02,0,3.81E-03,8.51E-02,0,0.224482124,0,3.42E-03,0,0,0,3.26E-02,1.22E-02,0,9.14E-03,0.218299057,3.49E-04,3.13E-03,0.345976918,0,3.07E-02,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.05E-03,-1.691415127,0.425786212,-1.40327774,-0.337226582,-2.017029214,-1.742841389,-1.238365244,-2.713352836,1.463258594,-1.683314273,0.723022501,-1.340393444,-0.795094283,7044.501377,4183.202184,11227.70356,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-00520-A,C3N-00520,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.25E-02,0,1.82E-20,3.60E-18,8.99E-18,0,9.51E-03,0,0,4.08E-19,7.26E-18,2.38E-18,0,0,3.03E-03,5.37E-03,3.79E-19,0.237411611,2.19E-18,0.197726532,1.12E-19,5.33E-03,3.27E-04,0,2.35E-18,0,8.43E-18,4.82E-19,0,3.53E-03,0,6.48E-03,0,0,2.61E-18,2.95E-03,2.02E-03,0.122308489,0.124328306,2.97E-02,0,0,2.12E-02,0,0.384109239,0,5.95E-02,0,0,0,1.76E-02,4.65E-02,0,3.33E-03,0.207351134,0.108566413,3.42E-02,5.56E-02,3.24E-02,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3.504331272,-0.178460747,-0.242888136,-1.144597295,-1.378702931,-0.104992313,-0.682985158,-0.109862444,-0.900703564,1.569574495,-0.680011241,0.191760782,-1.240880903,1.242117843,5840.467476,3924.20137,9764.668846,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-00859-A,C3N-00859,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.41E-02,2.44E-03,0,5.55E-18,0,2.08E-18,2.28E-02,2.76E-19,3.41E-18,0,9.71E-19,4.00E-03,6.01E-04,1.09E-18,0,0,4.01E-03,1.39E-02,0,1.90E-02,0,1.55E-03,3.72E-04,4.72E-03,6.62E-18,0,2.52E-03,0,8.03E-20,8.13E-03,2.75E-02,3.47E-03,4.18E-18,5.09E-02,5.70E-02,0,7.45E-03,9.41E-03,1.69E-02,0,0,5.48E-02,6.99E-02,0,0.12977877,0,0,3.22E-02,1.28E-03,0,3.68E-02,0,0.185643271,0,0.345265235,0,7.03E-02,0,1.48E-02,3.14E-02,2.78E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.465643345,1.564356068,0.956532568,1.233825599,-0.479072708,0.80443949,-0.785553003,2.230841656,0.570570382,-0.200093478,-0.626182932,-0.287049877,0.97846244,-0.554310802,3038.923669,2644.370039,5683.293707,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-00872-A,C3N-00872,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.177926548,0,0,4.35E-19,0,2.36E-18,4.61E-02,1.59E-02,8.12E-02,7.17E-02,4.59E-03,3.21E-18,1.55E-02,0,1.46E-02,7.39E-02,7.07E-04,0.524513105,3.22E-03,0.437779233,1.83E-02,2.14E-02,2.07E-02,6.91E-03,6.79E-18,1.61E-03,0,1.05E-03,4.56E-19,1.73E-02,8.81E-18,1.46E-03,0,1.82E-17,6.40E-02,0,8.30E-02,0.307491693,0.390445033,2.31E-02,0,5.50E-02,0.149473131,0,0.215750488,0,1.26E-02,0,4.99E-02,0,8.63E-02,0,1.62E-04,4.00E-02,0.207097987,3.59E-04,6.61E-04,1.61E-02,0.132943273,0,1.05E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.377115669,-0.278664379,0.248138947,-0.697537837,0.103318115,-0.869483008,0.51153038,-0.366900549,-1.082567936,1.870398552,0.314260087,1.989293078,-1.233601392,0.555595171,7832.470038,6278.029107,14110.49914,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01344-A,C3N-01344,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.102277861,9.95E-19,0,0,5.65E-19,0,0,0,7.42E-18,0,2.92E-19,7.67E-19,0,2.12E-18,2.19E-20,0,2.71E-18,0,6.62E-19,1.64E-02,3.31E-19,1.11E-02,1.99E-03,0,0,0,1.13E-19,0,5.27E-18,0,2.35E-02,3.71E-03,0,7.21E-02,1.39E-03,1.14E-18,1.15E-17,0,1.15E-17,4.42E-02,0,3.47E-02,1.21E-02,0,0.11682117,0,9.91E-02,0,1.86E-02,0,7.62E-02,0,8.96E-02,4.66E-03,0.200680109,0,0.221806886,2.34E-02,0,0,5.81E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.762226593,0.349684456,-0.396812251,0.137712717,2.940347545,0.233443073,0.117049522,1.38648037,-0.259023813,-0.197161799,0.244119482,-0.30886802,0.267114696,1.068768281,3031.933481,3776.546198,6808.479679,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01525-A,C3N-01525,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.255764541,0,0,1.25E-17,8.83E-18,6.39E-21,3.67E-02,5.06E-03,7.04E-18,7.64E-03,0,2.09E-18,9.16E-03,4.97E-03,9.95E-03,9.82E-02,3.28E-03,0.400281979,9.36E-03,0.622992964,0,1.08E-02,5.67E-03,1.11E-02,1.84E-17,5.31E-02,0,1.02E-02,2.61E-18,2.39E-03,0,0,0,0,0,8.84E-20,5.84E-02,0.262314399,0.320723703,0,0,3.69E-02,0.104719513,0,0.124913255,0,3.22E-02,0,0,0,5.99E-02,0.120359669,0,6.11E-03,0.198008067,0,3.18E-02,0,0.232313931,0,5.28E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.033936923,2.651293378,0.130626246,-0.888300351,0.121750323,1.882601204,1.358664058,2.030387319,0.629703017,1.968475431,1.398238035,1.877116406,-0.67029527,-0.45024582,7407.103417,7035.151955,14442.25537,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01526-A,C3N-01526,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.86E-02,0,0,6.55E-18,1.78E-17,3.39E-02,2.15E-02,1.39E-03,2.48E-18,0,0,0,4.93E-03,1.25E-02,5.72E-04,7.17E-02,0,0.382016661,6.23E-03,0.513474028,0,8.67E-04,3.77E-05,4.35E-03,6.85E-18,0,8.13E-18,0,1.23E-19,2.88E-02,0,0,3.80E-18,1.94E-20,0,0,3.28E-03,0.229137087,0.232417684,1.63E-02,0,6.06E-02,0.100744808,0,0.144147398,0,5.08E-02,0,1.50E-02,0,3.89E-02,7.96E-02,0,1.07E-02,0.174271138,1.76E-02,3.91E-03,0.252950634,3.44E-02,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.198583945,2.092040656,0.754697088,-1.20E-02,-0.595248117,1.231009441,-0.209081688,2.185977047,-0.587437631,1.604530189,-0.158902509,1.487404635,-0.744430111,-0.263525223,6428.034564,4843.35425,11271.38881,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01761-A,C3N-01761,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.88E-02,0,1.14E-17,0,7.45E-19,3.44E-18,2.06E-17,6.86E-03,0,5.95E-19,2.40E-17,1.23E-17,1.56E-02,1.12E-02,0,0.185705141,8.74E-18,0.70847269,2.13E-02,0.762720694,0,0,3.99E-03,0,0,7.45E-18,0,1.41E-19,0,2.77E-03,2.69E-17,6.24E-18,0,0,2.75E-02,0,1.14E-17,0.458361628,0.458361628,4.18E-03,0,2.71E-03,9.25E-02,0,0.163461823,0,3.52E-02,0,0,0,6.84E-02,2.17E-02,0,7.19E-03,0.229998202,0,6.93E-03,0.347617108,0,0,2.02E-02,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.86886259,-1.138641717,0.287104266,-0.870810758,-0.666947676,-0.992998113,-0.937120032,-1.07122901,-1.374719452,1.629555029,-0.990817573,0.911391458,-0.68118662,-1.65385842,6960.593486,4245.227399,11205.82088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01765-A,C3N-01765,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.385709251,6.09E-03,1.56E-02,3.96E-02,3.45E-19,1.13E-17,0.132035182,9.77E-03,0.176715243,0.18409375,8.30E-02,1.09E-20,1.04E-02,1.88E-02,2.46E-02,0.145543369,2.34E-03,0.528764457,3.27E-02,0.747813912,2.22E-02,1.99E-02,2.12E-02,1.58E-02,0,4.84E-02,7.60E-19,0,6.26E-18,1.26E-02,3.22E-02,2.74E-03,1.00E-18,1.24E-17,0.116741345,1.01E-17,0.197389264,0.339351587,0.536740851,2.65E-02,6.61E-03,1.46E-02,0.15082551,0,0.167463768,0,5.28E-02,0,9.98E-02,0,6.23E-03,4.94E-02,0,4.97E-02,0.227961499,4.90E-03,0,0.141955202,0,0,1.41E-03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.455078744,-0.711693628,0.125925848,-1.369280232,1.206095225,-0.823642015,0.17434572,0.839653304,-0.973497197,1.438362627,8.09E-02,3.074014285,-1.798089975,-0.327055551,8322.649314,8591.06139,16913.7107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01830-A,C3N-01830,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.206049786,0,0,6.52E-18,9.26E-18,0,3.82E-02,1.10E-03,1.81E-18,2.80E-02,0,0,6.12E-03,1.32E-02,9.32E-03,9.07E-02,0,0.312759043,7.72E-03,0.532419328,1.98E-04,1.29E-02,5.02E-03,2.36E-03,8.98E-18,7.21E-02,0,2.59E-03,2.05E-17,9.62E-03,8.70E-03,1.32E-18,1.08E-18,3.18E-20,1.88E-03,0,5.77E-02,0.20356628,0.261302494,1.37E-02,0,4.02E-02,7.65E-02,0,0.148369365,0,3.88E-02,0,5.63E-02,0,6.91E-02,0.171119695,0,1.79E-02,0.192388542,0,4.98E-02,0.12316596,0,0,2.64E-03,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.419634611,1.876637456,0.649845366,-0.370041125,0.894831163,1.161911614,0.627432791,2.370514834,0.107487926,1.367786114,0.628101077,1.273370183,-1.308397785,-0.25367492,7151.535829,6874.816632,14026.35246,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01847-A,C3N-01847,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.102885407,0,4.31E-19,0,6.29E-18,9.14E-03,4.00E-02,3.76E-03,0,4.87E-03,0,0,7.63E-03,1.49E-02,6.81E-03,8.98E-02,3.11E-18,0.33842921,1.26E-02,0.562435992,0,4.17E-03,1.68E-03,0,0,2.67E-03,0,4.88E-20,0,0,1.20E-18,0,3.39E-18,2.25E-03,1.05E-03,0,6.32E-03,0.22260115,0.228918247,0,0,5.06E-02,7.79E-02,0,0.231474007,0,1.35E-02,0,1.29E-02,0,3.91E-02,5.89E-02,0,5.99E-03,0.212188281,3.01E-02,3.57E-03,0.263800798,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.285683602,0.724246944,1.154987566,0.23395647,-0.628356107,2.90E-02,-1.317790146,2.580999462,2.71E-02,1.586765752,-1.279775131,1.978789566,-1.242402283,-0.608472878,6624.531234,5123.782744,11748.31398,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01848-A,C3N-01848,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.79E-02,0,0,3.32E-20,1.30E-17,1.16E-19,0,2.18E-02,2.55E-02,1.73E-02,1.47E-02,0,2.17E-02,8.33E-03,1.97E-21,0.18631007,0,0.708512811,1.99E-02,0.661234441,0,0,4.60E-03,9.79E-03,0,3.89E-18,0,2.84E-20,0,2.65E-03,1.13E-17,0,1.58E-17,6.08E-19,5.46E-02,2.48E-19,2.36E-02,0.461013316,0.484574865,1.10E-02,0,7.10E-03,0.185612984,0,8.88E-02,0,2.53E-02,0,9.09E-02,0,6.52E-02,0,0,1.02E-02,0.237784526,0,1.70E-04,0.277873347,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.86365618,-1.952859621,-0.794481774,-1.654868168,-0.407088475,-1.811995396,-2.163529808,-0.966593332,-2.124450354,0.894905781,-2.250886349,0.546515439,-0.794140345,-1.299150993,6683.097273,4739.418878,11422.51615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01875-A,C3N-01875,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.113201071,0,4.20E-18,4.70E-19,0,4.32E-18,1.69E-17,1.88E-02,1.29E-20,1.23E-03,1.23E-17,0,2.07E-02,2.55E-03,0,0.183214677,0,0.711090553,1.47E-02,0.858786829,0,2.02E-19,6.78E-03,3.93E-19,0,1.73E-17,0,0,2.94E-17,2.30E-02,4.73E-18,0,0,0,3.75E-02,0,3.14E-17,0.463558596,0.463558596,6.09E-04,0,1.43E-03,0.130411976,0,0.18997322,0,0,0,9.17E-02,0,5.32E-02,0,0,2.83E-02,0.286766108,2.95E-03,6.83E-03,0.207867461,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.881045234,-1.764750125,-0.960213565,-1.473857394,-0.269530666,-1.616907676,-1.224553639,-1.519633052,-1.106528514,1.67168485,-1.460613681,1.8269094,-0.534452195,-1.734938404,7040.933592,4677.219522,11718.15311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-01876-A,C3N-01876,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4.60E-02,0,5.77E-18,0,0,0,2.24E-17,2.00E-03,0,0,0,0,1.14E-02,7.48E-03,0,0.203828462,7.68E-18,0.744627412,1.92E-03,0.761638386,1.58E-18,0,8.17E-03,8.26E-20,1.95E-18,0,1.33E-17,0,0,2.07E-19,3.02E-17,0,3.07E-17,0,3.01E-02,1.96E-17,6.23E-18,0.483579107,0.483579107,3.99E-03,0,1.49E-03,7.14E-02,0,0.169175108,0,0,0,0,0,3.54E-02,4.04E-02,0,1.75E-02,0.304348025,4.83E-02,0,0.308025277,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-0.90297969,-1.859797623,-1.078962703,-1.424993583,-0.531427809,-1.500026591,-1.234465821,-0.936862133,-1.326872345,2.1629105,-1.013113426,0.763534292,-1.391299068,-0.97876193,7368.245386,4074.900599,11443.14599,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02249-A,C3N-02249,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1.39E-02,0,0,1.37E-18,0,0,5.66E-18,3.93E-03,0,4.36E-19,1.26E-17,0,8.49E-03,1.49E-03,0,0.245939725,0,0.653338677,2.35E-02,0.58301948,1.59E-18,0,1.69E-03,1.83E-18,0,3.39E-17,0,0,0,2.95E-18,1.02E-17,7.83E-18,0,1.24E-18,2.21E-02,3.09E-19,2.49E-17,0.461550321,0.461550321,7.48E-02,0,2.44E-03,3.39E-02,0,0.20711663,0,0,0,4.48E-02,0,8.92E-02,5.42E-03,0,0,0.183739041,0,1.73E-02,0.341239947,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-3.30E-02,-0.713369181,0.827332684,-1.171545177,-0.566017522,-0.554248023,-0.507234302,-1.22575424,-2.048022745,1.602198941,-0.517442781,-0.10510676,-0.907217907,-1.378538017,6705.846898,3992.943045,10698.78994,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02253-A,C3N-02253,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7.76E-03,0,0,7.31E-19,0,1.22E-17,0,6.64E-03,9.94E-18,3.80E-19,2.47E-17,1.70E-17,2.70E-02,1.00E-19,9.56E-20,0.215494628,1.18E-18,0.714824282,3.35E-03,0.813385121,5.30E-18,7.62E-19,1.79E-19,9.05E-18,0,4.48E-17,0,3.75E-19,0,0,0,0,1.05E-17,0,1.87E-02,6.55E-18,4.71E-17,0.477455721,0.477455721,0.111946205,0,1.30E-02,9.60E-02,0,0.171093134,0,2.69E-02,0,0,0,4.75E-02,3.85E-02,0,2.51E-03,0.25069308,0,6.95E-03,0.209816826,0,2.51E-02,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.437915715,-1.367327175,-8.48E-02,-1.390806733,-0.576586175,-0.822444413,-1.62499903,-1.579552741,-1.993526397,1.431854478,-1.623004552,-0.600977951,-1.385853161,-0.922023925,6443.253312,3497.954021,9941.207333,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
C3N-02436-A,C3N-02436,No,NA,NA,NA,NA,Adjacent_normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2.82E-02,0,3.68E-18,7.18E-19,5.58E-19,2.23E-19,7.12E-18,6.03E-19,4.64E-19,1.58E-18,7.00E-18,0,1.39E-02,8.95E-03,1.65E-03,0.12703206,1.84E-18,0.632200887,1.83E-02,0.434250372,0,6.18E-03,1.97E-04,3.96E-19,1.11E-18,2.64E-19,0,0,0,1.47E-02,0,0,0,8.13E-03,5.01E-02,0,1.10E-03,0.38571288,0.386810315,2.31E-02,0,0,1.30E-02,0,0.12179712,0,2.76E-02,0,0,0,5.82E-02,0.11396485,0,0,0.282291703,2.06E-02,2.12E-02,0.318086315,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.368084211,-0.723376975,1.694320365,-1.347477111,-0.770164913,-0.969217066,-1.64874165,-1.324307168,-0.970939319,2.305155839,-1.54215058,-0.14394336,-1.25664674,-1.143129981,7156.937295,4065.450121,11222.38742,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX019,NX019,No,b4,13,128N,CPT0203740002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX020,NX020,No,b2,6,129C,CPT0234180002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX021,NX021,No,b1,1,130N,CPT0234220002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX022,NX022,No,b3,10,129N,CPT0234300004,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX023,NX023,No,b3,11,127C,CPT0230070003,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX024,NX024,No,b1,1,131N,CPT0230290003,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX025,NX025,No,b3,9,131N,CPT0230310002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX026,NX026,No,b2,8,129N,CPT0230370002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX027,NX027,No,b1,3,131C,CPT0188640005,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX028,NX028,No,b3,12,130C,CPT0186260002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX029,NX029,No,b4,14,129C,CPT0231200003,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX030,NX030,No,b2,5,130N,CPT0231200002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX031,NX031,No,b2,7,128N,CPT0292690003,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX032,NX032,No,b1,2,130N,CPT0313410002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX033,NX033,No,b4,15,127C,CPT0313550002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX034,NX034,No,b1,4,129N,CPT0313400002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX035,NX035,No,b1,3,129C,CPT0313420003,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX036,NX036,No,b2,7,129N,CPT0313490002,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX037,NX037,No,b4,16,130C,CPT0313420007,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NX038,NX038,No,b2,6,131C,CPT0313420004,Enriched_Normal,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
